|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
decreases response to substance multiple interactions |
EXP |
ABCB1 protein results in decreased susceptibility to deoxynivalenol deoxynivalenol inhibits the reaction [valspodar inhibits the reaction [ABCB1 protein results in increased export of calcein AM]] |
CTD |
PMID:29174985 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCC3 |
ATP binding cassette subfamily C member 3 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ABCC3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
|
|
G |
ABCF1 |
ATP binding cassette subfamily F member 1 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of ABCF1 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr 6:30,571,442...30,591,522
Ensembl chr 6:30,571,393...30,597,179
|
|
G |
ABI1 |
abl interactor 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of ABI1 protein |
CTD |
PMID:23352502 |
|
NCBI chr10:26,746,596...26,860,958
Ensembl chr10:26,746,593...26,861,087
|
|
G |
ABRAXAS2 |
abraxas 2, BRISC complex subunit |
increases expression |
EXP |
deoxynivalenol results in increased expression of ABRAXAS2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr10:124,801,819...124,836,667
Ensembl chr10:124,801,819...124,836,667
|
|
G |
ACAN |
aggrecan |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ACAN mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:88,803,436...88,875,353
Ensembl chr15:88,803,436...88,875,353
|
|
G |
ACIN1 |
apoptotic chromatin condensation inducer 1 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of ACIN1 protein |
CTD |
PMID:23811945 |
|
NCBI chr14:23,058,564...23,095,614
Ensembl chr14:23,058,564...23,095,614
|
|
G |
ACSL4 |
acyl-CoA synthetase long chain family member 4 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ACSL4 protein |
CTD |
PMID:33890134 |
|
NCBI chr X:109,641,335...109,733,257
Ensembl chr X:109,624,244...109,733,403
|
|
G |
ACTA1 |
actin alpha 1, skeletal muscle |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of ACTA1 protein |
CTD |
PMID:23811945 |
|
NCBI chr 1:229,431,245...229,434,094
Ensembl chr 1:229,430,365...229,434,104
|
|
G |
ACTBL2 |
actin beta like 2 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of ACTBL2 protein |
CTD |
PMID:23352502 |
|
NCBI chr 5:57,480,018...57,482,811
Ensembl chr 5:57,480,018...57,482,811
|
|
G |
ADIRF |
adipogenesis regulatory factor |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ADIRF mRNA |
CTD |
PMID:31863870 |
|
NCBI chr10:86,968,482...86,970,915
Ensembl chr10:86,968,432...86,983,934
|
|
G |
AFG2B |
AFG2 AAA ATPase homolog B |
increases expression |
EXP |
deoxynivalenol results in increased expression of AFG2B mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:45,402,336...45,421,415
Ensembl chr15:45,402,336...45,421,415
|
|
G |
AGFG1 |
ArfGAP with FG repeats 1 |
affects phosphorylation increases expression |
ISO EXP |
deoxynivalenol affects the phosphorylation of AGFG1 protein deoxynivalenol results in increased expression of AGFG1 mRNA |
CTD |
PMID:23811945 PMID:31863870 |
|
NCBI chr 2:227,472,156...227,561,217
Ensembl chr 2:227,472,152...227,561,217
|
|
G |
AHNAK |
AHNAK nucleoprotein |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of AHNAK protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr11:62,433,544...62,546,806
Ensembl chr11:62,433,542...62,556,235
|
|
G |
AHR |
aryl hydrocarbon receptor |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of AHR mRNA; deoxynivalenol results in increased expression of AHR protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of AHR mRNA]]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of AHR protein]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of AHR mRNA]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of AHR protein]]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of AHR mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of AHR protein] |
CTD |
PMID:35381244 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
AJUBA |
ajuba LIM protein |
decreases phosphorylation |
EXP |
deoxynivalenol results in decreased phosphorylation of AJUBA protein |
CTD |
PMID:33890134 |
|
NCBI chr14:22,971,177...22,982,551
Ensembl chr14:22,971,177...22,982,551
|
|
G |
AK7 |
adenylate kinase 7 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of AK7 mRNA |
CTD |
PMID:26763390 |
|
NCBI chr14:96,392,128...96,489,427
Ensembl chr14:96,392,128...96,489,427
|
|
G |
AKAP8L |
A-kinase anchoring protein 8 like |
increases expression |
EXP |
deoxynivalenol results in increased expression of AKAP8L mRNA |
CTD |
PMID:31863870 |
|
NCBI chr19:15,380,050...15,418,988
Ensembl chr19:15,380,050...15,419,141
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation increases phosphorylation |
ISO EXP |
AKT1 protein affects the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; AKT1 protein affects the reaction [deoxynivalenol results in increased phosphorylation of CREB1 protein]; deoxynivalenol results in increased phosphorylation of and results in increased activity of AKT1 protein; Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased phosphorylation of AKT1 protein]; lauric acid inhibits the reaction [deoxynivalenol results in decreased phosphorylation of AKT1 protein] [Zearalenone co-treated with deoxynivalenol] results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:15976193 PMID:16424113 PMID:24937323 PMID:34506767 PMID:35090964 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
ALB |
albumin |
decreases expression increases expression multiple interactions |
ISO EXP |
deoxynivalenol results in decreased expression of ALB protein deoxynivalenol results in decreased expression of ALB mRNA; deoxynivalenol results in decreased expression of ALB protein deoxynivalenol results in increased expression of ALB mRNA [deoxynivalenol co-treated with Zearalenone] affects the expression of ALB mRNA; [deoxynivalenol co-treated with Zearalenone] results in decreased expression of ALB protein; [deoxynivalenol co-treated with Zearalenone] results in increased expression of ALB mRNA |
CTD |
PMID:25445755 PMID:28865950 PMID:28935499 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
ALDH3B1 |
aldehyde dehydrogenase 3 family member B1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ALDH3B1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr11:68,008,547...68,029,276
Ensembl chr11:68,008,578...68,029,282
|
|
G |
ALDOB |
aldolase, fructose-bisphosphate B |
increases expression multiple interactions |
EXP |
deoxynivalenol results in increased expression of ALDOB mRNA [deoxynivalenol co-treated with Zearalenone] affects the expression of ALDOB mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of ALDOB mRNA |
CTD |
PMID:28865950 PMID:28935499 |
|
NCBI chr 9:101,420,560...101,435,774
Ensembl chr 9:101,420,560...101,449,664
|
|
G |
ALKBH1 |
alkB homolog 1, histone H2A dioxygenase |
increases expression |
EXP |
deoxynivalenol results in increased expression of ALKBH1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr14:77,672,404...77,708,023
Ensembl chr14:77,672,404...77,708,023
|
|
G |
ALPI |
alkaline phosphatase, intestinal |
multiple interactions |
EXP |
deoxynivalenol results in decreased expression of and results in decreased activity of ALPI protein |
CTD |
PMID:20362602 |
|
NCBI chr 2:232,456,153...232,460,753
Ensembl chr 2:232,456,125...232,460,753
|
|
G |
ALPK2 |
alpha kinase 2 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ALPK2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr18:58,481,247...58,629,091
Ensembl chr18:58,481,247...58,629,091
|
|
G |
AMIGO2 |
adhesion molecule with Ig like domain 2 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of AMIGO2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr12:47,075,707...47,079,959
Ensembl chr12:47,075,707...47,079,959
|
|
G |
ANGPTL7 |
angiopoietin like 7 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ANGPTL7 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:11,189,355...11,195,981
Ensembl chr 1:11,189,355...11,195,981
|
|
G |
ANKRD13C |
ankyrin repeat domain 13C |
increases expression |
EXP |
deoxynivalenol results in increased expression of ANKRD13C mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:70,258,999...70,354,722
Ensembl chr 1:70,258,999...70,354,734
|
|
G |
ANKRD37 |
ankyrin repeat domain 37 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ANKRD37 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 4:185,396,841...185,400,723
Ensembl chr 4:185,396,021...185,400,628
|
|
G |
ANLN |
anillin, actin binding protein |
increases expression |
EXP |
deoxynivalenol results in increased expression of ANLN mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 7:36,389,862...36,453,791
Ensembl chr 7:36,389,821...36,453,791
|
|
G |
ANPEP |
alanyl aminopeptidase, membrane |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ANPEP mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:89,784,895...89,814,852
Ensembl chr15:89,784,895...89,815,401
|
|
G |
AOC1 |
amine oxidase copper containing 1 |
multiple interactions increases activity |
ISO |
Curcumin inhibits the reaction [deoxynivalenol results in increased activity of AOC1 protein] |
CTD |
PMID:35817260 |
|
NCBI chr 7:150,852,120...150,861,504
Ensembl chr 7:150,824,627...150,861,504
|
|
G |
AR |
androgen receptor |
decreases activity multiple interactions |
EXP |
deoxynivalenol results in decreased activity of AR protein [15-acetyldeoxynivalenol co-treated with 3-acetyldeoxynivalenol co-treated with deoxynivalenol co-treated with zearalenol co-treated with Zearalenone] results in decreased activity of AR protein; [15-acetyldeoxynivalenol co-treated with 3-acetyldeoxynivalenol co-treated with deoxynivalenol] results in decreased activity of AR protein |
CTD |
PMID:27481073 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
ARGLU1 |
arginine and glutamate rich 1 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of ARGLU1 protein |
CTD |
PMID:23811945 |
|
NCBI chr13:106,541,673...106,568,137
Ensembl chr13:106,541,673...106,568,137
|
|
G |
ARHGAP45 |
Rho GTPase activating protein 45 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of ARHGAP45 protein |
CTD |
PMID:23811945 |
|
NCBI chr19:1,065,959...1,086,628
Ensembl chr19:1,065,923...1,086,628
|
|
G |
ARK2N |
arkadia (RNF111) N-terminal like PKA signaling regulator 2N |
increases expression |
EXP |
deoxynivalenol results in increased expression of ARK2N mRNA |
CTD |
PMID:31863870 |
|
NCBI chr18:46,173,553...46,266,992
Ensembl chr18:46,173,553...46,266,992
|
|
G |
ARMC10 |
armadillo repeat containing 10 |
affects phosphorylation increases phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of ARMC10 protein deoxynivalenol results in increased phosphorylation of ARMC10 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr 7:103,075,140...103,099,759
Ensembl chr 7:103,074,881...103,099,759
|
|
G |
ASCC3 |
activating signal cointegrator 1 complex subunit 3 |
increases expression |
EXP |
deoxynivalenol results in increased expression of ASCC3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 6:100,508,194...100,881,329
Ensembl chr 6:100,508,194...100,881,372
|
|
G |
ASCL2 |
achaete-scute family bHLH transcription factor 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of ASCL2 mRNA |
CTD |
PMID:19438726 |
|
NCBI chr11:2,268,498...2,270,588
Ensembl chr11:2,268,498...2,270,588
|
|
G |
ASCL4 |
achaete-scute family bHLH transcription factor 4 |
increases expression |
EXP |
deoxynivalenol results in increased expression of ASCL4 mRNA |
CTD |
PMID:37419272 |
|
NCBI chr12:107,774,704...107,776,644
Ensembl chr12:107,774,704...107,776,644
|
|
G |
ASNS |
asparagine synthetase (glutamine-hydrolyzing) |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ASNS mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
|
|
G |
ATF1 |
activating transcription factor 1 |
multiple interactions increases phosphorylation increases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased phosphorylation of ATF1 protein]; Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased phosphorylation of ATF1 protein]; SB 203580 inhibits the reaction [deoxynivalenol results in increased phosphorylation of ATF1 protein] deoxynivalenol results in increased expression of ATF1 mRNA |
CTD |
PMID:16424113 PMID:22846391 |
|
NCBI chr12:50,763,459...50,821,162
Ensembl chr12:50,763,710...50,821,162
|
|
G |
ATF2 |
activating transcription factor 2 |
increases expression multiple interactions increases phosphorylation affects localization |
EXP ISO |
deoxynivalenol results in increased expression of ATF2 mRNA 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of ATF2 protein] deoxynivalenol affects the localization of ATF2 protein |
CTD |
PMID:12604842 PMID:15772366 PMID:22846391 |
|
NCBI chr 2:175,072,259...175,168,203
Ensembl chr 2:175,072,250...175,168,382
|
|
G |
ATF3 |
activating transcription factor 3 |
multiple interactions decreases expression increases expression increases response to substance decreases degradation |
EXP ISO |
[[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which affects the localization of ELAVL1 protein] which co-treated with deoxynivalenol] promotes the reaction [[ELAVL1 protein binds to ATF3 3' UTR] which results in increased stability of ATF3 mRNA]; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of ATF3 mRNA; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [deoxynivalenol results in increased expression of ATF3 mRNA]; ATF3 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] affects the phosphorylation of RELA protein]; ATF3 protein affects the reaction [deoxynivalenol results in increased expression of EGR1 protein]; EP300 protein affects the reaction [deoxynivalenol results in increased expression of ATF3 protein alternative form]; KAT2A protein affects the reaction [deoxynivalenol results in increased expression of ATF3 protein alternative form]; KAT2B protein affects the reaction [deoxynivalenol results in increased expression of ATF3 protein alternative form]; N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [deoxynivalenol results in decreased degradation of ATF3 protein]; SB 203580 inhibits the reaction [deoxynivalenol results in decreased degradation of ATF3 mRNA]; SB 203580 inhibits the reaction [deoxynivalenol results in decreased degradation of ATF3 protein] deoxynivalenol results in decreased expression of ATF3 mRNA deoxynivalenol results in increased expression of ATF3 mRNA; deoxynivalenol results in increased expression of ATF3 protein; deoxynivalenol results in increased expression of ATF3 protein alternative form ATF3 protein results in increased susceptibility to deoxynivalenol deoxynivalenol results in decreased degradation of ATF3 mRNA; deoxynivalenol results in decreased degradation of ATF3 protein |
CTD |
PMID:19101521 PMID:19360757 PMID:21074547 PMID:22003189 PMID:22846391 PMID:23253260 PMID:30286430 PMID:35314294 More...
|
|
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
|
|
G |
ATF6 |
activating transcription factor 6 |
multiple interactions increases expression |
ISO EXP |
ATF6 protein affects the reaction [deoxynivalenol results in increased expression of IL6 mRNA] deoxynivalenol results in increased expression of ATF6 protein deoxynivalenol results in increased expression of ATF6 mRNA |
CTD |
PMID:19336499 PMID:20682335 PMID:22846391 |
|
NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
|
|
G |
ATG14 |
autophagy related 14 |
increases expression |
EXP |
deoxynivalenol results in increased expression of ATG14 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr14:55,366,391...55,411,830
Ensembl chr14:55,366,391...55,411,830
|
|
G |
ATG4B |
autophagy related 4B cysteine peptidase |
increases expression |
EXP |
deoxynivalenol results in increased expression of ATG4B mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 2:241,637,693...241,673,857
Ensembl chr 2:241,637,213...241,673,857
|
|
G |
ATG5 |
autophagy related 5 |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of ATG5 mRNA; deoxynivalenol results in increased expression of ATG5 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 protein]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 protein]]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 protein] |
CTD |
PMID:35381244 |
|
NCBI chr 6:106,184,476...106,325,760
Ensembl chr 6:106,045,423...106,325,791
|
|
G |
ATP10A |
ATPase phospholipid transporting 10A (putative) |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ATP10A mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:25,672,237...25,865,088
Ensembl chr15:25,677,273...25,865,184
|
|
G |
ATP1A1-AS1 |
ATP1A1 antisense RNA 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ATP1A1OS mRNA |
CTD |
PMID:26763390 |
|
NCBI chr 1:116,392,865...116,418,622
Ensembl chr 1:116,378,437...116,421,301
|
|
G |
ATP5F1C |
ATP synthase F1 subunit gamma |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ATP5F1C protein |
CTD |
PMID:33890134 |
|
NCBI chr10:7,788,177...7,807,801
Ensembl chr10:7,788,147...7,807,815
|
|
G |
ATP5PD |
ATP synthase peripheral stalk subunit d |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ATP5PD protein |
CTD |
PMID:33890134 |
|
NCBI chr17:75,038,863...75,046,969
Ensembl chr17:75,038,863...75,046,985
|
|
G |
ATP6V1A |
ATPase H+ transporting V1 subunit A |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ATP6V1A protein |
CTD |
PMID:33890134 |
|
NCBI chr 3:113,747,035...113,812,056
Ensembl chr 3:113,746,770...113,812,056
|
|
G |
ATP6V1B2 |
ATPase H+ transporting V1 subunit B2 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ATP6V1B2 protein |
CTD |
PMID:33890134 |
|
NCBI chr 8:20,197,381...20,221,696
Ensembl chr 8:20,197,381...20,226,819
|
|
G |
ATP6V1D |
ATPase H+ transporting V1 subunit D |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ATP6V1D protein |
CTD |
PMID:33890134 |
|
NCBI chr14:67,337,872...67,359,804
Ensembl chr14:67,294,371...67,360,265
|
|
G |
ATP6V1G1 |
ATPase H+ transporting V1 subunit G1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ATP6V1G1 protein |
CTD |
PMID:33890134 |
|
NCBI chr 9:114,587,769...114,598,879
Ensembl chr 9:114,587,706...114,598,915
|
|
G |
ATP6V1H |
ATPase H+ transporting V1 subunit H |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ATP6V1H protein |
CTD |
PMID:33890134 |
|
NCBI chr 8:53,715,543...53,843,245
Ensembl chr 8:53,715,543...53,843,558
|
|
G |
ATP8B2 |
ATPase phospholipid transporting 8B2 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ATP8B2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:154,325,525...154,351,304
Ensembl chr 1:154,325,525...154,351,304
|
|
G |
ATRX |
ATRX chromatin remodeler |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of ATRX protein |
CTD |
PMID:23811945 |
|
NCBI chr X:77,504,880...77,786,216
Ensembl chr X:77,504,880...77,786,233
|
|
G |
B3GALT4 |
beta-1,3-galactosyltransferase 4 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of B3GALT4 mRNA |
CTD |
PMID:26763390 |
|
NCBI chr 6:33,277,123...33,278,825
Ensembl chr 6:33,277,123...33,284,832
|
|
G |
BACH2 |
BTB domain and CNC homolog 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of BACH2 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr 6:89,926,528...90,296,843
Ensembl chr 6:89,926,528...90,296,843
|
|
G |
BAD |
BCL2 associated agonist of cell death |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of BAD protein |
CTD |
PMID:15976193 |
|
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
|
|
G |
BAG3 |
BAG cochaperone 3 |
increases expression |
EXP |
deoxynivalenol results in increased expression of BAG3 mRNA |
CTD |
PMID:22846391 |
|
NCBI chr10:119,651,380...119,677,819
Ensembl chr10:119,651,380...119,677,819
|
|
G |
BAK1 |
BCL2 antagonist/killer 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of BAK1 mRNA |
CTD |
PMID:20702593 |
|
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression affects localization decreases expression |
EXP ISO |
[Zearalenone co-treated with deoxynivalenol] results in increased expression of BAX mRNA; [Zearalenone co-treated with deoxynivalenol] results in increased expression of BAX protein; Ascorbic Acid inhibits the reaction [deoxynivalenol results in increased expression of BAX protein] Curcumin inhibits the reaction [deoxynivalenol results in increased expression of BAX mRNA]; Curcumin inhibits the reaction [deoxynivalenol results in increased expression of BAX protein]; deoxynivalenol promotes the reaction [Zearalenone results in increased expression of BAX mRNA] deoxynivalenol results in increased expression of BAX mRNA; deoxynivalenol results in increased expression of BAX protein deoxynivalenol affects the localization of BAX protein deoxynivalenol results in decreased expression of BAX mRNA |
CTD |
PMID:15976193 PMID:17166419 PMID:19410639 PMID:22269384 PMID:25445755 PMID:35090964 PMID:35817260 More...
|
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BBC3 |
BCL2 binding component 3 |
increases expression |
EXP |
deoxynivalenol results in increased expression of BBC3 mRNA |
CTD |
PMID:22846391 |
|
NCBI chr19:47,220,824...47,232,860
Ensembl chr19:47,220,822...47,232,766
|
|
G |
BCL10 |
BCL10 immune signaling adaptor |
increases expression |
EXP |
deoxynivalenol results in increased expression of BCL10 mRNA |
CTD |
PMID:22846391 |
|
NCBI chr 1:85,265,776...85,276,632
Ensembl chr 1:85,265,776...85,276,632
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions decreases expression increases expression |
EXP ISO |
Ascorbic Acid inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein] deoxynivalenol results in decreased expression of BCL2 mRNA; deoxynivalenol results in decreased expression of BCL2 protein Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA]; Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]; deoxynivalenol promotes the reaction [Aflatoxin B1 results in decreased expression of BCL2 mRNA] deoxynivalenol results in increased expression of BCL2 mRNA |
CTD |
PMID:17166419 PMID:22269384 PMID:25445755 PMID:35817260 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of BCL2L1 mRNA |
CTD |
PMID:22846391 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BCL2L13 |
BCL2 like 13 |
increases expression |
EXP |
deoxynivalenol results in increased expression of BCL2L13 mRNA |
CTD |
PMID:22846391 |
|
NCBI chr22:17,628,877...17,730,855
Ensembl chr22:17,628,855...17,730,855
|
|
G |
BCL6 |
BCL6 transcription repressor |
increases expression |
ISO EXP |
deoxynivalenol results in increased expression of BCL6 mRNA |
CTD |
PMID:22968694 PMID:31863870 |
|
NCBI chr 3:187,721,377...187,745,468
Ensembl chr 3:187,721,377...187,745,725
|
|
G |
BCLAF1 |
BCL2 associated transcription factor 1 |
increases expression affects phosphorylation |
EXP ISO |
deoxynivalenol results in increased expression of BCLAF1 mRNA deoxynivalenol affects the phosphorylation of BCLAF1 protein |
CTD |
PMID:22846391 PMID:23352502 PMID:23811945 |
|
NCBI chr 6:136,256,627...136,289,846
Ensembl chr 6:136,256,627...136,289,851
|
|
G |
BECN1 |
beclin 1 |
increases expression multiple interactions |
EXP ISO |
deoxynivalenol results in increased expression of BECN1 mRNA 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of BECN1 mRNA]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of BECN1 mRNA]]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of BECN1 mRNA] |
CTD |
PMID:34677630 PMID:35381244 |
|
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
|
|
G |
BEND7 |
BEN domain containing 7 |
increases expression |
EXP |
deoxynivalenol results in increased expression of BEND7 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr10:13,438,481...13,529,634
Ensembl chr10:13,438,484...13,529,014
|
|
G |
BID |
BH3 interacting domain death agonist |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of BID mRNA |
CTD |
PMID:22269384 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
BIN1 |
bridging integrator 1 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of BIN1 protein |
CTD |
PMID:23352502 |
|
NCBI chr 2:127,048,023...127,107,154
Ensembl chr 2:127,048,027...127,107,288
|
|
G |
BMAL1 |
basic helix-loop-helix ARNT like 1 |
multiple interactions |
ISO |
BMAL1 protein inhibits the reaction [deoxynivalenol results in increased activity of GOT1 protein]; BMAL1 protein inhibits the reaction [deoxynivalenol results in increased activity of GPT protein]; BMAL1 protein inhibits the reaction [deoxynivalenol results in increased expression of IL1B protein]; BMAL1 protein inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein]; BMAL1 protein inhibits the reaction [deoxynivalenol results in increased expression of TNF protein]; BMAL1 protein promotes the reaction [deoxynivalenol results in decreased expression of CLOCK protein]; BMAL1 protein promotes the reaction [deoxynivalenol results in decreased expression of NR1D1 protein]; BMAL1 protein promotes the reaction [deoxynivalenol results in decreased expression of PER2 protein]; BMAL1 protein promotes the reaction [deoxynivalenol results in decreased expression of PER3 protein]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of CLOCK mRNA]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of CRY1 mRNA]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of CRY1 protein]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of CRY2 mRNA]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of CRY2 protein]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of NR1D1 mRNA]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of NR1D2 mRNA]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of PER1 mRNA]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of PER1 protein]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of PER3 mRNA] |
CTD |
PMID:36602574 |
|
NCBI chr11:13,276,652...13,387,266
Ensembl chr11:13,276,652...13,387,266
|
|
G |
BMP2 |
bone morphogenetic protein 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of BMP2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr20:6,767,686...6,780,246
Ensembl chr20:6,767,686...6,780,246
|
|
G |
BNIP1 |
BCL2 interacting protein 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of BNIP1 mRNA |
CTD |
PMID:22846391 |
|
NCBI chr 5:173,144,531...173,164,387
Ensembl chr 5:173,144,442...173,164,387
|
|
G |
BNIP2 |
BCL2 interacting protein 2 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of BNIP2 protein |
CTD |
PMID:23352502 |
|
NCBI chr15:59,659,146...59,689,320
Ensembl chr15:59,659,146...59,689,339
|
|
G |
BPTF |
bromodomain PHD finger transcription factor |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of BPTF protein |
CTD |
PMID:23352502 |
|
NCBI chr17:67,825,503...67,984,378
Ensembl chr17:67,825,503...67,984,378
|
|
G |
BRD3 |
bromodomain containing 3 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of BRD3 protein |
CTD |
PMID:23811945 |
|
NCBI chr 9:134,030,305...134,068,548
Ensembl chr 9:134,030,305...134,068,535
|
|
G |
BST1 |
bone marrow stromal cell antigen 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of BST1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 4:15,703,065...15,774,173
Ensembl chr 4:15,703,065...15,738,313
|
|
G |
BUB1B |
BUB1 mitotic checkpoint serine/threonine kinase B |
increases expression |
EXP |
deoxynivalenol results in increased expression of BUB1B mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:40,161,069...40,221,123
Ensembl chr15:40,161,023...40,221,123
|
|
G |
BUB3 |
BUB3 mitotic checkpoint protein |
increases expression |
EXP |
deoxynivalenol results in increased expression of BUB3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr10:123,154,402...123,170,467
Ensembl chr10:123,154,402...123,170,467
|
|
G |
C3 |
complement C3 |
increases expression |
ISO |
deoxynivalenol results in increased expression of C3 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
|
|
G |
C3AR1 |
complement C3a receptor 1 |
increases expression |
ISO |
deoxynivalenol results in increased expression of C3AR1 mRNA |
CTD |
PMID:12604170 PMID:22968694 |
|
NCBI chr12:8,056,844...8,066,359
Ensembl chr12:8,056,844...8,066,359
|
|
G |
C4B |
complement C4B (Chido/Rodgers blood group) |
increases expression |
ISO |
deoxynivalenol results in increased expression of C4B mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 6:32,014,795...32,035,418
Ensembl chr 6:32,014,795...32,035,418
|
|
G |
CACNA1D |
calcium voltage-gated channel subunit alpha1 D |
increases expression |
EXP |
deoxynivalenol results in increased expression of CACNA1D mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 3:53,494,611...53,813,733
Ensembl chr 3:53,328,963...53,813,733
|
|
G |
CACNG6 |
calcium voltage-gated channel auxiliary subunit gamma 6 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CACNG6 mRNA |
CTD |
PMID:26763390 |
|
NCBI chr19:53,991,149...54,012,666
Ensembl chr19:53,991,637...54,012,666
|
|
G |
CANX |
calnexin |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of CANX protein |
CTD |
PMID:23811945 |
|
NCBI chr 5:179,678,656...179,731,641
Ensembl chr 5:179,678,628...179,731,641
|
|
G |
CARD11 |
caspase recruitment domain family member 11 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of CARD11 protein |
CTD |
PMID:23811945 |
|
NCBI chr 7:2,906,142...3,043,867
Ensembl chr 7:2,906,142...3,044,228
|
|
G |
CASC3 |
CASC3 exon junction complex subunit |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of CASC3 protein |
CTD |
PMID:23811945 |
|
NCBI chr17:40,140,537...40,172,171
Ensembl chr17:40,140,318...40,172,171
|
|
G |
CASP1 |
caspase 1 |
increases expression increases cleavage multiple interactions |
ISO |
deoxynivalenol results in increased expression of CASP1 mRNA deoxynivalenol results in increased cleavage of CASP1 protein deoxynivalenol promotes the reaction [fumonisin B1 results in increased cleavage of CASP1 protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased cleavage of CASP1 protein] |
CTD |
PMID:36309173 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP3 |
caspase 3 |
increases activity multiple interactions increases expression increases cleavage decreases expression |
EXP ISO |
deoxynivalenol results in increased activity of CASP3 protein benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased expression of CASP3 mRNA]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased expression of CASP3 protein] deoxynivalenol results in increased expression of CASP3 mRNA; deoxynivalenol results in increased expression of CASP3 protein deoxynivalenol results in increased cleavage of CASP3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [deoxynivalenol results in increased activity of CASP3 protein]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased activity of CASP3 protein]; acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [deoxynivalenol results in increased expression of and results in increased cleavage of CASP3 protein]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased expression of and results in increased cleavage of CASP3 protein]; Curcumin inhibits the reaction [deoxynivalenol results in increased activity of CASP3 protein]; deoxynivalenol promotes the reaction [Aflatoxin B1 results in increased expression of CASP3 mRNA]; deoxynivalenol results in increased activity of and results in increased cleavage of CASP3 protein; deoxynivalenol results in increased expression of and results in increased cleavage of CASP3 protein; HCK protein affects the reaction [deoxynivalenol results in increased activity of CASP3 protein]; lauric acid inhibits the reaction [deoxynivalenol results in increased cleavage of CASP3 protein]; pifithrin inhibits the reaction [deoxynivalenol results in increased activity of CASP3 protein]; SB 203580 inhibits the reaction [deoxynivalenol results in increased activity of CASP3 protein]; Zearalenone promotes the reaction [deoxynivalenol results in increased expression of CASP3 mRNA] deoxynivalenol results in decreased expression of CASP3 protein [Zearalenone co-treated with Aflatoxin B1] promotes the reaction [deoxynivalenol results in increased expression of CASP3 mRNA]; [Zearalenone co-treated with deoxynivalenol] results in increased expression of CASP3 protein; Aflatoxin B1 promotes the reaction [deoxynivalenol results in increased expression of CASP3 mRNA]; Ascorbic Acid inhibits the reaction [deoxynivalenol results in increased expression of CASP3 protein]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in decreased expression of and results in increased cleavage of CASP3 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in decreased expression of and results in increased cleavage of CASP3 protein]; deoxynivalenol results in decreased expression of and results in increased cleavage of CASP3 protein |
CTD |
PMID:15772366 PMID:15976193 PMID:17166419 PMID:19410639 PMID:19664677 PMID:22269384 PMID:22491426 PMID:25445755 PMID:27757495 PMID:30668976 PMID:34506767 PMID:34673182 PMID:34677630 PMID:35090964 PMID:35314294 PMID:35817260 PMID:35925383 More...
|
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP7 |
caspase 7 |
increases activity |
EXP |
deoxynivalenol results in increased activity of CASP7 protein |
CTD |
PMID:27757495 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP8 |
caspase 8 |
increases expression multiple interactions |
EXP ISO |
deoxynivalenol results in increased expression of CASP8 mRNA benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased expression of CASP8 mRNA] [Aflatoxin B1 co-treated with deoxynivalenol] promotes the reaction [Zearalenone results in increased expression of CASP8 mRNA]; [Aflatoxin B1 co-treated with deoxynivalenol] results in increased expression of CASP8 mRNA; [Zearalenone co-treated with Aflatoxin B1] promotes the reaction [deoxynivalenol results in increased expression of CASP8 mRNA]; [Zearalenone co-treated with deoxynivalenol] promotes the reaction [Aflatoxin B1 results in increased expression of CASP8 mRNA]; Zearalenone promotes the reaction [[Aflatoxin B1 co-treated with deoxynivalenol] results in increased expression of CASP8 mRNA] deoxynivalenol results in increased activity of and results in increased cleavage of CASP8 protein |
CTD |
PMID:22491426 PMID:22846391 PMID:30668976 PMID:34673182 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
decreases expression increases expression multiple interactions increases activity |
EXP ISO |
deoxynivalenol results in decreased expression of CASP9 protein deoxynivalenol results in increased expression of CASP9 mRNA benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased expression of CASP9 mRNA] Zearalenone promotes the reaction [[Aflatoxin B1 co-treated with deoxynivalenol] results in increased expression of CASP9 mRNA] deoxynivalenol results in increased activity of and results in increased cleavage of CASP9 protein deoxynivalenol results in increased expression of CASP9 mRNA; deoxynivalenol results in increased expression of CASP9 protein deoxynivalenol results in increased activity of CASP9 protein |
CTD |
PMID:22269384 PMID:22491426 PMID:30668976 PMID:34673182 PMID:35314294 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CASR |
calcium sensing receptor |
multiple interactions |
ISO |
CASR affects the reaction [deoxynivalenol results in increased secretion of CCK protein] |
CTD |
PMID:25787141 |
|
NCBI chr 3:122,183,668...122,291,629
Ensembl chr 3:122,183,668...122,291,629
|
|
G |
CAT |
catalase |
increases expression multiple interactions decreases expression decreases activity increases activity |
EXP ISO |
deoxynivalenol results in increased expression of CAT mRNA; deoxynivalenol results in increased expression of CAT protein Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of CAT mRNA] deoxynivalenol results in decreased activity of CAT protein deoxynivalenol results in increased activity of CAT protein Lutein inhibits the reaction [deoxynivalenol results in increased expression of CAT protein] |
CTD |
PMID:20347963 PMID:34400200 PMID:34673182 PMID:35314294 PMID:35817260 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CBLL1 |
Cbl proto-oncogene like 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CBLL1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 7:107,744,142...107,761,667
Ensembl chr 7:107,743,073...107,761,667
|
|
G |
CBS |
cystathionine beta-synthase |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CBS mRNA |
CTD |
PMID:31863870 |
|
NCBI chr21:43,053,191...43,076,873
Ensembl chr21:43,053,191...43,076,943
|
|
G |
CBX5 |
chromobox 5 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of CBX5 protein |
CTD |
PMID:23811945 |
|
NCBI chr12:54,230,942...54,280,122
Ensembl chr12:54,230,942...54,280,133
|
|
G |
CCDC112 |
coiled-coil domain containing 112 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CCDC112 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 5:115,267,190...115,296,654
Ensembl chr 5:115,267,190...115,296,693
|
|
G |
CCK |
cholecystokinin |
increases secretion multiple interactions increases expression |
ISO |
deoxynivalenol results in increased secretion of CCK protein 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [deoxynivalenol results in increased secretion of CCK protein]; 2-aminoethyl diphenylborinate inhibits the reaction [deoxynivalenol results in increased secretion of CCK protein]; [N-(2-hydroxy-3-(2-cyano-3-chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamine co-treated with Ruthenium Red] inhibits the reaction [deoxynivalenol results in increased expression of CCK protein]; CASR affects the reaction [deoxynivalenol results in increased secretion of CCK protein]; Egtazic Acid inhibits the reaction [deoxynivalenol results in increased secretion of CCK protein]; N-(2-hydroxy-3-(2-cyano-3-chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamine inhibits the reaction [deoxynivalenol results in increased expression of CCK protein]; Nitrendipine inhibits the reaction [deoxynivalenol results in increased secretion of CCK protein]; Ruthenium Red inhibits the reaction [deoxynivalenol results in increased expression of CCK protein]; triphenylphosphine oxide inhibits the reaction [deoxynivalenol results in increased secretion of CCK protein]; TRPA1 affects the reaction [deoxynivalenol results in increased secretion of CCK protein] |
CTD |
PMID:22903826 PMID:24385417 PMID:25787141 PMID:26979077 |
|
NCBI chr 3:42,257,826...42,266,185
Ensembl chr 3:42,257,825...42,266,185
|
|
G |
CCL1 |
C-C motif chemokine ligand 1 |
increases expression |
ISO |
deoxynivalenol results in increased expression of CCL1 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr17:34,360,328...34,363,233
Ensembl chr17:34,360,328...34,363,233
|
|
G |
CCL11 |
C-C motif chemokine ligand 11 |
increases expression |
ISO |
deoxynivalenol results in increased expression of CCL11 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
|
|
G |
CCL13 |
C-C motif chemokine ligand 13 |
increases expression |
ISO |
deoxynivalenol results in increased expression of CCL12 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr17:34,356,480...34,358,610
Ensembl chr17:34,356,480...34,358,610
|
|
G |
CCL17 |
C-C motif chemokine ligand 17 |
increases expression |
ISO |
deoxynivalenol results in increased expression of CCL17 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr16:57,396,093...57,416,063
Ensembl chr16:57,404,767...57,416,063
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
increases expression multiple interactions |
ISO EXP |
deoxynivalenol results in increased expression of CCL2 mRNA; deoxynivalenol results in increased expression of CCL2 protein Fatty Acids, Omega-3 inhibits the reaction [deoxynivalenol results in increased expression of CCL2 mRNA] |
CTD |
PMID:15371230 PMID:15681167 PMID:17090620 PMID:22846391 PMID:22968694 PMID:24793808 More...
|
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL20 |
C-C motif chemokine ligand 20 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CCL20 mRNA |
CTD |
PMID:27757495 PMID:35314294 |
|
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
|
|
G |
CCL22 |
C-C motif chemokine ligand 22 |
increases expression |
ISO |
deoxynivalenol results in increased expression of CCL22 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189
|
|
G |
CCL24 |
C-C motif chemokine ligand 24 |
increases expression |
ISO |
deoxynivalenol results in increased expression of CCL24 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 7:75,810,825...75,823,372
Ensembl chr 7:75,810,825...75,823,356
|
|
G |
CCL25 |
C-C motif chemokine ligand 25 |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of CCL25 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr19:8,052,341...8,062,650
Ensembl chr19:8,052,318...8,062,660
|
|
G |
CCL3 |
C-C motif chemokine ligand 3 |
increases expression |
EXP ISO |
deoxynivalenol results in increased expression of CCL3 mRNA |
CTD |
PMID:22846391 PMID:22968694 |
|
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
|
|
G |
CCL4 |
C-C motif chemokine ligand 4 |
increases expression |
EXP ISO |
deoxynivalenol results in increased expression of CCL4 mRNA |
CTD |
PMID:21074547 PMID:22846391 PMID:22968694 PMID:27757495 |
|
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
|
|
G |
CCL5 |
C-C motif chemokine ligand 5 |
increases expression multiple interactions |
ISO EXP |
deoxynivalenol results in increased expression of CCL5 mRNA benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased expression of CCL5 mRNA] |
CTD |
PMID:22968694 PMID:27757495 PMID:35925383 |
|
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
multiple interactions increases expression |
ISO |
Fatty Acids, Omega-3 inhibits the reaction [deoxynivalenol results in increased expression of CCL7 mRNA] |
CTD |
PMID:15371230 PMID:15681167 PMID:22968694 PMID:24793808 |
|
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
|
|
G |
CCN1 |
cellular communication network factor 1 |
increases expression |
ISO |
deoxynivalenol results in increased expression of CCN1 mRNA |
CTD |
PMID:15371230 |
|
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
|
|
G |
CCN2 |
cellular communication network factor 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CCN2 mRNA |
CTD |
PMID:35588983 |
|
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
|
|
G |
CCNB1 |
cyclin B1 |
multiple interactions increases expression |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased expression of CCNB1 mRNA] |
CTD |
PMID:34677630 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CCND1 |
cyclin D1 |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of CCND1 mRNA; deoxynivalenol results in increased expression of CCND1 protein Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of CCND1 protein] |
CTD |
PMID:22454431 PMID:24937323 PMID:32416088 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCNE1 |
cyclin E1 |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of CCNE1 mRNA |
CTD |
PMID:27456127 |
|
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
|
|
G |
CCNG2 |
cyclin G2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CCNG2 mRNA |
CTD |
PMID:30169763 |
|
NCBI chr 4:77,157,207...77,170,060
Ensembl chr 4:77,157,207...77,433,388
|
|
G |
CCNY |
cyclin Y |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of CCNY protein |
CTD |
PMID:23811945 |
|
NCBI chr10:35,247,025...35,572,667
Ensembl chr10:35,247,025...35,572,669
|
|
G |
CCR1 |
C-C motif chemokine receptor 1 |
increases expression |
ISO |
deoxynivalenol results in increased expression of CCR1 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
|
|
G |
CCR2 |
C-C motif chemokine receptor 2 |
increases expression |
ISO |
deoxynivalenol results in increased expression of CCR2 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
|
|
G |
CCR3 |
C-C motif chemokine receptor 3 |
increases expression |
ISO |
deoxynivalenol results in increased expression of CCR3 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
|
|
G |
CCR4 |
C-C motif chemokine receptor 4 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CCR4 mRNA |
CTD |
PMID:27757495 |
|
NCBI chr 3:32,951,644...32,956,349
Ensembl chr 3:32,951,644...32,956,349
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
increases expression |
ISO |
deoxynivalenol results in increased expression of CCR7 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,553,769...40,565,472
|
|
G |
CD14 |
CD14 molecule |
multiple interactions |
EXP |
deoxynivalenol inhibits the reaction [IFNG protein results in increased expression of CD14 protein] |
CTD |
PMID:19549553 |
|
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
|
|
G |
CD248 |
CD248 molecule |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CD248 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr11:66,314,494...66,317,044
Ensembl chr11:66,314,494...66,317,044
|
|
G |
CD40 |
CD40 molecule |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of CD40 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
|
|
G |
CD55 |
CD55 molecule (Cromer blood group) |
increases expression |
EXP |
deoxynivalenol results in increased expression of CD55 mRNA |
CTD |
PMID:22846391 PMID:24247028 |
|
NCBI chr 1:207,321,678...207,360,966
Ensembl chr 1:207,321,519...207,386,804
|
|
G |
CD68 |
CD68 molecule |
increases expression |
ISO |
deoxynivalenol results in increased expression of CD68 mRNA |
CTD |
PMID:25549547 |
|
NCBI chr17:7,579,638...7,582,111
Ensembl chr17:7,579,491...7,582,111
|
|
G |
CD69 |
CD69 molecule |
increases expression |
EXP |
deoxynivalenol results in increased expression of CD69 mRNA |
CTD |
PMID:22846391 PMID:24247028 |
|
NCBI chr12:9,752,486...9,760,901
Ensembl chr12:9,752,486...9,760,901
|
|
G |
CD80 |
CD80 molecule |
increases expression |
ISO |
deoxynivalenol results in increased expression of CD80 mRNA |
CTD |
PMID:21074547 |
|
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
|
|
G |
CD86 |
CD86 molecule |
increases expression |
ISO |
deoxynivalenol results in increased expression of CD86 mRNA |
CTD |
PMID:21074547 |
|
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
|
|
G |
CDAN1 |
codanin 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CDAN1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:42,723,544...42,737,128
Ensembl chr15:42,723,544...42,737,128
|
|
G |
CDH13 |
cadherin 13 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CDH13 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr16:82,626,969...83,800,640
Ensembl chr16:82,626,965...83,800,640
|
|
G |
CDK1 |
cyclin dependent kinase 1 |
increases expression multiple interactions |
EXP |
deoxynivalenol results in increased expression of CDK1 mRNA 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased expression of CDK1 mRNA] |
CTD |
PMID:31863870 PMID:34677630 |
|
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression multiple interactions decreases degradation |
EXP ISO |
deoxynivalenol results in increased expression of CDKN1A mRNA; deoxynivalenol results in increased expression of CDKN1A protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased expression of CDKN1A mRNA]; EGR1 protein affects the reaction [deoxynivalenol results in increased expression of CDKN1A protein]; U 0126 inhibits the reaction [deoxynivalenol results in decreased degradation of CDKN1A mRNA] |
CTD |
PMID:18006205 PMID:22454431 PMID:30169763 PMID:30286430 PMID:31863870 PMID:34677630 More...
|
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
|
|
G |
CDKN3 |
cyclin dependent kinase inhibitor 3 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CDKN3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr14:54,397,007...54,420,218
Ensembl chr14:54,396,849...54,420,218
|
|
G |
CEBPA |
CCAAT enhancer binding protein alpha |
decreases expression multiple interactions |
EXP |
deoxynivalenol results in decreased expression of CEBPA mRNA [deoxynivalenol co-treated with Zearalenone] results in decreased expression of CEBPA mRNA |
CTD |
PMID:28865950 PMID:28935499 |
|
NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
|
|
G |
CEBPB |
CCAAT enhancer binding protein beta |
multiple interactions increases activity affects localization |
ISO |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased activity of CEBPB protein] deoxynivalenol affects the localization of CEBPB protein |
CTD |
PMID:12604842 PMID:15772366 |
|
NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,830...50,192,668
|
|
G |
CENPW |
centromere protein W |
increases expression |
EXP |
deoxynivalenol results in increased expression of CENPW mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 6:126,340,115...126,483,320
Ensembl chr 6:126,340,115...126,348,875
|
|
G |
CERCAM |
cerebral endothelial cell adhesion molecule |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CERCAM mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 9:128,419,160...128,437,351
Ensembl chr 9:128,411,751...128,437,351
|
|
G |
CGREF1 |
cell growth regulator with EF-hand domain 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CGREF1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 2:27,099,353...27,119,128
Ensembl chr 2:27,098,889...27,119,128
|
|
G |
CHAC1 |
ChaC glutathione specific gamma-glutamylcyclotransferase 1 |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of CHAC1 mRNA |
CTD |
PMID:23253260 |
|
NCBI chr15:40,953,471...40,956,512
Ensembl chr15:40,952,962...40,956,512
|
|
G |
CHAMP1 |
chromosome alignment maintaining phosphoprotein 1 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of CHAMP1 protein |
CTD |
PMID:23352502 |
|
NCBI chr13:114,314,503...114,327,322
Ensembl chr13:114,314,482...114,337,626
|
|
G |
CHKA |
choline kinase alpha |
increases expression |
EXP |
deoxynivalenol results in increased expression of CHKA mRNA |
CTD |
PMID:31863870 |
|
NCBI chr11:68,052,859...68,121,388
Ensembl chr11:68,052,859...68,121,444
|
|
G |
CHN1 |
chimerin 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CHN1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 2:174,798,809...175,005,381
Ensembl chr 2:174,798,809...175,005,381
|
|
G |
CHORDC1 |
cysteine and histidine rich domain containing 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CHORDC1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr11:90,200,429...90,223,049
Ensembl chr11:90,200,429...90,223,077
|
|
G |
CHUK |
component of inhibitor of nuclear factor kappa B kinase complex |
increases phosphorylation increases expression |
EXP ISO |
deoxynivalenol results in increased phosphorylation of CHUK protein deoxynivalenol results in increased expression of CHUK mRNA |
CTD |
PMID:20633634 PMID:34400200 |
|
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
|
|
G |
CISH |
cytokine inducible SH2 containing protein |
increases expression |
ISO |
deoxynivalenol results in increased expression of CISH mRNA |
CTD |
PMID:19625342 |
|
NCBI chr 3:50,606,489...50,611,774
Ensembl chr 3:50,606,489...50,611,774
|
|
G |
CKAP2 |
cytoskeleton associated protein 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CKAP2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr13:52,455,478...52,476,627
Ensembl chr13:52,455,429...52,476,628
|
|
G |
CKAP5 |
cytoskeleton associated protein 5 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CKAP5 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr11:46,743,048...46,846,280
Ensembl chr11:46,743,048...46,846,308
|
|
G |
CKS1B |
CDC28 protein kinase regulatory subunit 1B |
increases expression |
EXP |
deoxynivalenol results in increased expression of CKS1B mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:154,974,681...154,979,251
Ensembl chr 1:154,974,653...154,979,251
|
|
G |
CLDN1 |
claudin 1 |
increases expression decreases expression multiple interactions affects expression |
EXP ISO |
deoxynivalenol results in increased expression of CLDN1 mRNA deoxynivalenol results in decreased expression of CLDN1 mRNA; deoxynivalenol results in decreased expression of CLDN1 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 mRNA]]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 protein]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 mRNA]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 protein]]; Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of CLDN1 mRNA]; Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of CLDN1 protein]; lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of CLDN1 protein]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of CLDN1 protein] [deoxynivalenol co-treated with Zearalenone] results in decreased expression of CLDN1 mRNA; [deoxynivalenol co-treated with Zearalenone] results in decreased expression of CLDN1 protein; deoxynivalenol results in decreased expression of and affects the localization of CLDN1 protein deoxynivalenol affects the expression of CLDN1 protein |
CTD |
PMID:24568843 PMID:28865950 PMID:28935499 PMID:34506767 PMID:35381244 PMID:35817260 More...
|
|
NCBI chr 3:190,305,707...190,322,446
Ensembl chr 3:190,305,707...190,322,446
|
|
G |
CLDN2 |
claudin 2 |
affects expression increases expression |
ISO |
deoxynivalenol affects the expression of CLDN2 protein deoxynivalenol results in increased expression of CLDN2 mRNA |
CTD |
PMID:24568843 |
|
NCBI chr X:106,900,164...106,930,861
Ensembl chr X:106,900,164...106,930,861
|
|
G |
CLDN3 |
claudin 3 |
multiple interactions increases expression affects expression |
EXP ISO |
deoxynivalenol results in decreased expression of and affects the localization of CLDN3 protein [deoxynivalenol results in increased susceptibility to Antigens] which results in decreased expression of CLDN3 mRNA deoxynivalenol results in increased expression of CLDN3 mRNA deoxynivalenol affects the expression of CLDN3 protein |
CTD |
PMID:24568843 PMID:28935500 |
|
NCBI chr 7:73,768,997...73,770,270
Ensembl chr 7:73,768,997...73,770,270
|
|
G |
CLDN4 |
claudin 4 |
decreases expression increases expression multiple interactions |
EXP ISO |
deoxynivalenol results in decreased expression of CLDN4 protein deoxynivalenol results in increased expression of CLDN4 mRNA deoxynivalenol results in decreased expression of and affects the localization of CLDN4 protein |
CTD |
PMID:19289138 PMID:20362602 PMID:24568843 |
|
NCBI chr 7:73,830,996...73,832,690
Ensembl chr 7:73,799,542...73,832,690
|
|
G |
CLIC3 |
chloride intracellular channel 3 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CLIC3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 9:136,994,608...136,996,568
Ensembl chr 9:136,994,608...136,996,568
|
|
G |
CLOCK |
clock circadian regulator |
decreases expression multiple interactions |
ISO |
deoxynivalenol results in decreased expression of CLOCK protein BMAL1 protein promotes the reaction [deoxynivalenol results in decreased expression of CLOCK protein]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of CLOCK mRNA] |
CTD |
PMID:36602574 |
|
NCBI chr 4:55,427,903...55,546,909
Ensembl chr 4:55,427,903...55,546,909
|
|
G |
CNPY2 |
canopy FGF signaling regulator 2 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CNPY2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr12:56,309,844...56,316,346
Ensembl chr12:56,309,842...56,316,119
|
|
G |
COL15A1 |
collagen type XV alpha 1 chain |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of COL15A1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 9:98,943,907...99,070,787
Ensembl chr 9:98,943,179...99,070,787
|
|
G |
COL4A1 |
collagen type IV alpha 1 chain |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of COL4A1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr13:110,148,963...110,307,157
Ensembl chr13:110,148,963...110,307,202
|
|
G |
COL5A1 |
collagen type V alpha 1 chain |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of COL5A1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 9:134,641,803...134,844,843
Ensembl chr 9:134,641,803...134,844,843
|
|
G |
COL6A2 |
collagen type VI alpha 2 chain |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of COL6A2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr21:46,098,112...46,132,848
Ensembl chr21:46,098,112...46,132,848
|
|
G |
COMT |
catechol-O-methyltransferase |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of COMT protein |
CTD |
PMID:23811945 |
|
NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
|
|
G |
CORO1A |
coronin 1A |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of CORO1A protein |
CTD |
PMID:23811945 |
|
NCBI chr16:30,183,602...30,189,076
Ensembl chr16:30,182,827...30,189,076
|
|
G |
CORO2B |
coronin 2B |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CORO2B mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:68,518,373...68,727,806
Ensembl chr15:68,578,993...68,727,806
|
|
G |
COX5B |
cytochrome c oxidase subunit 5B |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of COX5B protein |
CTD |
PMID:33890134 |
|
NCBI chr 2:97,646,062...97,648,383
Ensembl chr 2:97,646,062...97,648,383
|
|
G |
CPSF2 |
cleavage and polyadenylation specific factor 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CPSF2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr14:92,121,969...92,172,145
Ensembl chr14:92,121,969...92,172,145
|
|
G |
CREB1 |
cAMP responsive element binding protein 1 |
multiple interactions increases phosphorylation increases activity affects localization |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased phosphorylation of CREB1 protein]; AKT1 protein affects the reaction [deoxynivalenol results in increased phosphorylation of CREB1 protein]; Celecoxib inhibits the reaction [deoxynivalenol results in increased phosphorylation of CREB1 protein]; deoxynivalenol promotes the reaction [CREB1 protein modified form binds to IL6 promoter]; Docosahexaenoic Acids inhibits the reaction [deoxynivalenol promotes the reaction [CREB1 protein modified form binds to IL6 promoter]]; Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased activity of CREB1 protein]; Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased phosphorylation of CREB1 protein]; SB 203580 inhibits the reaction [deoxynivalenol results in increased phosphorylation of CREB1 protein] deoxynivalenol affects the localization of CREB1 protein |
CTD |
PMID:12604842 PMID:16424113 PMID:32416088 |
|
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
|
|
G |
CREB5 |
cAMP responsive element binding protein 5 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CREB5 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 7:28,299,321...28,825,894
Ensembl chr 7:28,299,321...28,825,894
|
|
G |
CREBBP |
CREB binding protein |
increases expression |
EXP |
deoxynivalenol results in increased expression of CREBBP mRNA |
CTD |
PMID:24247028 |
|
NCBI chr16:3,725,054...3,880,713
Ensembl chr16:3,725,054...3,880,713
|
|
G |
CRELD1 |
cysteine rich with EGF like domains 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CRELD1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 3:9,933,834...9,945,406
Ensembl chr 3:9,933,793...9,945,413
|
|
G |
CRP |
C-reactive protein |
increases expression |
ISO |
deoxynivalenol results in increased expression of CRP mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
CRY1 |
cryptochrome circadian regulator 1 |
multiple interactions |
ISO |
deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of CRY1 mRNA]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of CRY1 protein] |
CTD |
PMID:36602574 |
|
NCBI chr12:106,991,364...107,093,549
Ensembl chr12:106,991,364...107,093,549
|
|
G |
CRY2 |
cryptochrome circadian regulator 2 |
multiple interactions |
ISO |
deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of CRY2 mRNA]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of CRY2 protein] |
CTD |
PMID:36602574 |
|
NCBI chr11:45,847,118...45,883,244
Ensembl chr11:45,847,118...45,883,248
|
|
G |
CSF3 |
colony stimulating factor 3 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CSF3 mRNA |
CTD |
PMID:27757495 |
|
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
|
|
G |
CTHRC1 |
collagen triple helix repeat containing 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CTHRC1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 8:103,371,538...103,382,989
Ensembl chr 8:103,371,538...103,382,989
|
|
G |
CTNNA1 |
catenin alpha 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CTNNA1 protein |
CTD |
PMID:33890134 |
|
NCBI chr 5:138,753,425...138,935,034
Ensembl chr 5:138,610,967...138,935,034
|
|
G |
CTNNB1 |
catenin beta 1 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of CTNNB1 protein |
CTD |
PMID:23811945 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CTSO |
cathepsin O |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CTSO mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 4:155,924,118...155,953,866
Ensembl chr 4:155,921,580...155,953,912
|
|
G |
CWF19L2 |
CWF19 like cell cycle control factor 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CWF19L2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr11:107,326,360...107,457,825
Ensembl chr11:107,326,360...107,457,825
|
|
G |
CX3CL1 |
C-X3-C motif chemokine ligand 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CX3CL1 mRNA |
CTD |
PMID:22846391 |
|
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
multiple interactions increases expression |
EXP ISO |
[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL1 mRNA; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [deoxynivalenol results in increased expression of CXCL1 mRNA]; ELAVL1 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL1 mRNA] deoxynivalenol results in increased expression of CXCL1 mRNA; deoxynivalenol results in increased expression of CXCL3 mRNA |
CTD |
PMID:15371230 PMID:15681167 PMID:22003189 PMID:22968694 PMID:27757495 |
|
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
decreases expression increases expression |
ISO |
deoxynivalenol results in decreased expression of CXCL10 mRNA deoxynivalenol results in increased expression of CXCL10 mRNA; deoxynivalenol results in increased expression of CXCL10 protein |
CTD |
PMID:15371230 PMID:22968694 PMID:34400200 |
|
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL11 |
C-X-C motif chemokine ligand 11 |
decreases expression increases expression |
ISO EXP |
deoxynivalenol results in decreased expression of CXCL11 mRNA deoxynivalenol results in increased expression of CXCL11 mRNA |
CTD |
PMID:22968694 PMID:27757495 |
|
NCBI chr 4:76,033,682...76,036,070
Ensembl chr 4:76,033,682...76,041,415
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
increases expression multiple interactions |
ISO EXP |
deoxynivalenol results in increased expression of CXCL2 mRNA; deoxynivalenol results in increased expression of CXCL2 protein deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of CXCL2 mRNA]; Fatty Acids, Omega-3 inhibits the reaction [deoxynivalenol results in increased expression of CXCL2 mRNA] |
CTD |
PMID:12604170 PMID:15371230 PMID:15681167 PMID:22968694 PMID:24793808 PMID:27757495 More...
|
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL5 |
C-X-C motif chemokine ligand 5 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CXCL5 mRNA |
CTD |
PMID:27757495 |
|
NCBI chr 4:73,995,642...73,998,677
Ensembl chr 4:73,995,642...73,998,677
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
decreases degradation multiple interactions increases secretion increases expression |
EXP |
deoxynivalenol results in decreased degradation of CXCL8 mRNA 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [deoxynivalenol results in decreased degradation of CXCL8 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased secretion of CXCL8 protein]; 2-Aminopurine inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA]; 2-Aminopurine inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 protein]; 2-chloro-5-nitrobenzanilide promotes the reaction [deoxynivalenol results in decreased degradation of CXCL8 mRNA]; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL8 mRNA; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA]; [deoxynivalenol results in increased expression of ELAVL1 protein] which results in decreased degradation of CXCL8 mRNA; [deoxynivalenol results in increased phosphorylation of MAPK1 protein] which results in increased expression of CXCL8 protein; [deoxynivalenol results in increased phosphorylation of MAPK3 protein] which results in increased expression of CXCL8 protein; Adenine inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 protein]; AG 1879 inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 protein]; cereulide inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA]; cereulide inhibits the reaction [deoxynivalenol results in increased secretion of CXCL8 protein]; Cycloheximide inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 protein]; Dactinomycin inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 protein]; deoxynivalenol inhibits the reaction [IL1B protein results in increased expression of CXCL8 protein]; deoxynivalenol inhibits the reaction [NFKB2 protein binds to CXCL8 promoter]; deoxynivalenol promotes the reaction [RELA protein binds to CXCL8 promoter]; EIF2AK2 protein affects the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA]; ELAVL1 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL8 mRNA]; ELAVL1 protein affects the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA]; ELAVL1 protein affects the reaction [deoxynivalenol results in increased expression of CXCL8 protein]; GW 506033X inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA]; GW 506033X inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 protein]; lipopolysaccharide, E coli O55-B5 inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA]; lipopolysaccharide, E coli O55-B5 inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 protein]; PPARG protein affects the reaction [deoxynivalenol results in decreased degradation of CXCL8 mRNA]; prolinedithiocarbamate inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 protein]; RELA protein promotes the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA]; SB 203580 inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA]; SB 203580 inhibits the reaction [deoxynivalenol results in increased expression of CXCL8 protein]; SB 203580 inhibits the reaction [deoxynivalenol results in increased secretion of CXCL8 protein]; triptolide inhibits the reaction [deoxynivalenol results in increased secretion of CXCL8 protein] deoxynivalenol results in increased secretion of CXCL8 mRNA; deoxynivalenol results in increased secretion of CXCL8 protein [deoxynivalenol results in increased expression of EGR1 protein] which results in increased expression of CXCL8 protein; deoxynivalenol results in increased expression of CXCL8 mRNA; deoxynivalenol results in increased expression of CXCL8 protein |
CTD |
PMID:16364386 PMID:17166736 PMID:17636245 PMID:17707346 PMID:18308354 PMID:18485432 PMID:18599499 PMID:19591856 PMID:20181660 PMID:20633634 PMID:22003189 PMID:23792671 PMID:27757495 PMID:32065293 PMID:33170220 PMID:35314294 PMID:37315771 More...
|
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CXCL9 |
C-X-C motif chemokine ligand 9 |
increases expression |
ISO |
deoxynivalenol results in increased expression of CXCL9 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
|
|
G |
CXCR1 |
C-X-C motif chemokine receptor 1 |
increases expression |
ISO |
deoxynivalenol results in increased expression of CXCR1 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 2:218,162,841...218,166,962
Ensembl chr 2:218,162,841...218,166,962
|
|
G |
CXCR2 |
C-X-C motif chemokine receptor 2 |
increases expression |
ISO |
deoxynivalenol results in increased expression of CXCR2 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251
|
|
G |
CXCR4 |
C-X-C motif chemokine receptor 4 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CXCR4 mRNA |
CTD |
PMID:22846391 PMID:27757495 |
|
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
|
|
G |
CYC1 |
cytochrome c1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CYC1 protein |
CTD |
PMID:33890134 |
|
NCBI chr 8:144,095,076...144,097,525
Ensembl chr 8:144,095,039...144,097,525
|
|
G |
CYCS |
cytochrome c, somatic |
affects localization increases expression decreases expression increases activity |
ISO EXP |
deoxynivalenol affects the localization of CYCS protein deoxynivalenol results in increased expression of CYCS mRNA; deoxynivalenol results in increased expression of CYCS protein deoxynivalenol results in decreased expression of CYCS protein deoxynivalenol results in increased activity of CYCS protein |
CTD |
PMID:15976193 PMID:22269384 PMID:22846391 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYP11B1 |
cytochrome P450 family 11 subfamily B member 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CYP11B1 mRNA |
CTD |
PMID:22982764 |
|
NCBI chr 8:142,872,357...142,879,825
Ensembl chr 8:142,872,356...142,879,846
|
|
G |
CYP11B2 |
cytochrome P450 family 11 subfamily B member 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CYP11B2 mRNA |
CTD |
PMID:22982764 |
|
NCBI chr 8:142,910,559...142,917,843
Ensembl chr 8:142,910,559...142,917,843
|
|
G |
CYP17A1 |
cytochrome P450 family 17 subfamily A member 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CYP17A1 mRNA |
CTD |
PMID:22982764 |
|
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
|
|
G |
CYP19A1 |
cytochrome P450 family 19 subfamily A member 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CYP19A1 mRNA |
CTD |
PMID:22982764 |
|
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
increases expression multiple interactions |
EXP ISO |
deoxynivalenol results in increased expression of CYP1A1 mRNA 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of CYP1A1 mRNA]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of CYP1A1 mRNA]]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:22982764 PMID:35381244 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CYP1B1 mRNA |
CTD |
PMID:20702593 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP21A2 |
cytochrome P450 family 21 subfamily A member 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of CYP21A2 mRNA |
CTD |
PMID:22982764 |
|
NCBI chr 6:32,038,415...32,041,644
Ensembl chr 6:32,038,327...32,041,644
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
affects expression multiple interactions |
EXP |
deoxynivalenol affects the expression of CYP3A4 mRNA [deoxynivalenol co-treated with Zearalenone] affects the expression of CYP3A4 mRNA; [deoxynivalenol co-treated with Zearalenone] results in decreased expression of CYP3A4 protein; [deoxynivalenol co-treated with Zearalenone] results in increased expression of CYP3A4 mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of CYP3A4 protein |
CTD |
PMID:28865950 PMID:28935499 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
CYP4F3 |
cytochrome P450 family 4 subfamily F member 3 |
multiple interactions |
EXP |
[deoxynivalenol co-treated with Zearalenone] results in decreased expression of CYP4F3 mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of CYP4F3 mRNA |
CTD |
PMID:28865950 PMID:28935499 |
|
NCBI chr19:15,640,897...15,662,825
Ensembl chr19:15,640,897...15,662,825
|
|
G |
CYTL1 |
cytokine like 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of CYTL1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 4:5,014,586...5,019,458
Ensembl chr 4:5,014,586...5,019,458
|
|
G |
DDB2 |
damage specific DNA binding protein 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of DDB2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr11:47,214,454...47,239,217
Ensembl chr11:47,214,465...47,239,217
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
increases expression decreases expression |
EXP ISO |
deoxynivalenol results in increased expression of DDIT3 mRNA deoxynivalenol results in decreased expression of DDIT3 mRNA |
CTD |
PMID:22846391 PMID:23253260 PMID:30169763 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DDIT4 |
DNA damage inducible transcript 4 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of DDIT4 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
|
|
G |
DDX21 |
DExD-box helicase 21 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of DDX21 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr10:68,956,170...68,985,068
Ensembl chr10:68,956,135...68,985,068
|
|
G |
DDX39A |
DExD-box helicase 39A |
increases expression |
EXP |
deoxynivalenol results in increased expression of DDX39A mRNA |
CTD |
PMID:31863870 |
|
NCBI chr19:14,408,798...14,419,383
Ensembl chr19:14,408,798...14,419,383
|
|
G |
DDX52 |
DExD-box helicase 52 |
increases expression |
EXP |
deoxynivalenol results in increased expression of DDX52 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr17:37,609,739...37,643,446
Ensembl chr17:37,609,739...37,643,446
|
|
G |
DEPTOR |
DEP domain containing MTOR interacting protein |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of DEPTOR mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 8:119,873,722...120,050,918
Ensembl chr 8:119,873,717...120,050,918
|
|
G |
DFFA |
DNA fragmentation factor subunit alpha |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of DFFA protein |
CTD |
PMID:23811945 |
|
NCBI chr 1:10,456,522...10,472,529
Ensembl chr 1:10,456,522...10,472,529
|
|
G |
DKC1 |
dyskerin pseudouridine synthase 1 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of DKC1 protein |
CTD |
PMID:23811945 |
|
NCBI chr X:154,762,864...154,777,689
Ensembl chr X:154,762,742...154,777,689
|
|
G |
DNAH10 |
dynein axonemal heavy chain 10 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of DNAH10 protein |
CTD |
PMID:23811945 |
|
NCBI chr12:123,762,301...123,935,720
Ensembl chr12:123,762,188...123,935,720
|
|
G |
DNAJA1 |
DnaJ heat shock protein family (Hsp40) member A1 |
increases expression decreases expression |
ISO EXP |
deoxynivalenol results in increased expression of DNAJA1 mRNA deoxynivalenol results in decreased expression of DNAJA1 protein |
CTD |
PMID:15371230 PMID:33890134 |
|
NCBI chr 9:33,025,273...33,039,907
Ensembl chr 9:33,025,273...33,039,907
|
|
G |
DNAJC1 |
DnaJ heat shock protein family (Hsp40) member C1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of DNAJC1 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr10:21,756,548...22,003,730
Ensembl chr10:21,756,548...22,003,769
|
|
G |
DNAJC3 |
DnaJ heat shock protein family (Hsp40) member C3 |
multiple interactions decreases expression |
ISO |
deoxynivalenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of DNAJC3 mRNA] deoxynivalenol results in decreased expression of DNAJC3 mRNA |
CTD |
PMID:10652249 |
|
NCBI chr13:95,677,139...95,794,988
Ensembl chr13:95,677,139...95,794,988
|
|
G |
DNAJC5 |
DnaJ heat shock protein family (Hsp40) member C5 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of DNAJC5 protein |
CTD |
PMID:23352502 |
|
NCBI chr20:63,895,126...63,936,011
Ensembl chr20:63,895,126...63,936,031
|
|
G |
DNMT1 |
DNA methyltransferase 1 |
affects phosphorylation increases expression |
ISO |
deoxynivalenol affects the phosphorylation of DNMT1 protein deoxynivalenol results in increased expression of DNMT1 mRNA; deoxynivalenol results in increased expression of DNMT1 protein |
CTD |
PMID:23352502 PMID:23811945 PMID:32738333 |
|
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
|
|
G |
DNMT3A |
DNA methyltransferase 3 alpha |
increases expression |
ISO |
deoxynivalenol results in increased expression of DNMT3A mRNA; deoxynivalenol results in increased expression of DNMT3A protein |
CTD |
PMID:32738333 |
|
NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590
|
|
G |
DNTTIP2 |
deoxynucleotidyltransferase terminal interacting protein 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of DNTTIP2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:93,866,284...93,879,206
Ensembl chr 1:93,866,284...93,879,918
|
|
G |
DSC1 |
desmocollin 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of DSC1 protein |
CTD |
PMID:33890134 |
|
NCBI chr18:31,129,236...31,162,856
Ensembl chr18:31,129,236...31,162,856
|
|
G |
DUSP1 |
dual specificity phosphatase 1 |
increases expression multiple interactions |
EXP ISO |
deoxynivalenol results in increased expression of DUSP1 mRNA; deoxynivalenol results in increased expression of DUSP1 protein Fatty Acids, Omega-3 promotes the reaction [deoxynivalenol results in increased expression of DUSP1 mRNA] [deoxynivalenol results in increased expression of DUSP1 protein] which results in decreased activity of MAPK8 protein; [deoxynivalenol results in increased expression of DUSP1 protein] which results in decreased activity of MAPK9 protein |
CTD |
PMID:15371230 PMID:15681167 PMID:20708668 |
|
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
|
|
G |
DUSP6 |
dual specificity phosphatase 6 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of DUSP6 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
|
|
G |
DUSP8 |
dual specificity phosphatase 8 |
increases expression |
EXP |
deoxynivalenol results in increased expression of DUSP8 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr11:1,554,051...1,572,848
Ensembl chr11:1,554,051...1,572,271
|
|
G |
DYNC1LI1 |
dynein cytoplasmic 1 light intermediate chain 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of DYNC1LI1 protein |
CTD |
PMID:23352502 |
|
NCBI chr 3:32,525,974...32,570,858
Ensembl chr 3:32,525,974...32,570,858
|
|
G |
ECM1 |
extracellular matrix protein 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ECM1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:150,508,109...150,513,789
Ensembl chr 1:150,508,062...150,513,789
|
|
G |
ECT2 |
epithelial cell transforming 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of ECT2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 3:172,750,726...172,829,265
Ensembl chr 3:172,750,682...172,821,474
|
|
G |
EEF1B2 |
eukaryotic translation elongation factor 1 beta 2 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of EEF1B2 protein |
CTD |
PMID:23352502 |
|
NCBI chr 2:206,159,609...206,162,928
Ensembl chr 2:206,159,585...206,162,928
|
|
G |
EEF1D |
eukaryotic translation elongation factor 1 delta |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of EEF1D protein |
CTD |
PMID:23811945 |
|
NCBI chr 8:143,579,728...143,597,415
Ensembl chr 8:143,579,697...143,599,541
|
|
G |
EGF |
epidermal growth factor |
increases expression |
EXP |
deoxynivalenol results in increased expression of EGF mRNA |
CTD |
PMID:27757495 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of EGFR protein |
CTD |
PMID:33890134 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EGR1 |
early growth response 1 |
increases expression multiple interactions |
EXP |
[deoxynivalenol results in increased expression of EGR1 protein] which results in increased expression of CXCL8 protein; deoxynivalenol results in increased expression of EGR1 mRNA; deoxynivalenol results in increased expression of EGR1 protein ATF3 protein affects the reaction [deoxynivalenol results in increased expression of EGR1 protein]; deoxynivalenol results in increased expression of and results in increased phosphorylation of EGR1 protein; EGR1 protein affects the reaction [deoxynivalenol results in increased expression of CDKN1A protein]; EGR1 protein promotes the reaction [deoxynivalenol results in increased expression of PPARG mRNA] |
CTD |
PMID:17707346 PMID:18485432 PMID:19360757 PMID:30286430 PMID:33890134 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
EID2 |
EP300 interacting inhibitor of differentiation 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of EID2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr19:39,538,707...39,540,161
Ensembl chr19:39,538,707...39,540,161
|
|
G |
EIF2A |
eukaryotic translation initiation factor 2A |
increases phosphorylation |
EXP |
deoxynivalenol results in increased phosphorylation of EIF2A protein |
CTD |
PMID:20682335 |
|
NCBI chr 3:150,546,787...150,586,016
Ensembl chr 3:150,546,678...150,586,016
|
|
G |
EIF2AK2 |
eukaryotic translation initiation factor 2 alpha kinase 2 |
decreases expression affects response to substance multiple interactions |
ISO EXP |
deoxynivalenol results in decreased expression of EIF2AK2 mRNA EIF2AK2 protein affects the susceptibility to deoxynivalenol EIF2AK2 protein affects the reaction [deoxynivalenol results in increased activity of RELA protein]; EIF2AK2 protein affects the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA] |
CTD |
PMID:17090620 PMID:18599499 PMID:22491426 |
|
NCBI chr 2:37,099,210...37,156,980
Ensembl chr 2:37,099,210...37,157,522
|
|
G |
EIF2B4 |
eukaryotic translation initiation factor 2B subunit delta |
increases expression |
EXP |
deoxynivalenol results in increased expression of EIF2B4 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 2:27,364,352...27,370,338
Ensembl chr 2:27,364,352...27,370,338
|
|
G |
EIF2S2 |
eukaryotic translation initiation factor 2 subunit beta |
affects expression |
EXP |
deoxynivalenol affects the expression of EIF2S2 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr20:34,088,309...34,112,243
Ensembl chr20:34,088,309...34,112,243
|
|
G |
EIF3B |
eukaryotic translation initiation factor 3 subunit B |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of EIF3B protein |
CTD |
PMID:23811945 |
|
NCBI chr 7:2,354,086...2,380,745
Ensembl chr 7:2,354,086...2,380,745
|
|
G |
EIF3C |
eukaryotic translation initiation factor 3 subunit C |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of EIF3C protein |
CTD |
PMID:23811945 |
|
NCBI chr16:28,688,558...28,735,730
Ensembl chr16:28,688,558...28,735,727
|
|
G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of EIF4EBP1 protein |
CTD |
PMID:23352502 |
|
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
|
|
G |
EIF4G1 |
eukaryotic translation initiation factor 4 gamma 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of EIF4G1 protein |
CTD |
PMID:23352502 |
|
NCBI chr 3:184,314,606...184,335,358
Ensembl chr 3:184,314,495...184,335,358
|
|
G |
EIF5B |
eukaryotic translation initiation factor 5B |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of EIF5B protein |
CTD |
PMID:23811945 |
|
NCBI chr 2:99,337,389...99,401,326
Ensembl chr 2:99,337,389...99,401,326
|
|
G |
ELAVL1 |
ELAV like RNA binding protein 1 |
multiple interactions |
EXP |
[[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which affects the localization of ELAVL1 protein] which co-treated with deoxynivalenol] promotes the reaction [[ELAVL1 protein binds to ATF3 3' UTR] which results in increased stability of ATF3 mRNA]; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] affects the localization of ELAVL1 protein; [deoxynivalenol results in increased expression of ELAVL1 protein] which results in decreased degradation of CXCL8 mRNA; deoxynivalenol results in increased expression of and results in increased localization of ELAVL1 protein; ELAVL1 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL1 mRNA]; ELAVL1 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL8 mRNA]; ELAVL1 protein affects the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA]; ELAVL1 protein affects the reaction [deoxynivalenol results in increased expression of CXCL8 protein] |
CTD |
PMID:19591856 PMID:22003189 |
|
NCBI chr19:7,958,573...8,005,641
Ensembl chr19:7,958,573...8,005,659
|
|
G |
ELK1 |
ETS transcription factor ELK1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of ELK1 protein |
CTD |
PMID:33890134 |
|
NCBI chr X:47,635,520...47,650,604
Ensembl chr X:47,635,521...47,650,604
|
|
G |
EMC10 |
ER membrane protein complex subunit 10 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of EMC10 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr19:50,476,507...50,490,871
Ensembl chr19:50,476,400...50,490,871
|
|
G |
EMILIN1 |
elastin microfibril interfacer 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of EMILIN1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 2:27,078,615...27,086,403
Ensembl chr 2:27,078,615...27,086,403
|
|
G |
ENG |
endoglin |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ENG mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 9:127,815,016...127,854,658
Ensembl chr 9:127,811,130...127,854,773
|
|
G |
ENGASE |
endo-beta-N-acetylglucosaminidase |
increases expression |
EXP |
deoxynivalenol results in increased expression of ENGASE mRNA |
CTD |
PMID:23792671 |
|
NCBI chr17:79,074,824...79,088,599
Ensembl chr17:79,074,824...79,088,599
|
|
G |
EP300 |
E1A binding protein p300 |
multiple interactions increases expression |
EXP |
EP300 protein affects the reaction [deoxynivalenol results in increased expression of ATF3 protein alternative form] deoxynivalenol results in increased expression of EP300 protein |
CTD |
PMID:30286430 |
|
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,510...41,180,077
|
|
G |
EP400 |
E1A binding protein p400 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of EP400 protein |
CTD |
PMID:23352502 |
|
NCBI chr12:131,949,942...132,080,460
Ensembl chr12:131,949,942...132,080,460
|
|
G |
EPB41L2 |
erythrocyte membrane protein band 4.1 like 2 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of EPB41L2 protein |
CTD |
PMID:23811945 |
|
NCBI chr 6:130,839,347...131,063,245
Ensembl chr 6:130,839,347...131,063,322
|
|
G |
EPHX1 |
epoxide hydrolase 1 |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of EPHX1 mRNA |
CTD |
PMID:15371230 |
|
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
|
|
G |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
decreases expression increases expression |
EXP ISO |
deoxynivalenol results in decreased expression of ERN1 mRNA deoxynivalenol results in increased expression of ERN1 protein |
CTD |
PMID:19336499 PMID:20682335 |
|
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
|
|
G |
ESR1 |
estrogen receptor 1 |
increases phosphorylation multiple interactions |
EXP |
deoxynivalenol results in increased phosphorylation of ESR1 protein ESR1 promotes the reaction [deoxynivalenol results in increased expression of PGR mRNA]; ESR1 promotes the reaction [deoxynivalenol results in increased expression of TFF1 mRNA] |
CTD |
PMID:35588983 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
ETNK1 |
ethanolamine kinase 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of ETNK1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr12:22,625,171...22,690,665
Ensembl chr12:22,625,075...22,690,665
|
|
G |
EVI2A |
ecotropic viral integration site 2A |
increases expression |
EXP |
deoxynivalenol results in increased expression of EVI2A mRNA |
CTD |
PMID:24247028 |
|
NCBI chr17:31,316,410...31,321,622
Ensembl chr17:31,316,410...31,321,749
|
|
G |
EVL |
Enah/Vasp-like |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of EVL protein |
CTD |
PMID:23811945 |
|
NCBI chr14:99,971,422...100,144,236
Ensembl chr14:99,971,449...100,144,236
|
|
G |
EXOSC2 |
exosome component 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of EXOSC2 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr 9:130,693,760...130,704,894
Ensembl chr 9:130,693,721...130,707,288
|
|
G |
F3 |
coagulation factor III, tissue factor |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of F3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
|
|
G |
FABP3 |
fatty acid binding protein 3 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of FABP3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:31,359,588...31,373,076
Ensembl chr 1:31,365,253...31,376,850
|
|
G |
FABP4 |
fatty acid binding protein 4 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of FABP4 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236
|
|
G |
FABP6 |
fatty acid binding protein 6 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of FABP6 mRNA |
CTD |
PMID:35224661 |
|
NCBI chr 5:160,187,381...160,238,722
Ensembl chr 5:160,187,367...160,238,735
|
|
G |
FAM200C |
family with sequence similarity 200 member C |
increases expression |
EXP |
deoxynivalenol results in increased expression of FAM200C mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 5:160,393,148...160,400,054
Ensembl chr 5:160,393,148...160,400,054
|
|
G |
FAM83D |
family with sequence similarity 83 member D |
increases expression |
EXP |
deoxynivalenol results in increased expression of FAM83D mRNA |
CTD |
PMID:31863870 |
|
NCBI chr20:38,926,417...38,953,106
Ensembl chr20:38,926,312...38,953,106
|
|
G |
FAS |
Fas cell surface death receptor |
multiple interactions increases expression |
ISO |
Bentonite inhibits the reaction [deoxynivalenol results in increased expression of FAS protein]; Charcoal inhibits the reaction [deoxynivalenol results in increased expression of FAS protein] deoxynivalenol results in increased expression of FAS mRNA |
CTD |
PMID:26115597 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FASLG |
Fas ligand |
increases expression |
ISO |
deoxynivalenol results in increased expression of FASL mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FASTKD2 |
FAST kinase domains 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of FASTKD2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 2:206,765,606...206,796,189
Ensembl chr 2:206,765,357...206,796,189
|
|
G |
FBXO22 |
F-box protein 22 |
increases expression |
EXP |
deoxynivalenol results in increased expression of FBXO22 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:75,903,878...75,942,511
Ensembl chr15:75,903,876...75,942,511
|
|
G |
FBXO28 |
F-box protein 28 |
increases expression |
EXP |
deoxynivalenol results in increased expression of FBXO28 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:224,114,111...224,162,047
Ensembl chr 1:224,114,111...224,162,047
|
|
G |
FDFT1 |
farnesyl-diphosphate farnesyltransferase 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of FDFT1 protein |
CTD |
PMID:33890134 |
|
NCBI chr 8:11,795,582...11,839,309
Ensembl chr 8:11,795,573...11,839,395
|
|
G |
FDPS |
farnesyl diphosphate synthase |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of FDPS protein |
CTD |
PMID:33890134 |
|
NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666
|
|
G |
FLNA |
filamin A |
decreases phosphorylation increases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of FLNA protein deoxynivalenol results in increased phosphorylation of FLNA protein |
CTD |
PMID:23811945 |
|
NCBI chr X:154,348,531...154,374,634
Ensembl chr X:154,348,524...154,374,634
|
|
G |
FMNL1 |
formin like 1 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of FMNL1 protein |
CTD |
PMID:23352502 |
|
NCBI chr17:45,221,885...45,247,318
Ensembl chr17:45,221,444...45,247,319
|
|
G |
FMOD |
fibromodulin |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of FMOD mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:203,340,628...203,351,122
Ensembl chr 1:203,340,628...203,351,758
|
|
G |
FN1 |
fibronectin 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of FN1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
|
|
G |
FNBP1 |
formin binding protein 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of FNBP1 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr 9:129,887,187...130,053,879
Ensembl chr 9:129,887,187...130,043,189
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions affects activity |
EXP ISO |
deoxynivalenol results in increased expression of FOS mRNA deoxynivalenol inhibits the reaction [Cadmium Chloride results in decreased expression of FOS mRNA] Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of FOS protein] deoxynivalenol affects the activity of FOS protein deoxynivalenol results in increased expression of FOS mRNA; deoxynivalenol results in increased expression of FOS protein |
CTD |
PMID:10662601 PMID:15371230 PMID:15681167 PMID:19360757 PMID:21873375 PMID:22968694 PMID:24937323 PMID:32416088 PMID:33309878 PMID:35314294 More...
|
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
|
|
G |
FOSB |
FosB proto-oncogene, AP-1 transcription factor subunit |
affects activity increases expression multiple interactions |
ISO EXP |
deoxynivalenol affects the activity of FOSB protein deoxynivalenol results in increased expression of FOSB mRNA [Cadmium Chloride co-treated with deoxynivalenol] results in increased expression of FOSB mRNA |
CTD |
PMID:10662601 PMID:33309878 |
|
NCBI chr19:45,467,996...45,475,179
Ensembl chr19:45,467,995...45,475,179
|
|
G |
FOSL1 |
FOS like 1, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[Cadmium Chloride co-treated with deoxynivalenol] results in increased expression of FOSL1 mRNA |
CTD |
PMID:33309878 |
|
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
|
|
G |
FOSL2 |
FOS like 2, AP-1 transcription factor subunit |
multiple interactions increases expression affects activity |
ISO EXP |
Fatty Acids, Omega-3 inhibits the reaction [deoxynivalenol results in increased expression of FOSL2 mRNA] deoxynivalenol results in increased expression of FOSL2 mRNA; deoxynivalenol results in increased expression of FOSL2 protein [Cadmium Chloride co-treated with deoxynivalenol] results in increased expression of FOSL2 mRNA deoxynivalenol affects the activity of FOSL2 protein |
CTD |
PMID:10662601 PMID:15371230 PMID:15681167 PMID:33309878 PMID:33890134 |
|
NCBI chr 2:28,392,858...28,417,317
Ensembl chr 2:28,392,448...28,417,317
|
|
G |
FOXO1 |
forkhead box O1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of FOXO1 protein |
CTD |
PMID:15976193 |
|
NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641
|
|
G |
FOXP3 |
forkhead box P3 |
increases expression |
EXP |
deoxynivalenol results in increased expression of FOXP3 mRNA |
CTD |
PMID:27757495 |
|
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
|
|
G |
FUCA1 |
alpha-L-fucosidase 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of FUCA1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:23,845,077...23,868,290
Ensembl chr 1:23,845,077...23,868,290
|
|
G |
FUT1 |
fucosyltransferase 1 (H blood group) |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of FUT1 mRNA |
CTD |
PMID:26763390 |
|
NCBI chr19:48,748,011...48,755,358
Ensembl chr19:48,748,011...48,755,390
|
|
G |
G3BP1 |
G3BP stress granule assembly factor 1 |
decreases phosphorylation increases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of G3BP1 protein deoxynivalenol results in increased phosphorylation of G3BP1 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr 5:151,771,954...151,812,785
Ensembl chr 5:151,771,045...151,812,911
|
|
G |
G3BP2 |
G3BP stress granule assembly factor 2 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of G3BP2 protein |
CTD |
PMID:23352502 |
|
NCBI chr 4:75,642,786...75,724,437
Ensembl chr 4:75,641,849...75,724,589
|
|
G |
GABPA |
GA binding protein transcription factor subunit alpha |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of GABPA protein |
CTD |
PMID:33890134 |
|
NCBI chr21:25,734,972...25,772,460
Ensembl chr21:25,734,570...25,772,460
|
|
G |
GADD45A |
growth arrest and DNA damage inducible alpha |
increases expression |
EXP |
deoxynivalenol results in increased expression of GADD45A mRNA |
CTD |
PMID:30169763 PMID:31863870 |
|
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
|
|
G |
GALNT1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of GALNT1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr18:35,580,922...35,711,834
Ensembl chr18:35,581,117...35,711,834
|
|
G |
GALP |
galanin like peptide |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of GALP mRNA; deoxynivalenol results in increased expression of GALP protein GALP protein promotes the reaction [deoxynivalenol results in increased expression of IL11 protein]; GALP protein promotes the reaction [deoxynivalenol results in increased expression of IL1B protein]; GALP protein promotes the reaction [deoxynivalenol results in increased expression of IL6 protein] |
CTD |
PMID:32738333 |
|
NCBI chr19:56,176,008...56,185,775
Ensembl chr19:56,176,008...56,185,775
|
|
G |
GALR2 |
galanin receptor 2 |
increases expression |
ISO |
deoxynivalenol results in increased expression of GALR2 mRNA |
CTD |
PMID:32738333 |
|
NCBI chr17:76,071,962...76,077,537
Ensembl chr17:76,074,781...76,077,537
|
|
G |
GALR3 |
galanin receptor 3 |
increases expression |
ISO |
deoxynivalenol results in increased expression of GALR3 mRNA |
CTD |
PMID:32738333 |
|
NCBI chr22:37,823,382...37,825,485
Ensembl chr22:37,823,382...37,825,485
|
|
G |
GATAD2A |
GATA zinc finger domain containing 2A |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of GATAD2A protein |
CTD |
PMID:23352502 |
|
NCBI chr19:19,385,843...19,508,932
Ensembl chr19:19,385,826...19,508,932
|
|
G |
GCG |
glucagon |
multiple interactions increases expression increases secretion |
ISO |
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [deoxynivalenol results in increased secretion of GCG protein alternative form]; 2-aminoethyl diphenylborinate inhibits the reaction [deoxynivalenol results in increased secretion of GCG protein alternative form]; Egtazic Acid inhibits the reaction [deoxynivalenol results in increased secretion of GCG protein alternative form]; Nitrendipine inhibits the reaction [deoxynivalenol results in increased secretion of GCG protein alternative form]; triphenylphosphine oxide inhibits the reaction [deoxynivalenol results in increased secretion of GCG protein alternative form] deoxynivalenol results in increased expression of GCG protein |
CTD |
PMID:25787141 PMID:28633506 |
|
NCBI chr 2:162,142,882...162,152,247
Ensembl chr 2:162,142,882...162,152,404
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
decreases expression multiple interactions |
ISO EXP |
deoxynivalenol results in decreased expression of GCLC mRNA Resveratrol inhibits the reaction [deoxynivalenol results in decreased expression of GCLC protein] Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of GCLC mRNA] |
CTD |
PMID:35817260 PMID:37419272 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
increases expression |
ISO |
deoxynivalenol results in increased expression of GCLM mRNA |
CTD |
PMID:34400200 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GDF5 |
growth differentiation factor 5 |
increases expression |
EXP |
deoxynivalenol results in increased expression of GDF5 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr20:35,433,347...35,454,749
Ensembl chr20:35,433,347...35,454,746
|
|
G |
GH1 |
growth hormone 1 |
multiple interactions decreases secretion decreases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in decreased expression of GH1 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in decreased expression of GH1 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in decreased expression of GH1 mRNA]; deoxynivalenol results in decreased expression of and results in decreased secretion of GH1 protein; farnesylthiosalicylic acid inhibits the reaction [deoxynivalenol results in decreased expression of GH1 mRNA]; farnesylthiosalicylic acid inhibits the reaction [deoxynivalenol results in decreased expression of GH1 protein]; pyrazolanthrone inhibits the reaction [deoxynivalenol results in decreased expression of GH1 mRNA]; pyrazolanthrone inhibits the reaction [deoxynivalenol results in decreased expression of GH1 protein]; SB 203580 inhibits the reaction [deoxynivalenol results in decreased expression of GH1 mRNA]; SB 203580 inhibits the reaction [deoxynivalenol results in decreased expression of GH1 protein] deoxynivalenol results in decreased secretion of GH1 protein |
CTD |
PMID:26141394 PMID:32738333 PMID:34673182 |
|
NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
|
|
G |
GHR |
growth hormone receptor |
affects expression |
ISO |
deoxynivalenol affects the expression of GHR mRNA |
CTD |
PMID:34673182 |
|
NCBI chr 5:42,423,439...42,721,878
Ensembl chr 5:42,423,439...42,721,878
|
|
G |
GHRH |
growth hormone releasing hormone |
increases expression |
ISO |
deoxynivalenol results in increased expression of GHRH mRNA |
CTD |
PMID:34673182 |
|
NCBI chr20:37,251,086...37,261,814
Ensembl chr20:37,251,086...37,261,819
|
|
G |
GIP |
gastric inhibitory polypeptide |
increases expression |
ISO |
deoxynivalenol results in increased expression of GIP protein |
CTD |
PMID:28633506 |
|
NCBI chr17:48,958,554...48,968,596
Ensembl chr17:48,958,554...48,968,596
|
|
G |
GKAP1 |
G kinase anchoring protein 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of GKAP1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 9:83,739,425...83,817,769
Ensembl chr 9:83,739,425...83,829,516
|
|
G |
GLDN |
gliomedin |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of GLDN mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:51,341,655...51,413,365
Ensembl chr15:51,341,655...51,408,005
|
|
G |
GOT1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions increases activity |
ISO |
BMAL1 protein inhibits the reaction [deoxynivalenol results in increased activity of GOT1 protein] |
CTD |
PMID:36602574 |
|
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
|
|
G |
GP1BB |
glycoprotein Ib platelet subunit beta |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of GP1BB protein |
CTD |
PMID:23811945 |
|
NCBI chr22:19,723,539...19,724,771
Ensembl chr22:19,723,539...19,724,771
|
|
G |
GPKOW |
G-patch domain and KOW motifs |
increases expression |
EXP |
deoxynivalenol results in increased expression of GPKOW mRNA |
CTD |
PMID:31863870 |
|
NCBI chr X:49,113,407...49,123,735
Ensembl chr X:49,113,407...49,123,735
|
|
G |
GPN1 |
GPN-loop GTPase 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of GPN1 protein |
CTD |
PMID:23352502 |
|
NCBI chr 2:27,628,247...27,651,511
Ensembl chr 2:27,628,247...27,651,511
|
|
G |
GPT |
glutamic--pyruvic transaminase |
multiple interactions increases expression increases activity |
ISO |
acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [deoxynivalenol results in increased activity of GPT protein]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased activity of GPT protein]; BMAL1 protein inhibits the reaction [deoxynivalenol results in increased activity of GPT protein]; deoxynivalenol promotes the reaction [Aflatoxin B1 results in increased activity of GPT protein] Bentonite inhibits the reaction [deoxynivalenol results in increased expression of GPT protein]; Charcoal inhibits the reaction [deoxynivalenol results in increased expression of GPT protein] |
CTD |
PMID:25445755 PMID:26115597 PMID:34400200 PMID:35925383 PMID:36602574 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
GPX1 |
glutathione peroxidase 1 |
increases phosphorylation increases expression |
ISO |
deoxynivalenol results in increased phosphorylation of GPX1 protein deoxynivalenol results in increased expression of GPX1 mRNA |
CTD |
PMID:23811945 PMID:34400200 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GPX4 |
glutathione peroxidase 4 |
multiple interactions decreases expression |
EXP |
Resveratrol inhibits the reaction [deoxynivalenol results in decreased expression of GPX4 protein] deoxynivalenol results in decreased expression of GPX4 mRNA |
CTD |
PMID:37419272 |
|
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
|
|
G |
GREM1 |
gremlin 1, DAN family BMP antagonist |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of GREM1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:32,718,004...32,745,106
Ensembl chr15:32,718,004...32,745,106
|
|
G |
GSDMD |
gasdermin D |
multiple interactions increases expression |
ISO |
deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of GSDMD mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of GSDMD protein]; deoxynivalenol results in increased expression of and results in increased cleavage of GSDMD protein; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of GSDMD mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of GSDMD protein] deoxynivalenol results in increased expression of GSDMD mRNA; deoxynivalenol results in increased expression of GSDMD protein |
CTD |
PMID:35925383 PMID:36309173 |
|
NCBI chr 8:143,553,387...143,563,062
Ensembl chr 8:143,553,207...143,563,062
|
|
G |
GSDME |
gasdermin E |
multiple interactions |
ISO EXP |
acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [deoxynivalenol results in increased expression of and results in increased cleavage of GSDME protein]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased expression of and results in increased cleavage of GSDME protein]; deoxynivalenol results in increased expression of and results in increased cleavage of GSDME protein [GSDME protein co-treated with deoxynivalenol] results in increased secretion of IL1B protein; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased cleavage of GSDME protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased cleavage of GSDME protein]; deoxynivalenol results in decreased expression of and results in increased cleavage of GSDME protein; GSDME protein inhibits the reaction [deoxynivalenol results in increased cleavage of PARP1 protein]; GSDME protein promotes the reaction [deoxynivalenol results in increased secretion of IL6 protein] |
CTD |
PMID:35925383 |
|
NCBI chr 7:24,698,355...24,795,539
Ensembl chr 7:24,698,355...24,757,940
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of GSK3B protein |
CTD |
PMID:15976193 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
GSS |
glutathione synthetase |
increases expression multiple interactions |
EXP |
deoxynivalenol results in increased expression of GSS mRNA Resveratrol inhibits the reaction [deoxynivalenol results in decreased expression of GSS protein]; Resveratrol promotes the reaction [deoxynivalenol results in increased expression of GSS protein] |
CTD |
PMID:37419272 |
|
NCBI chr20:34,928,432...34,956,027
Ensembl chr20:34,928,432...34,956,027
|
|
G |
H1-0 |
H1.0 linker histone |
increases expression |
EXP |
deoxynivalenol results in increased expression of H1-0 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr22:37,805,229...37,807,432
Ensembl chr22:37,805,229...37,807,432
|
|
G |
H1-10 |
H1.10 linker histone |
increases expression |
EXP |
deoxynivalenol results in increased expression of H1-10 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 3:129,314,771...129,316,286
Ensembl chr 3:129,314,771...129,316,286
|
|
G |
H1-2 |
H1.2 linker histone, cluster member |
increases expression |
EXP |
deoxynivalenol results in increased expression of H1-2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,055,740...26,056,470
|
|
G |
H1-5 |
H1.5 linker histone, cluster member |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of H1F5 protein |
CTD |
PMID:23352502 |
|
NCBI chr 6:27,866,792...27,867,588
Ensembl chr 6:27,866,792...27,867,588
|
|
G |
H2BC5 |
H2B clustered histone 5 |
increases expression |
EXP |
deoxynivalenol results in increased expression of H2BC5 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 6:26,158,121...26,171,349
Ensembl chr 6:26,158,122...26,171,349
|
|
G |
HAPLN1 |
hyaluronan and proteoglycan link protein 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of HAPLN1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 5:83,637,805...83,720,855
Ensembl chr 5:83,637,805...83,720,855
|
|
G |
HAUS2 |
HAUS augmin like complex subunit 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of HAUS2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:42,548,838...42,569,994
Ensembl chr15:42,548,828...42,569,994
|
|
G |
HBA1 |
hemoglobin subunit alpha 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of HBA protein |
CTD |
PMID:23811945 |
|
NCBI chr16:176,680...177,522
Ensembl chr16:176,680...177,522
|
|
G |
HBB |
hemoglobin subunit beta |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of HBB-B1 protein |
CTD |
PMID:23811945 |
|
NCBI chr11:5,225,464...5,227,071
Ensembl chr11:5,225,464...5,229,395
|
|
G |
HCK |
HCK proto-oncogene, Src family tyrosine kinase |
increases phosphorylation affects response to substance multiple interactions |
EXP ISO |
deoxynivalenol results in increased phosphorylation of HCK protein HCK protein affects the susceptibility to deoxynivalenol 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of and results in increased activity of HCK protein]; deoxynivalenol results in increased phosphorylation of and results in increased activity of HCK protein; HCK protein affects the reaction [deoxynivalenol results in increased activity of CASP3 protein]; HCK protein affects the reaction [deoxynivalenol results in increased expression of TNF protein] |
CTD |
PMID:15772366 PMID:20181660 PMID:22491426 |
|
NCBI chr20:32,052,242...32,101,856
Ensembl chr20:32,052,197...32,101,856
|
|
G |
HDAC1 |
histone deacetylase 1 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of HDAC1 protein |
CTD |
PMID:23352502 |
|
NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635
|
|
G |
HDAC2 |
histone deacetylase 2 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of HDAC2 protein |
CTD |
PMID:23352502 |
|
NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
|
|
G |
HDGF |
heparin binding growth factor |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of HDGF protein |
CTD |
PMID:23811945 |
|
NCBI chr 1:156,742,107...156,767,366
Ensembl chr 1:156,742,109...156,766,925
|
|
G |
HEMGN |
hemogen |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of HEMGN protein |
CTD |
PMID:23811945 |
|
NCBI chr 9:97,926,791...97,944,852
Ensembl chr 9:97,926,791...97,944,856
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
increases expression multiple interactions |
EXP |
deoxynivalenol results in increased expression of HIF1A mRNA 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased expression of HIF1A mRNA] |
CTD |
PMID:34677630 |
|
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
|
|
G |
HINFP |
histone H4 transcription factor |
increases expression |
EXP |
deoxynivalenol results in increased expression of HINFP protein |
CTD |
PMID:33890134 |
|
NCBI chr11:119,121,580...119,136,059
Ensembl chr11:119,121,580...119,136,059
|
|
G |
HINT1 |
histidine triad nucleotide binding protein 1 |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of HINT1 mRNA |
CTD |
PMID:15371230 |
|
NCBI chr 5:131,159,027...131,165,256
Ensembl chr 5:131,155,383...131,224,468
|
|
G |
HLX |
H2.0 like homeobox |
increases expression |
EXP |
deoxynivalenol results in increased expression of HLX mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:220,879,443...220,885,059
Ensembl chr 1:220,879,431...220,885,059
|
|
G |
HMGCR |
3-hydroxy-3-methylglutaryl-CoA reductase |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of HMGCR mRNA |
CTD |
PMID:22982764 |
|
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
|
|
G |
HMOX1 |
heme oxygenase 1 |
decreases expression multiple interactions increases expression decreases response to substance |
EXP ISO |
deoxynivalenol results in decreased expression of HMOX1 mRNA 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased expression of HMOX1 mRNA] Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of HMOX1 mRNA]; HMOX1 protein inhibits the reaction [deoxynivalenol results in increased expression of IL1B protein]; HMOX1 protein inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein]; HMOX1 protein inhibits the reaction [deoxynivalenol results in increased expression of TNF protein] HMOX1 protein results in decreased susceptibility to deoxynivalenol deoxynivalenol results in increased expression of HMOX1 mRNA; deoxynivalenol results in increased expression of HMOX1 protein |
CTD |
PMID:24355168 PMID:26763390 PMID:31034930 PMID:31863870 PMID:34400200 PMID:34677630 PMID:35314294 PMID:35817260 More...
|
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HNF4A |
hepatocyte nuclear factor 4 alpha |
increases expression multiple interactions |
EXP |
deoxynivalenol results in increased expression of HNF4 mRNA; deoxynivalenol results in increased expression of HNF4A mRNA [deoxynivalenol co-treated with Zearalenone] affects the expression of HNF4A mRNA |
CTD |
PMID:28865950 PMID:35314294 |
|
NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,699...44,432,845
|
|
G |
HOXA7 |
homeobox A7 |
multiple interactions increases expression |
EXP |
AG 1879 inhibits the reaction [deoxynivalenol results in increased expression of HOXA7 mRNA] |
CTD |
PMID:19438726 |
|
NCBI chr 7:27,153,716...27,156,675
Ensembl chr 7:27,153,716...27,157,936
|
|
G |
HSD3B2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of HSD3B2 mRNA |
CTD |
PMID:22982764 |
|
NCBI chr 1:119,414,931...119,423,034
Ensembl chr 1:119,414,931...119,423,035
|
|
G |
HSP90AB1 |
heat shock protein 90 alpha family class B member 1 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of HSP90AB1 protein |
CTD |
PMID:23811945 |
|
NCBI chr 6:44,246,194...44,253,883
Ensembl chr 6:44,246,166...44,253,888
|
|
G |
HSPA1L |
heat shock protein family A (Hsp70) member 1 like |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of HSPA1L protein |
CTD |
PMID:33890134 |
|
NCBI chr 6:31,809,619...31,815,283
Ensembl chr 6:31,809,619...31,815,283
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions increases phosphorylation decreases expression |
ISO EXP |
calpain inhibitor III inhibits the reaction [deoxynivalenol results in increased degradation of HSPA5 protein]; deoxynivalenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HSPA5 mRNA]; deoxynivalenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HSPA5 protein]; deoxynivalenol results in increased degradation of and results in decreased expression of HSPA5 protein; phenylalanyl-glycyl-NHO-Bz inhibits the reaction [deoxynivalenol results in increased degradation of HSPA5 protein] deoxynivalenol results in increased phosphorylation of HSPA5 protein deoxynivalenol results in decreased expression of HSPA5 mRNA |
CTD |
PMID:10652249 PMID:19336499 PMID:20682335 PMID:23811945 PMID:24356939 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
HSPA8 |
heat shock protein family A (Hsp70) member 8 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of HSPA8 protein |
CTD |
PMID:23811945 |
|
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
|
|
G |
HSPH1 |
heat shock protein family H (Hsp110) member 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of HSPH1 protein |
CTD |
PMID:23352502 |
|
NCBI chr13:31,134,973...31,162,388
Ensembl chr13:31,134,973...31,162,388
|
|
G |
HYLS1 |
HYLS1 centriolar and ciliogenesis associated |
increases expression |
EXP |
deoxynivalenol results in increased expression of HYLS1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr11:125,883,614...125,900,646
Ensembl chr11:125,883,614...125,900,646
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
increases expression multiple interactions |
ISO EXP |
deoxynivalenol results in increased expression of ICAM1 mRNA; deoxynivalenol results in increased expression of ICAM1 protein deoxynivalenol inhibits the reaction [IFNG protein results in increased expression of ICAM1 protein] |
CTD |
PMID:19549553 PMID:21074547 PMID:34400200 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
ID1 |
inhibitor of DNA binding 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ID1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
|
|
G |
IFITM3 |
interferon induced transmembrane protein 3 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of IFITM3 protein |
CTD |
PMID:33890134 |
|
NCBI chr11:319,676...320,860
Ensembl chr11:319,676...329,475
|
|
G |
IFNA1 |
interferon alpha 1 |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of IFNA1 mRNA |
CTD |
PMID:17090620 |
|
NCBI chr 9:21,440,439...21,441,316
Ensembl chr 9:21,440,439...21,441,316
|
|
G |
IFNAR1 |
interferon alpha and beta receptor subunit 1 |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of IFNAR1 mRNA |
CTD |
PMID:17090620 |
|
NCBI chr21:33,324,395...33,359,864
Ensembl chr21:33,324,387...33,359,864
|
|
G |
IFNB1 |
interferon beta 1 |
multiple interactions increases expression |
ISO |
deoxynivalenol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IFNB1 mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA] deoxynivalenol results in increased expression of IFNB1 mRNA |
CTD |
PMID:14644621 PMID:17090620 PMID:19857559 |
|
NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
|
|
G |
IFNG |
interferon gamma |
affects expression multiple interactions increases expression |
EXP ISO |
deoxynivalenol affects the expression of IFNG mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; Adenine inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased abundance of Nitric Oxide]; deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]; deoxynivalenol inhibits the reaction [IFNG protein results in increased expression of CD14 protein]; deoxynivalenol inhibits the reaction [IFNG protein results in increased expression of ICAM1 protein]; deoxynivalenol inhibits the reaction [IFNG protein results in increased expression of IFNGR1 protein]; lactacystin inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; SB 203580 inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]] deoxynivalenol results in increased expression of IFNG mRNA; deoxynivalenol results in increased expression of IFNG protein [deoxynivalenol results in increased susceptibility to Antigens] which results in increased expression of IFNG protein; Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of IFNG protein]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IFNG mRNA] |
CTD |
PMID:9194413 PMID:9707511 PMID:14644621 PMID:17090620 PMID:17166736 PMID:19549553 PMID:20702593 PMID:22968694 PMID:24937323 PMID:25766886 PMID:28935500 PMID:32416088 More...
|
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IFNGR1 |
interferon gamma receptor 1 |
multiple interactions decreases expression |
EXP ISO |
deoxynivalenol inhibits the reaction [IFNG protein results in increased expression of IFNGR1 protein] deoxynivalenol results in decreased expression of IFNGR1 mRNA |
CTD |
PMID:17090620 PMID:19549553 |
|
NCBI chr 6:137,197,484...137,219,385
Ensembl chr 6:137,197,483...137,219,449
|
|
G |
IGF1 |
insulin like growth factor 1 |
multiple interactions increases expression decreases expression |
ISO |
deoxynivalenol promotes the reaction [Glutathione results in increased expression of IGF1 mRNA] deoxynivalenol results in increased expression of IGF1 mRNA deoxynivalenol results in decreased expression of IGF1 protein |
CTD |
PMID:19805407 PMID:32738333 |
|
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IGFALS |
insulin like growth factor binding protein acid labile subunit |
decreases expression increases expression multiple interactions |
ISO |
deoxynivalenol results in decreased expression of IGFALS mRNA; deoxynivalenol results in decreased expression of IGFALS protein deoxynivalenol results in increased expression of IGFALS mRNA deoxynivalenol inhibits the reaction [Glutathione results in increased expression of IGFALS mRNA] |
CTD |
PMID:19625342 PMID:19805407 PMID:23298694 PMID:32738333 |
|
NCBI chr16:1,790,413...1,794,908
Ensembl chr16:1,790,413...1,794,971
|
|
G |
IGFBP3 |
insulin like growth factor binding protein 3 |
multiple interactions |
ISO |
deoxynivalenol promotes the reaction [Glutathione results in increased expression of IGFBP3 mRNA] |
CTD |
PMID:19805407 |
|
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
|
|
G |
IGFBP6 |
insulin like growth factor binding protein 6 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of IGFBP6 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr12:53,097,667...53,102,340
Ensembl chr12:53,097,436...53,102,345
|
|
G |
IL10 |
interleukin 10 |
increases expression |
ISO |
deoxynivalenol results in increased expression of IL10 mRNA |
CTD |
PMID:9194413 PMID:9707511 PMID:22968694 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL10RB |
interleukin 10 receptor subunit beta |
increases expression |
ISO |
deoxynivalenol results in increased expression of IL10RB mRNA |
CTD |
PMID:22968694 |
|
NCBI chr21:33,266,367...33,310,182
Ensembl chr21:33,266,367...33,311,420
|
|
G |
IL11 |
interleukin 11 |
increases expression affects expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of IL11 mRNA deoxynivalenol affects the expression of IL11 mRNA GALP protein promotes the reaction [deoxynivalenol results in increased expression of IL11 protein] deoxynivalenol results in increased expression of IL11 mRNA; deoxynivalenol results in increased expression of IL11 protein Fatty Acids, Omega-3 inhibits the reaction [deoxynivalenol results in increased expression of IL11 mRNA] |
CTD |
PMID:15371230 PMID:15681167 PMID:32738333 PMID:34673182 |
|
NCBI chr19:55,364,382...55,370,463
Ensembl chr19:55,364,382...55,370,463
|
|
G |
IL12A |
interleukin 12A |
increases expression |
ISO EXP |
deoxynivalenol results in increased expression of IL12A mRNA |
CTD |
PMID:9707511 PMID:27757495 |
|
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
|
|
G |
IL12B |
interleukin 12B |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of IL12B mRNA [Lipopolysaccharides co-treated with deoxynivalenol] results in increased expression of IL12B protein |
CTD |
PMID:9194413 PMID:9707511 PMID:28935500 |
|
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
|
|
G |
IL13 |
interleukin 13 |
multiple interactions |
ISO |
deoxynivalenol promotes the reaction [Antigens, Dermatophagoides results in increased expression of and results in increased secretion of IL13 protein] |
CTD |
PMID:33170220 |
|
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
|
|
G |
IL15 |
interleukin 15 |
increases expression |
EXP |
deoxynivalenol results in increased expression of IL15 mRNA |
CTD |
PMID:27757495 |
|
NCBI chr 4:141,636,583...141,733,987
Ensembl chr 4:141,636,583...141,733,987
|
|
G |
IL17A |
interleukin 17A |
multiple interactions increases expression |
ISO |
[deoxynivalenol results in increased susceptibility to Antigens] which results in increased expression of IL17A protein; Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of IL17A protein] |
CTD |
PMID:28935500 PMID:32416088 |
|
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL18 |
interleukin 18 |
decreases expression multiple interactions increases secretion increases expression |
ISO |
deoxynivalenol results in decreased expression of IL18 mRNA acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [deoxynivalenol results in increased expression of IL18 mRNA]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased expression of IL18 mRNA]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased secretion of IL18 protein]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL18 mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL18 protein]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased secretion of IL18 protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL18 mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL18 protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased secretion of IL18 protein] deoxynivalenol results in increased expression of IL18 mRNA; deoxynivalenol results in increased expression of IL18 protein |
CTD |
PMID:22968694 PMID:35925383 PMID:36309173 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
|
|
G |
IL18RAP |
interleukin 18 receptor accessory protein |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of IL18RAP mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 2:102,418,621...102,452,565
Ensembl chr 2:102,418,689...102,452,565
|
|
G |
IL1A |
interleukin 1 alpha |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of IL1A mRNA Fatty Acids, Omega-3 inhibits the reaction [deoxynivalenol results in increased expression of IL1A mRNA]; Lipopolysaccharides promotes the reaction [deoxynivalenol results in increased expression of IL1A mRNA] |
CTD |
PMID:15371230 PMID:15681167 PMID:16009389 PMID:32738333 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
increases expression increases secretion multiple interactions decreases expression |
EXP ISO |
deoxynivalenol results in increased expression of IL1B mRNA; deoxynivalenol results in increased expression of IL1B protein deoxynivalenol results in increased secretion of IL1B protein GALP protein promotes the reaction [deoxynivalenol results in increased expression of IL1B protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; [GSDME protein co-treated with deoxynivalenol] results in increased secretion of IL1B protein; [Zearalenone co-treated with deoxynivalenol] results in increased expression of IL1B mRNA; Adenine inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased secretion of IL1B protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased secretion of IL1B protein]; deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased abundance of Nitric Oxide]; deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]; deoxynivalenol inhibits the reaction [IL1B protein results in increased expression of CXCL8 protein]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; lactacystin inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; SB 203580 inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]] 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of IL1B mRNA]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of IL1B mRNA]]; [deoxynivalenol results in increased susceptibility to Antigens] which results in increased expression of IL1B protein; [Lipopolysaccharides co-treated with deoxynivalenol] results in increased expression of IL1B mRNA; [Lipopolysaccharides co-treated with deoxynivalenol] results in increased expression of IL1B protein; acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [deoxynivalenol results in increased expression of IL1B mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [deoxynivalenol results in increased expression of IL1B mRNA]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased expression of IL1B mRNA]; BMAL1 protein inhibits the reaction [deoxynivalenol results in increased expression of IL1B protein]; Curcumin inhibits the reaction [deoxynivalenol results in increased expression of IL1B mRNA]; deoxynivalenol promotes the reaction [Antigens, Dermatophagoides results in increased expression of IL1B protein]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL1B mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL1B protein]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased secretion of IL1B protein]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL1B mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL1B protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased secretion of IL1B protein]; HMOX1 protein inhibits the reaction [deoxynivalenol results in increased expression of IL1B protein]; Lipopolysaccharides promotes the reaction [deoxynivalenol results in increased expression of IL1B mRNA]; Lipopolysaccharides promotes the reaction [deoxynivalenol results in increased expression of IL1B protein]; Poly I-C promotes the reaction [deoxynivalenol results in increased expression of IL1B mRNA]; resiquimod promotes the reaction [deoxynivalenol results in increased expression of IL1B mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of IL1B mRNA]; stattic inhibits the reaction [deoxynivalenol results in increased expression of IL1B mRNA]; Zymosan promotes the reaction [deoxynivalenol results in increased expression of IL1B mRNA] deoxynivalenol results in decreased expression of IL1B mRNA |
CTD |
PMID:9194413 PMID:9707511 PMID:10344227 PMID:12604842 PMID:12773775 PMID:15371230 PMID:15681167 PMID:16009389 PMID:16364386 PMID:16687389 PMID:18308354 PMID:18433975 PMID:18614267 PMID:20702593 PMID:21873375 PMID:22454431 PMID:22968694 PMID:24793808 PMID:25392278 PMID:25549547 PMID:25766886 PMID:28935500 PMID:31034930 PMID:32738333 PMID:33170220 PMID:33890134 PMID:34400200 PMID:34673182 PMID:35090964 PMID:35381244 PMID:35817260 PMID:35925383 PMID:36309173 PMID:36602574 More...
|
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL1F10 |
interleukin 1 family member 10 |
increases expression |
ISO |
deoxynivalenol results in increased expression of IL1F10 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 2:113,067,970...113,075,843
Ensembl chr 2:113,067,970...113,075,843
|
|
G |
IL1R1 |
interleukin 1 receptor type 1 |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of IL1R1 mRNA IL1R1 protein affects the susceptibility to [Lipopolysaccharides co-treated with deoxynivalenol] |
CTD |
PMID:12773775 PMID:22968694 |
|
NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874
|
|
G |
IL1RL1 |
interleukin 1 receptor like 1 |
increases expression |
ISO |
deoxynivalenol results in increased expression of IL1RL1 mRNA |
CTD |
PMID:26304032 |
|
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
|
|
G |
IL1RN |
interleukin 1 receptor antagonist |
increases expression |
ISO |
deoxynivalenol results in increased expression of IL1RN mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
|
|
G |
IL2 |
interleukin 2 |
affects secretion increases expression increases stability multiple interactions affects expression |
ISO EXP |
deoxynivalenol affects the secretion of IL2 protein deoxynivalenol results in increased expression of IL2 mRNA deoxynivalenol results in increased stability of IL2 mRNA deoxynivalenol promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA]; deoxynivalenol promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 protein] deoxynivalenol affects the expression of IL2 mRNA |
CTD |
PMID:8560498 PMID:8658534 PMID:9194413 PMID:9439728 PMID:9707511 PMID:17166736 More...
|
|
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL22RA2 |
interleukin 22 receptor subunit alpha 2 |
increases expression |
ISO |
deoxynivalenol results in increased expression of IL22RA2 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 6:137,143,820...137,173,644
Ensembl chr 6:137,143,820...137,173,648
|
|
G |
IL23A |
interleukin 23 subunit alpha |
increases expression |
ISO |
deoxynivalenol results in increased expression of IL23A mRNA |
CTD |
PMID:22968694 |
|
NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
|
|
G |
IL33 |
interleukin 33 |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of IL33 mRNA; deoxynivalenol results in increased expression of IL33 protein deoxynivalenol promotes the reaction [Antigens, Dermatophagoides results in increased expression of IL33 protein]; Oligosaccharides analog inhibits the reaction [deoxynivalenol results in increased expression of IL33 mRNA]; Oligosaccharides analog inhibits the reaction [deoxynivalenol results in increased expression of IL33 protein] |
CTD |
PMID:26304032 PMID:33170220 |
|
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
|
|
G |
IL36G |
interleukin 36 gamma |
increases expression |
EXP |
deoxynivalenol results in increased expression of IL36G protein |
CTD |
PMID:33890134 |
|
NCBI chr 2:112,978,006...112,985,658
Ensembl chr 2:112,973,203...112,985,658
|
|
G |
IL4 |
interleukin 4 |
increases expression multiple interactions affects secretion |
EXP ISO |
deoxynivalenol results in increased expression of IL4 mRNA deoxynivalenol results in increased expression of IL4 mRNA; deoxynivalenol results in increased expression of IL4 protein deoxynivalenol promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL4 mRNA]; deoxynivalenol promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL4 protein]; deoxynivalenol promotes the reaction [Antigens, Dermatophagoides results in increased expression of and results in increased secretion of IL4 protein] deoxynivalenol affects the secretion of IL4 protein |
CTD |
PMID:8560498 PMID:8658534 PMID:9194413 PMID:9707511 PMID:22846391 PMID:24937323 PMID:33170220 More...
|
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL5 |
interleukin 5 |
affects secretion increases expression multiple interactions |
ISO |
deoxynivalenol affects the secretion of IL5 protein deoxynivalenol results in increased expression of IL5 mRNA deoxynivalenol promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL5 mRNA]; deoxynivalenol promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL5 protein]; deoxynivalenol promotes the reaction [Antigens, Dermatophagoides results in increased expression of and results in increased secretion of IL5 protein] |
CTD |
PMID:8560498 PMID:8658534 PMID:33170220 |
|
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
|
|
G |
IL6 |
interleukin 6 |
decreases expression increases secretion multiple interactions increases expression increases stability |
EXP ISO |
deoxynivalenol results in decreased expression of IL6 mRNA deoxynivalenol results in increased secretion of IL6 protein [Zearalenone co-treated with deoxynivalenol] results in increased expression of IL6 mRNA; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased secretion of IL6 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased secretion of IL6 protein]; GSDME protein promotes the reaction [deoxynivalenol results in increased secretion of IL6 protein] GALP protein promotes the reaction [deoxynivalenol results in increased expression of IL6 protein] deoxynivalenol results in increased expression of IL6 mRNA; deoxynivalenol results in increased expression of IL6 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of IL6 mRNA]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of IL6 mRNA]]; [deoxynivalenol results in increased susceptibility to Antigens] which results in increased expression of IL6 protein; [Docosahexaenoic Acids co-treated with Eicosapentaenoic Acid] inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; [Lipopolysaccharides co-treated with deoxynivalenol] results in increased expression of IL6 protein; acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; AKT1 protein affects the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; ATF6 protein affects the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased secretion of IL6 protein]; BMAL1 protein inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein]; Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein]; Curcumin inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; deoxynivalenol promotes the reaction [CREB1 protein modified form binds to IL6 promoter]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of IL6 mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; Dichlororibofuranosylbenzimidazole inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; Docosahexaenoic Acids inhibits the reaction [deoxynivalenol promotes the reaction [CREB1 protein modified form binds to IL6 promoter]]; Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased expression of IL6]; Eicosapentaenoic Acid inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein]; Eicosapentaenoic Acid inhibits the reaction [deoxynivalenol results in increased expression of IL6]; Fatty Acids, Omega-3 inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; Fish Oils inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; HMOX1 protein inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein]; Indomethacin inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; Indomethacin inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; Indomethacin inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein]; Lipopolysaccharides promotes the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; Lipopolysaccharides promotes the reaction [deoxynivalenol results in increased expression of IL6 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [deoxynivalenol results in increased expression of IL6 protein]; Poly I-C promotes the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; PTGS2 protein affects the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; PTGS2 protein affects the reaction [deoxynivalenol results in increased expression of IL6 protein]; resiquimod promotes the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; SB 203580 inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; stattic inhibits the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; Zymosan promotes the reaction [deoxynivalenol results in increased expression of IL6 mRNA] deoxynivalenol results in increased stability of IL6 mRNA |
CTD |
PMID:9194413 PMID:9707511 PMID:10344227 PMID:11295263 PMID:11922776 PMID:12604842 PMID:12649040 PMID:14644621 PMID:14690764 PMID:15173396 PMID:15371230 PMID:15570035 PMID:15681167 PMID:16009389 PMID:16364386 PMID:16424113 PMID:16524712 PMID:16687389 PMID:17090620 PMID:18433975 PMID:18614267 PMID:19336499 PMID:19625342 PMID:20702593 PMID:21873375 PMID:22454431 PMID:22968694 PMID:24793808 PMID:24937323 PMID:27757495 PMID:28935500 PMID:31034930 PMID:32416088 PMID:32738333 PMID:33170220 PMID:34400200 PMID:34673182 PMID:35090964 PMID:35381244 PMID:35817260 PMID:35925383 PMID:36309173 PMID:36602574 More...
|
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IL7 |
interleukin 7 |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of IL7 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 8:78,675,044...78,805,463
Ensembl chr 8:78,675,743...78,805,523
|
|
G |
IL9 |
interleukin 9 |
multiple interactions |
ISO |
deoxynivalenol promotes the reaction [Antigens, Dermatophagoides results in increased expression of and results in increased secretion of IL9 protein] |
CTD |
PMID:33170220 |
|
NCBI chr 5:135,892,246...135,895,841
Ensembl chr 5:135,892,246...135,895,841
|
|
G |
INPP5D |
inositol polyphosphate-5-phosphatase D |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of INPP5D protein |
CTD |
PMID:23352502 |
|
NCBI chr 2:233,060,342...233,207,903
Ensembl chr 2:233,059,967...233,207,903
|
|
G |
IRAK1 |
interleukin 1 receptor associated kinase 1 |
multiple interactions |
ISO |
deoxynivalenol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of IRAK1 protein] |
CTD |
PMID:26961612 |
|
NCBI chr X:154,010,507...154,019,902
Ensembl chr X:154,010,506...154,019,902
|
|
G |
IRF2BP2 |
interferon regulatory factor 2 binding protein 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of IRF2BP2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:234,604,269...234,610,178
Ensembl chr 1:234,604,269...234,610,178
|
|
G |
IST1 |
IST1 factor associated with ESCRT-III |
increases expression |
EXP |
deoxynivalenol results in increased expression of IST1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr16:71,894,408...71,931,199
Ensembl chr16:71,845,996...71,931,199
|
|
G |
ITGA10 |
integrin subunit alpha 10 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ITGA10 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:145,891,208...145,910,050
Ensembl chr 1:145,891,208...145,910,111
|
|
G |
ITGB2 |
integrin subunit beta 2 |
increases expression |
ISO |
deoxynivalenol results in increased expression of ITGB2 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989
|
|
G |
ITGBL1 |
integrin subunit beta like 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ITGBL1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr13:101,452,675...101,720,856
Ensembl chr13:101,452,593...101,720,856
|
|
G |
ITIH5 |
inter-alpha-trypsin inhibitor heavy chain 5 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ITIH5 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr10:7,559,270...7,666,966
Ensembl chr10:7,559,270...7,666,998
|
|
G |
JAK1 |
Janus kinase 1 |
increases expression increases phosphorylation |
ISO |
deoxynivalenol results in increased expression of JAK1 mRNA deoxynivalenol results in increased phosphorylation of JAK1 protein |
CTD |
PMID:22454431 PMID:36602574 |
|
NCBI chr 1:64,833,229...65,067,746
Ensembl chr 1:64,833,223...65,067,754
|
|
G |
JAK2 |
Janus kinase 2 |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of JAK2 mRNA alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [deoxynivalenol results in increased expression of JAK2 mRNA]; stattic inhibits the reaction [deoxynivalenol results in increased expression of JAK2 mRNA] |
CTD |
PMID:22454431 |
|
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases phosphorylation increases activity increases expression affects localization affects activity |
EXP ISO |
[Cadmium Chloride co-treated with deoxynivalenol] results in increased expression of JUN mRNA; deoxynivalenol results in increased expression of and results in increased phosphorylation of JUN protein deoxynivalenol results in increased phosphorylation of JUN protein deoxynivalenol results in increased activity of JUN protein deoxynivalenol results in increased expression of JUN mRNA; deoxynivalenol results in increased expression of JUN protein deoxynivalenol affects the localization of JUN protein deoxynivalenol affects the activity of JUN protein 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased activity of JUN protein]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of JUN protein]; Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of JUN protein]; Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased phosphorylation of JUN protein] |
CTD |
PMID:10662601 PMID:12604842 PMID:15371230 PMID:15681167 PMID:15772366 PMID:16424113 PMID:19360757 PMID:23352502 PMID:23792671 PMID:24937323 PMID:32416088 PMID:33309878 PMID:33890134 More...
|
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
JUNB |
JunB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression increases activity affects activity |
ISO EXP |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased activity of JUNB protein] [Cadmium Chloride co-treated with deoxynivalenol] results in increased expression of JUNB mRNA deoxynivalenol results in increased expression of JUNB mRNA deoxynivalenol affects the activity of JUNB protein |
CTD |
PMID:10662601 PMID:15371230 PMID:15681167 PMID:15772366 PMID:33309878 |
|
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
|
|
G |
JUND |
JunD proto-oncogene, AP-1 transcription factor subunit |
affects activity multiple interactions affects localization increases activity increases expression |
ISO EXP |
deoxynivalenol affects the activity of JUND protein [Cadmium Chloride co-treated with deoxynivalenol] results in increased expression of JUND mRNA deoxynivalenol affects the localization of JUND protein deoxynivalenol results in increased activity of JUND protein deoxynivalenol results in increased expression of JUND mRNA; deoxynivalenol results in increased expression of JUND protein 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased activity of JUND protein] |
CTD |
PMID:10662601 PMID:12604842 PMID:15772366 PMID:22846391 PMID:33309878 PMID:33890134 More...
|
|
NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622
|
|
G |
KAT2A |
lysine acetyltransferase 2A |
multiple interactions |
EXP |
KAT2A protein affects the reaction [deoxynivalenol results in increased expression of ATF3 protein alternative form] |
CTD |
PMID:30286430 |
|
NCBI chr17:42,113,111...42,121,367
Ensembl chr17:42,113,111...42,121,367
|
|
G |
KAT2B |
lysine acetyltransferase 2B |
increases expression multiple interactions |
EXP |
deoxynivalenol results in increased expression of KAT2B protein KAT2B protein affects the reaction [deoxynivalenol results in increased expression of ATF3 protein alternative form] |
CTD |
PMID:30286430 |
|
NCBI chr 3:20,040,446...20,154,404
Ensembl chr 3:20,040,446...20,154,404
|
|
G |
KBTBD11 |
kelch repeat and BTB domain containing 11 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of KBTBD11 protein |
CTD |
PMID:23811945 |
|
NCBI chr 8:1,973,677...2,006,936
Ensembl chr 8:1,973,677...2,006,936
|
|
G |
KCNMB4 |
potassium calcium-activated channel subfamily M regulatory beta subunit 4 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of KCNMB4 mRNA |
CTD |
PMID:26763390 |
|
NCBI chr12:70,366,290...70,434,292
Ensembl chr12:70,366,290...70,434,292
|
|
G |
KDELR3 |
KDEL endoplasmic reticulum protein retention receptor 3 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of KDELR3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr22:38,468,096...38,483,447
Ensembl chr22:38,468,078...38,483,447
|
|
G |
KDM4B |
lysine demethylase 4B |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of KDM4B protein |
CTD |
PMID:23811945 |
|
NCBI chr19:4,969,113...5,153,598
Ensembl chr19:4,969,113...5,153,598
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of KEAP1 mRNA |
CTD |
PMID:34400200 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
KHDC4 |
KH domain containing 4, pre-mRNA splicing factor |
increases expression |
EXP |
deoxynivalenol results in increased expression of KHDC4 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:155,913,045...155,934,413
Ensembl chr 1:155,913,045...155,934,413
|
|
G |
KHDRBS3 |
KH RNA binding domain containing, signal transduction associated 3 |
increases expression |
EXP |
deoxynivalenol results in increased expression of KHDRBS3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 8:135,457,456...135,656,516
Ensembl chr 8:135,457,456...135,656,722
|
|
G |
KIF11 |
kinesin family member 11 |
increases expression |
EXP |
deoxynivalenol results in increased expression of KIF11 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr10:92,593,130...92,655,395
Ensembl chr10:92,574,105...92,655,395
|
|
G |
KIF2C |
kinesin family member 2C |
increases expression |
EXP |
deoxynivalenol results in increased expression of KIF2C mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:44,739,837...44,767,767
Ensembl chr 1:44,739,818...44,767,767
|
|
G |
KITLG |
KIT ligand |
increases expression |
EXP |
deoxynivalenol results in increased expression of KITLG mRNA |
CTD |
PMID:27757495 PMID:31863870 |
|
NCBI chr12:88,492,793...88,580,471
Ensembl chr12:88,492,793...88,580,851
|
|
G |
KLF4 |
KLF transcription factor 4 |
affects expression affects localization |
EXP |
deoxynivalenol affects the expression of KLF4 protein deoxynivalenol affects the localization of KLF4 protein |
CTD |
PMID:33890134 |
|
NCBI chr 9:107,484,852...107,489,769
Ensembl chr 9:107,484,852...107,490,482
|
|
G |
KLHL30 |
kelch like family member 30 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of KLHL30 mRNA |
CTD |
PMID:26763390 |
|
NCBI chr 2:238,138,668...238,152,947
Ensembl chr 2:238,138,668...238,152,947
|
|
G |
KMT2A |
lysine methyltransferase 2A |
multiple interactions increases expression |
EXP |
AG 1879 inhibits the reaction [deoxynivalenol results in increased expression of KMT2A mRNA]; deoxynivalenol promotes the reaction [SP1 protein binds to KMT2A promoter]; SP1 protein promotes the reaction [deoxynivalenol results in increased expression of KMT2A mRNA] |
CTD |
PMID:19438726 |
|
NCBI chr11:118,436,492...118,526,832
Ensembl chr11:118,436,456...118,526,832
|
|
G |
KRT18 |
keratin 18 |
increases expression |
EXP |
deoxynivalenol results in increased expression of KRT18 protein |
CTD |
PMID:33890134 |
|
NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906
|
|
G |
KRT20 |
keratin 20 |
multiple interactions decreases expression |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of KRT20 protein] |
CTD |
PMID:34506767 |
|
NCBI chr17:40,875,889...40,885,242
Ensembl chr17:40,875,889...40,885,242
|
|
G |
LAMB1 |
laminin subunit beta 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of LAMB1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 7:107,923,799...108,003,161
Ensembl chr 7:107,923,799...108,003,213
|
|
G |
LARP7 |
La ribonucleoprotein 7, transcriptional regulator |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of LARP7 protein |
CTD |
PMID:23352502 |
|
NCBI chr 4:112,637,143...112,657,586
Ensembl chr 4:112,637,077...112,657,696
|
|
G |
LCN1 |
lipocalin 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of LCN1 protein |
CTD |
PMID:33890134 |
|
NCBI chr 9:135,521,440...135,526,540
Ensembl chr 9:135,521,438...135,526,540
|
|
G |
LCP1 |
lymphocyte cytosolic protein 1 |
increases phosphorylation affects phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of LCP1 protein deoxynivalenol affects the phosphorylation of LCP1 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr13:46,125,923...46,182,177
Ensembl chr13:46,125,920...46,211,871
|
|
G |
LGALS3BP |
galectin 3 binding protein |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of LGALS3BP protein |
CTD |
PMID:33890134 |
|
NCBI chr17:78,971,255...78,979,923
Ensembl chr17:78,971,238...78,979,947
|
|
G |
LGR5 |
leucine rich repeat containing G protein-coupled receptor 5 |
decreases expression multiple interactions |
ISO |
deoxynivalenol results in decreased expression of LGR5 protein lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of LGR5 protein] |
CTD |
PMID:34506767 |
|
NCBI chr12:71,439,129...71,586,310
Ensembl chr12:71,439,798...71,586,310
|
|
G |
LHCGR |
luteinizing hormone/choriogonadotropin receptor |
multiple interactions |
ISO |
[Colforsin co-treated with deoxynivalenol] results in increased expression of LHCGR mRNA |
CTD |
PMID:26783879 |
|
NCBI chr 2:48,686,774...48,755,724
Ensembl chr 2:48,686,774...48,755,730
|
|
G |
LIG1 |
DNA ligase 1 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of LIG1 protein |
CTD |
PMID:23811945 |
|
NCBI chr19:48,115,445...48,170,344
Ensembl chr19:48,115,445...48,170,603
|
|
G |
LIPA |
lipase A, lysosomal acid type |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of LIPA protein |
CTD |
PMID:33890134 |
|
NCBI chr10:89,213,572...89,251,775
Ensembl chr10:89,213,569...89,414,557
|
|
G |
LMNA |
lamin A/C |
affects phosphorylation decreases phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of LMNA protein deoxynivalenol results in decreased phosphorylation of LMNA protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr 1:156,082,573...156,140,081
Ensembl chr 1:156,082,572...156,140,081
|
|
G |
LMNB1 |
lamin B1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of LMNB1 protein |
CTD |
PMID:23811945 |
|
NCBI chr 5:126,776,623...126,837,020
Ensembl chr 5:126,776,623...126,837,020
|
|
G |
LMO2 |
LIM domain only 2 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of LMO2 mRNA |
CTD |
PMID:26763390 |
|
NCBI chr11:33,858,576...33,892,076
Ensembl chr11:33,858,576...33,892,076
|
|
G |
LOXL3 |
lysyl oxidase like 3 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of LOXL3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 2:74,532,258...74,555,702
Ensembl chr 2:74,532,258...74,555,690
|
|
G |
LPXN |
leupaxin |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of LPXN protein |
CTD |
PMID:23352502 |
|
NCBI chr11:58,526,871...58,578,891
Ensembl chr11:58,526,871...58,578,220
|
|
G |
LSP1 |
lymphocyte specific protein 1 |
affects phosphorylation decreases expression increases phosphorylation |
ISO EXP |
deoxynivalenol affects the phosphorylation of LSP1 protein deoxynivalenol results in decreased expression of LSP1 mRNA deoxynivalenol results in increased phosphorylation of LSP1 protein |
CTD |
PMID:23352502 PMID:23811945 PMID:31863870 |
|
NCBI chr11:1,853,084...1,892,263
Ensembl chr11:1,850,904...1,892,267
|
|
G |
LTA |
lymphotoxin alpha |
increases expression |
ISO |
deoxynivalenol results in increased expression of LTA mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 6:31,560,610...31,574,324
Ensembl chr 6:31,572,054...31,574,324
|
|
G |
LTB |
lymphotoxin beta |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of LTB mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 6:31,580,558...31,582,425
Ensembl chr 6:31,580,525...31,582,522
|
|
G |
LTBP2 |
latent transforming growth factor beta binding protein 2 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of LTBP2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr14:74,498,183...74,612,237
Ensembl chr14:74,498,183...74,612,378
|
|
G |
LYZ |
lysozyme |
multiple interactions decreases expression |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of LYZ protein] |
CTD |
PMID:34506767 |
|
NCBI chr12:69,348,381...69,354,234
Ensembl chr12:69,348,381...69,354,234
|
|
G |
MAFF |
MAF bZIP transcription factor F |
increases expression |
EXP |
deoxynivalenol results in increased expression of MAFF mRNA |
CTD |
PMID:24247028 |
|
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
|
|
G |
MALL |
mal, T cell differentiation protein like |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of MALL mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 2:110,083,870...110,118,139
Ensembl chr 2:110,083,870...110,116,022
|
|
G |
MAP1LC3B |
microtubule associated protein 1 light chain 3 beta |
increases expression multiple interactions |
EXP ISO |
deoxynivalenol results in increased expression of MAP1LC3B mRNA 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of MAP1LC3B mRNA]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of MAP1LC3B mRNA]]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of MAP1LC3B mRNA] |
CTD |
PMID:34677630 PMID:35381244 |
|
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
|
|
G |
MAP2K4 |
mitogen-activated protein kinase kinase 4 |
multiple interactions increases phosphorylation |
ISO |
Celecoxib inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAP2K4 protein] |
CTD |
PMID:32416088 |
|
NCBI chr17:12,020,877...12,143,828
Ensembl chr17:12,020,829...12,143,830
|
|
G |
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
multiple interactions increases phosphorylation |
EXP |
AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAP2K6 protein] |
CTD |
PMID:20181660 |
|
NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865
|
|
G |
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
multiple interactions increases phosphorylation |
EXP |
AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAP3K5 protein] |
CTD |
PMID:20181660 |
|
NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097
|
|
G |
MAP4 |
microtubule associated protein 4 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of MAP4 protein |
CTD |
PMID:23811945 |
|
NCBI chr 3:47,850,695...48,088,848
Ensembl chr 3:47,850,690...48,089,272
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO EXP |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein]; AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein]; Celecoxib inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein]; Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein]; Eicosapentaenoic Acid inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein]; Fish Oils inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein]; Lipopolysaccharides inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK1 protein] [deoxynivalenol results in increased phosphorylation of MAPK1 protein] which results in increased expression of CXCL8 protein; deoxynivalenol results in increased phosphorylation of and results in increased activity of MAPK1 protein; MAPK1 protein promotes the reaction [deoxynivalenol results in increased expression of PPARG mRNA] |
CTD |
PMID:12377986 PMID:12604842 PMID:14644621 PMID:14690764 PMID:15570035 PMID:15772366 PMID:15976193 PMID:16009389 PMID:16424113 PMID:17707346 PMID:18006205 PMID:18485432 PMID:18502741 PMID:19360757 PMID:20633634 PMID:23352502 PMID:23811945 PMID:24937323 PMID:32416088 More...
|
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK12 |
mitogen-activated protein kinase 12 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of MAPK12 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr22:50,252,901...50,261,683
Ensembl chr22:50,245,450...50,261,716
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
multiple interactions increases expression increases phosphorylation |
EXP ISO |
deoxynivalenol results in increased phosphorylation of and results in increased activity of MAPK14 protein deoxynivalenol results in increased expression of MAPK14 mRNA deoxynivalenol results in increased phosphorylation of MAPK14 protein |
CTD |
PMID:15976193 PMID:16364386 PMID:20702593 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP ISO |
[deoxynivalenol results in increased phosphorylation of MAPK3 protein] which results in increased expression of CXCL8 protein; deoxynivalenol results in increased phosphorylation of and results in increased activity of MAPK3 protein; MAPK3 protein promotes the reaction [deoxynivalenol results in increased expression of PPARG mRNA] 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK3 protein]; AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK3 protein]; Celecoxib inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK3 protein]; Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK3 protein]; Eicosapentaenoic Acid inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK3 protein]; Fish Oils inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK3 protein]; Lipopolysaccharides inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:12377986 PMID:12604842 PMID:14644621 PMID:14690764 PMID:15570035 PMID:15772366 PMID:15976193 PMID:16009389 PMID:16424113 PMID:17707346 PMID:18006205 PMID:18485432 PMID:18502741 PMID:19360757 PMID:20633634 PMID:23352502 PMID:23811945 PMID:24937323 PMID:32416088 More...
|
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
decreases activity increases phosphorylation multiple interactions |
EXP ISO |
deoxynivalenol results in decreased activity of MAPK8 protein deoxynivalenol results in increased phosphorylation of MAPK8 protein 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK8 protein]; AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK8 protein]; Celecoxib inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK8 protein]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein]; Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK8 protein]; Eicosapentaenoic Acid inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK8 protein]; Fish Oils inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK8 protein] [deoxynivalenol results in increased expression of DUSP1 protein] which results in decreased activity of MAPK8 protein; deoxynivalenol results in increased phosphorylation of and results in increased activity of MAPK8 protein |
CTD |
PMID:12377986 PMID:12604842 PMID:14644621 PMID:14690764 PMID:15570035 PMID:15772366 PMID:16424113 PMID:18485432 PMID:18502741 PMID:19360757 PMID:20708668 PMID:23352502 PMID:32416088 More...
|
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
decreases activity increases phosphorylation decreases phosphorylation decreases expression multiple interactions |
EXP ISO |
deoxynivalenol results in decreased activity of MAPK9 protein deoxynivalenol results in increased phosphorylation of MAPK9 protein deoxynivalenol results in decreased phosphorylation of MAPK9 protein deoxynivalenol results in decreased expression of MAPK9 mRNA 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK9 protein]; AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK9 protein]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]; Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK9 protein]; Eicosapentaenoic Acid inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK9 protein]; Fish Oils inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAPK9 protein] [deoxynivalenol results in increased expression of DUSP1 protein] which results in decreased activity of MAPK9 protein; deoxynivalenol results in increased phosphorylation of and results in increased activity of MAPK9 protein |
CTD |
PMID:12377986 PMID:12604842 PMID:14644621 PMID:14690764 PMID:15371230 PMID:15570035 PMID:15772366 PMID:16424113 PMID:18485432 PMID:18502741 PMID:19360757 PMID:20633634 PMID:20708668 PMID:23352502 PMID:23811945 More...
|
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MARCKS |
myristoylated alanine rich protein kinase C substrate |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of MARCKS protein |
CTD |
PMID:23811945 |
|
NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475
|
|
G |
MDM2 |
MDM2 proto-oncogene |
increases expression |
EXP |
deoxynivalenol results in increased expression of MDM2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
|
|
G |
MDM4 |
MDM4 regulator of p53 |
increases expression |
EXP |
deoxynivalenol results in increased expression of MDM4 mRNA |
CTD |
PMID:22846391 |
|
NCBI chr 1:204,516,406...204,558,120
Ensembl chr 1:204,516,379...204,558,120
|
|
G |
MEIS3 |
Meis homeobox 3 |
decreases response to substance decreases expression |
EXP |
MEIS3 protein results in decreased susceptibility to deoxynivalenol deoxynivalenol results in decreased expression of MEIS3 mRNA |
CTD |
PMID:26763390 |
|
NCBI chr19:47,403,124...47,422,233
Ensembl chr19:47,403,124...47,419,527
|
|
G |
MET |
MET proto-oncogene, receptor tyrosine kinase |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of MET protein |
CTD |
PMID:23811945 |
|
NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
|
|
G |
METTL14 |
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit |
increases expression |
EXP |
deoxynivalenol results in increased expression of METTL14 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 4:118,685,392...118,715,430
Ensembl chr 4:118,685,392...118,715,433
|
|
G |
MICALL1 |
MICAL like 1 |
decreases phosphorylation |
EXP |
deoxynivalenol results in decreased phosphorylation of MICALL1 protein |
CTD |
PMID:33890134 |
|
NCBI chr22:37,906,297...37,942,822
Ensembl chr22:37,905,657...37,942,822
|
|
G |
MIR17HG |
miR-17-92a-1 cluster host gene |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of MIR17HG mRNA |
CTD |
PMID:23253260 |
|
NCBI chr13:91,347,820...91,354,575
Ensembl chr13:91,347,686...91,397,592
|
|
G |
MIR221 |
microRNA 221 |
multiple interactions |
EXP |
[Zearalenone co-treated with deoxynivalenol] results in decreased expression of MIR221 mRNA |
CTD |
PMID:35090964 |
|
NCBI chr X:45,746,157...45,746,266
Ensembl chr X:45,746,157...45,746,266
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
increases phosphorylation multiple interactions increases expression |
ISO EXP |
deoxynivalenol results in increased phosphorylation of MKI67 protein Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of MKI67 protein] deoxynivalenol results in increased expression of MKI67 mRNA |
CTD |
PMID:23352502 PMID:23811945 PMID:31863870 PMID:32416088 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
MKNK2 |
MAPK interacting serine/threonine kinase 2 |
affects phosphorylation decreases expression |
ISO EXP |
deoxynivalenol affects the phosphorylation of MKNK2 protein deoxynivalenol results in decreased expression of MKNK2 mRNA |
CTD |
PMID:23811945 PMID:31863870 |
|
NCBI chr19:2,037,471...2,051,244
Ensembl chr19:2,037,465...2,051,244
|
|
G |
MMUT |
methylmalonyl-CoA mutase |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of MMUT protein |
CTD |
PMID:33890134 |
|
NCBI chr 6:49,430,360...49,463,253
Ensembl chr 6:49,430,360...49,463,253
|
|
G |
MPO |
myeloperoxidase |
increases activity |
ISO |
deoxynivalenol results in increased activity of MPO protein |
CTD |
PMID:24937323 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
MRAP2 |
melanocortin 2 receptor accessory protein 2 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of MRAP2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 6:84,033,178...84,146,282
Ensembl chr 6:84,033,772...84,090,881
|
|
G |
MRPL39 |
mitochondrial ribosomal protein L39 |
increases expression |
EXP |
deoxynivalenol results in increased expression of MRPL39 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr21:25,585,656...25,607,859
Ensembl chr21:25,585,656...25,607,517
|
|
G |
MRPS18B |
mitochondrial ribosomal protein S18B |
increases expression |
EXP |
deoxynivalenol results in increased expression of MRPS18B mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 6:30,617,840...30,626,392
Ensembl chr 6:30,617,840...30,626,395
|
|
G |
MRPS22 |
mitochondrial ribosomal protein S22 |
increases expression |
EXP |
deoxynivalenol results in increased expression of MRPS22 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 3:139,343,994...139,357,140
Ensembl chr 3:139,005,806...139,360,497
|
|
G |
MRPS30 |
mitochondrial ribosomal protein S30 |
increases expression |
EXP |
deoxynivalenol results in increased expression of MRPS30 mRNA |
CTD |
PMID:24247028 PMID:31863870 |
|
NCBI chr 5:44,808,947...44,815,514
Ensembl chr 5:44,808,947...44,820,428
|
|
G |
MRPS31 |
mitochondrial ribosomal protein S31 |
increases expression |
EXP |
deoxynivalenol results in increased expression of MRPS31 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr13:40,729,128...40,771,190
Ensembl chr13:40,729,128...40,771,190
|
|
G |
MSX2 |
msh homeobox 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of MSX2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 5:174,724,582...174,730,896
Ensembl chr 5:174,724,582...174,730,896
|
|
G |
MTA3 |
metastasis associated 1 family member 3 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of MTA3 protein |
CTD |
PMID:23352502 |
|
NCBI chr 2:42,494,110...42,756,946
Ensembl chr 2:42,494,569...42,756,947
|
|
G |
MTDH |
metadherin |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of LYRIC protein |
CTD |
PMID:23352502 |
|
NCBI chr 8:97,644,184...97,730,260
Ensembl chr 8:97,644,184...97,730,260
|
|
G |
MTHFD2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of MTHFD2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 2:74,198,615...74,217,565
Ensembl chr 2:74,186,172...74,217,565
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
decreases phosphorylation multiple interactions |
ISO |
deoxynivalenol results in decreased phosphorylation of MTOR protein lauric acid inhibits the reaction [deoxynivalenol results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:34506767 |
|
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
|
|
G |
MTREX |
Mtr4 exosome RNA helicase |
increases expression |
EXP |
deoxynivalenol results in increased expression of MTREX mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 5:55,307,989...55,425,579
Ensembl chr 5:55,307,989...55,425,579
|
|
G |
MUC16 |
mucin 16, cell surface associated |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of MUC16 protein |
CTD |
PMID:23811945 |
|
NCBI chr19:8,848,844...9,065,751
Ensembl chr19:8,848,844...9,010,390
|
|
G |
MUC2 |
mucin 2, oligomeric mucus/gel-forming |
multiple interactions decreases expression |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of MUC2 protein] |
CTD |
PMID:34506767 |
|
NCBI chr11:1,074,874...1,110,508
Ensembl chr11:1,074,875...1,110,511
|
|
G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
increases expression multiple interactions |
EXP |
deoxynivalenol results in increased expression of MUC5AC mRNA deoxynivalenol results in increased expression of and results in increased secretion of MUC5AC protein |
CTD |
PMID:24496642 |
|
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
|
|
G |
MUC5B |
mucin 5B, oligomeric mucus/gel-forming |
increases expression multiple interactions |
EXP |
deoxynivalenol results in increased expression of MUC5B mRNA deoxynivalenol results in increased expression of and results in increased secretion of MUC5B protein |
CTD |
PMID:24496642 |
|
NCBI chr11:1,223,066...1,262,172
Ensembl chr11:1,223,066...1,262,172
|
|
G |
MYBBP1A |
MYB binding protein 1a |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of MYBBP1A protein |
CTD |
PMID:23352502 |
|
NCBI chr17:4,538,904...4,555,384
Ensembl chr17:4,538,897...4,555,386
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
EXP |
deoxynivalenol results in increased expression of MYC mRNA |
CTD |
PMID:24247028 |
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
G |
MYCN |
MYCN proto-oncogene, bHLH transcription factor |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of MYCN protein |
CTD |
PMID:23352502 |
|
NCBI chr 2:15,940,550...15,947,004
Ensembl chr 2:15,940,550...15,947,007
|
|
G |
MYD88 |
MYD88 innate immune signal transduction adaptor |
multiple interactions increases expression |
ISO |
deoxynivalenol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MYD88 protein] deoxynivalenol results in increased expression of MYD88 mRNA; deoxynivalenol results in increased expression of MYD88 protein |
CTD |
PMID:26961612 PMID:34400200 |
|
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
|
|
G |
MYH11 |
myosin heavy chain 11 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of MYH11 protein |
CTD |
PMID:23811945 |
|
NCBI chr16:15,703,135...15,857,028
Ensembl chr16:15,703,135...15,858,438
|
|
G |
MYH9 |
myosin heavy chain 9 |
increases phosphorylation affects phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of MYH9 protein deoxynivalenol affects the phosphorylation of MYH9 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr22:36,281,280...36,387,967
Ensembl chr22:36,281,280...36,388,010
|
|
G |
MYL9 |
myosin light chain 9 |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of MYL9 protein modified form Curcumin inhibits the reaction [deoxynivalenol results in increased expression of MYL9 protein modified form] |
CTD |
PMID:35817260 |
|
NCBI chr20:36,541,519...36,551,447
Ensembl chr20:36,541,497...36,551,447
|
|
G |
MYLK |
myosin light chain kinase |
multiple interactions increases expression |
ISO |
Curcumin inhibits the reaction [deoxynivalenol results in increased expression of MYLK mRNA]; Curcumin inhibits the reaction [deoxynivalenol results in increased expression of MYLK protein] deoxynivalenol results in increased expression of MYLK mRNA; deoxynivalenol results in increased expression of MYLK protein |
CTD |
PMID:35817260 |
|
NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332
|
|
G |
MYO5C |
myosin VC |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of MYO5C mRNA |
CTD |
PMID:26763390 |
|
NCBI chr15:52,192,322...52,295,804
Ensembl chr15:52,192,322...52,295,804
|
|
G |
MZF1 |
myeloid zinc finger 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of MZF1 protein |
CTD |
PMID:33890134 |
|
NCBI chr19:58,561,932...58,573,573
Ensembl chr19:58,561,931...58,573,575
|
|
G |
NAGLU |
N-acetyl-alpha-glucosaminidase |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of NAGLU mRNA |
CTD |
PMID:31863870 |
|
NCBI chr17:42,536,241...42,544,449
Ensembl chr17:42,536,241...42,544,449
|
|
G |
NAMPT |
nicotinamide phosphoribosyltransferase |
increases expression |
EXP |
deoxynivalenol results in increased expression of NAMPT mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,285,966
|
|
G |
NANOS1 |
nanos C2HC-type zinc finger 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of NANOS1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr10:119,029,714...119,033,730
Ensembl chr10:119,029,714...119,033,730
|
|
G |
NCL |
nucleolin |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of NCL protein |
CTD |
PMID:23352502 |
|
NCBI chr 2:231,453,531...231,464,484
Ensembl chr 2:231,453,531...231,483,641
|
|
G |
NDC80 |
NDC80 kinetochore complex component |
increases expression |
EXP |
deoxynivalenol results in increased expression of NDC80 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr18:2,571,557...2,616,635
Ensembl chr18:2,571,557...2,616,635
|
|
G |
NDUFB7 |
NADH:ubiquinone oxidoreductase subunit B7 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of NDUFB7 protein |
CTD |
PMID:33890134 |
|
NCBI chr19:14,566,078...14,572,066
Ensembl chr19:14,566,078...14,572,066
|
|
G |
NDUFB8 |
NADH:ubiquinone oxidoreductase subunit B8 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of NDUFB8 protein |
CTD |
PMID:33890134 |
|
NCBI chr10:100,523,729...100,529,923
Ensembl chr10:100,523,740...100,530,000
|
|
G |
NDUFB9 |
NADH:ubiquinone oxidoreductase subunit B9 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of NDUFB9 protein |
CTD |
PMID:33890134 |
|
NCBI chr 8:124,539,123...124,549,979
Ensembl chr 8:124,539,101...124,580,648
|
|
G |
NDUFS4 |
NADH:ubiquinone oxidoreductase subunit S4 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of NDUFS4 protein |
CTD |
PMID:33890134 |
|
NCBI chr 5:53,560,639...53,683,338
Ensembl chr 5:53,560,633...53,683,338
|
|
G |
NDUFS5 |
NADH:ubiquinone oxidoreductase subunit S5 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of NDUFS5 protein |
CTD |
PMID:33890134 |
|
NCBI chr 1:39,026,350...39,034,615
Ensembl chr 1:39,026,318...39,034,636
|
|
G |
NDUFS7 |
NADH:ubiquinone oxidoreductase core subunit S7 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of NDUFS7 protein |
CTD |
PMID:33890134 |
|
NCBI chr19:1,383,907...1,395,584
Ensembl chr19:1,383,527...1,395,589
|
|
G |
NDUFV3 |
NADH:ubiquinone oxidoreductase subunit V3 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of NDUFV3 protein |
CTD |
PMID:33890134 |
|
NCBI chr21:42,893,309...42,913,299
Ensembl chr21:42,879,644...42,913,304
|
|
G |
NEDD4L |
NEDD4 like E3 ubiquitin protein ligase |
increases expression |
EXP |
deoxynivalenol results in increased expression of NEDD4L mRNA |
CTD |
PMID:31863870 |
|
NCBI chr18:58,044,226...58,401,540
Ensembl chr18:58,044,226...58,401,540
|
|
G |
NFATC1 |
nuclear factor of activated T cells 1 |
affects localization |
EXP ISO |
deoxynivalenol affects the localization of NFATC1 protein |
CTD |
PMID:21074547 PMID:22846391 |
|
NCBI chr18:79,395,930...79,529,323
Ensembl chr18:79,395,856...79,529,325
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
increases activity decreases expression multiple interactions increases expression |
EXP ISO |
deoxynivalenol analog results in increased activity of NFE2L2 protein; deoxynivalenol results in increased activity of NFE2L2 protein deoxynivalenol results in decreased expression of NFE2L2 mRNA 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased expression of NFE2L2 mRNA]; Resveratrol inhibits the reaction [deoxynivalenol results in decreased expression of NFE2L2 protein] |
CTD |
PMID:30244016 PMID:34400200 PMID:34677630 PMID:37419272 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions increases expression increases activity affects localization |
ISO EXP |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased activity of NFKB1 protein]; deoxynivalenol results in decreased activity of [NFKB1 protein binds to NFKB1 protein]; deoxynivalenol results in decreased activity of [REL protein binds to NFKB1 protein] deoxynivalenol results in increased expression of NFKB1 mRNA deoxynivalenol affects the localization of NFKB1 protein |
CTD |
PMID:8887449 PMID:12604842 PMID:15772366 PMID:35314294 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKB2 |
nuclear factor kappa B subunit 2 |
increases expression multiple interactions |
EXP |
deoxynivalenol results in increased expression of NFKB2 mRNA deoxynivalenol inhibits the reaction [NFKB2 protein binds to CXCL8 promoter] |
CTD |
PMID:17636245 PMID:22846391 |
|
NCBI chr10:102,394,110...102,402,529
Ensembl chr10:102,394,110...102,402,524
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
increases degradation multiple interactions increases phosphorylation increases expression decreases expression |
EXP ISO |
deoxynivalenol results in increased degradation of NFKBIA protein deoxynivalenol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of NFKBIA protein] deoxynivalenol results in increased phosphorylation of NFKBIA protein deoxynivalenol results in increased expression of NFKBIA mRNA deoxynivalenol results in decreased expression of NFKBIA mRNA; deoxynivalenol results in decreased expression of NFKBIA protein lipopolysaccharide, E coli O55-B5 inhibits the reaction [deoxynivalenol results in increased degradation of NFKBIA protein] |
CTD |
PMID:8887449 PMID:18485432 PMID:23253260 PMID:24937323 PMID:26961612 PMID:34400200 More...
|
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NFKBIB |
NFKB inhibitor beta |
increases expression |
EXP |
deoxynivalenol results in increased expression of NFKBIB mRNA |
CTD |
PMID:22846391 |
|
NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893
|
|
G |
NFYA |
nuclear transcription factor Y subunit alpha |
increases expression |
EXP |
deoxynivalenol results in increased expression of NFYA protein |
CTD |
PMID:33890134 |
|
NCBI chr 6:41,072,974...41,102,403
Ensembl chr 6:41,072,974...41,102,403
|
|
G |
NHERF1 |
NHERF family PDZ scaffold protein 1 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of NHERF1 protein |
CTD |
PMID:23811945 |
|
NCBI chr17:74,748,628...74,769,353
Ensembl chr17:74,748,628...74,769,353
|
|
G |
NIBAN3 |
niban apoptosis regulator 3 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of NIBAN3 protein |
CTD |
PMID:23811945 |
|
NCBI chr19:17,523,301...17,555,537
Ensembl chr19:17,523,301...17,553,839
|
|
G |
NIPBL |
NIPBL cohesin loading factor |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of NIPBL protein |
CTD |
PMID:23811945 |
|
NCBI chr 5:36,876,769...37,066,413
Ensembl chr 5:36,876,769...37,066,413
|
|
G |
NLRP3 |
NLR family pyrin domain containing 3 |
multiple interactions increases expression |
ISO |
deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of NLRP3 mRNA]; deoxynivalenol promotes the reaction [fumonisin B1 results in increased expression of NLRP3 protein]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of NLRP3 mRNA]; fumonisin B1 promotes the reaction [deoxynivalenol results in increased expression of NLRP3 protein] deoxynivalenol results in increased expression of NLRP3 mRNA; deoxynivalenol results in increased expression of NLRP3 protein |
CTD |
PMID:36309173 |
|
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,108
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
multiple interactions |
EXP |
[[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which affects the localization of ELAVL1 protein] which co-treated with deoxynivalenol] promotes the reaction [[ELAVL1 protein binds to ATF3 3' UTR] which results in increased stability of ATF3 mRNA]; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] affects the localization of ELAVL1 protein; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] affects the phosphorylation of RELA protein; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of ATF3 mRNA; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL1 mRNA; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL8 mRNA; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [deoxynivalenol results in increased expression of ATF3 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [deoxynivalenol results in increased expression of CXCL1 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA]; ATF3 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] affects the phosphorylation of RELA protein]; ELAVL1 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL1 mRNA]; ELAVL1 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL8 mRNA] |
CTD |
PMID:22003189 |
|
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
|
|
G |
NOLC1 |
nucleolar and coiled-body phosphoprotein 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of NOLC1 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr10:102,152,389...102,163,870
Ensembl chr10:102,152,176...102,163,871
|
|
G |
NOP56 |
NOP56 ribonucleoprotein |
affects phosphorylation increases phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of NOP56 protein deoxynivalenol results in increased phosphorylation of NOP56 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr20:2,652,632...2,658,393
Ensembl chr20:2,652,593...2,658,393
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions increases activity increases expression |
ISO EXP |
Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of NOS2 protein]; deoxynivalenol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA]; deoxynivalenol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]; Ro 31-8220 inhibits the reaction [deoxynivalenol results in increased expression of NOS2 protein] deoxynivalenol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] deoxynivalenol results in increased activity of NOS2 protein deoxynivalenol results in increased expression of NOS2 mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; Adenine inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]; deoxynivalenol results in increased ubiquitination of and results in increased degradation of NOS2 protein; lactacystin inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; lactacystin inhibits the reaction [deoxynivalenol results in increased degradation of NOS2 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; SB 203580 inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]] |
CTD |
PMID:19857559 PMID:21748807 PMID:24937323 PMID:25766886 PMID:32416088 PMID:34673182 More...
|
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NPFFR2 |
neuropeptide FF receptor 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of NPFFR2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 4:72,032,000...72,148,305
Ensembl chr 4:72,031,902...72,148,305
|
|
G |
NPM1 |
nucleophosmin 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of NPM1 protein |
CTD |
PMID:23811945 |
|
NCBI chr 5:171,387,116...171,410,900
Ensembl chr 5:171,387,116...171,411,810
|
|
G |
NPY |
neuropeptide Y |
increases expression |
ISO |
deoxynivalenol results in increased expression of NPY mRNA |
CTD |
PMID:32738333 |
|
NCBI chr 7:24,284,190...24,291,862
Ensembl chr 7:24,284,188...24,291,862
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression multiple interactions decreases expression |
ISO EXP |
deoxynivalenol results in increased expression of NQO1 mRNA Resveratrol inhibits the reaction [deoxynivalenol results in decreased expression of NQO1 protein] deoxynivalenol results in decreased expression of NQO1 mRNA |
CTD |
PMID:34400200 PMID:37419272 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NR1D1 |
nuclear receptor subfamily 1 group D member 1 |
increases expression multiple interactions decreases expression |
EXP ISO |
deoxynivalenol results in increased expression of NR1D1 mRNA BMAL1 protein promotes the reaction [deoxynivalenol results in decreased expression of NR1D1 protein]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of NR1D1 mRNA] |
CTD |
PMID:22846391 PMID:36602574 |
|
NCBI chr17:40,092,793...40,100,589
Ensembl chr17:40,092,793...40,100,589
|
|
G |
NR1D2 |
nuclear receptor subfamily 1 group D member 2 |
multiple interactions |
ISO |
deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of NR1D2 mRNA] |
CTD |
PMID:36602574 |
|
NCBI chr 3:23,945,286...23,980,617
Ensembl chr 3:23,945,286...23,980,617
|
|
G |
NR4A1 |
nuclear receptor subfamily 4 group A member 1 |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of NR4A1 mRNA [Colforsin co-treated with deoxynivalenol] results in increased expression of NR4A1 mRNA |
CTD |
PMID:15371230 PMID:26783879 |
|
NCBI chr12:52,022,832...52,059,503
Ensembl chr12:52,022,832...52,059,507
|
|
G |
NR4A3 |
nuclear receptor subfamily 4 group A member 3 |
increases expression |
EXP |
deoxynivalenol results in increased expression of NR4A3 mRNA |
CTD |
PMID:26763390 |
|
NCBI chr 9:99,821,885...99,866,891
Ensembl chr 9:99,821,855...99,866,891
|
|
G |
NR5A1 |
nuclear receptor subfamily 5 group A member 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of NR5A1 mRNA |
CTD |
PMID:22982764 |
|
NCBI chr 9:124,481,236...124,507,399
Ensembl chr 9:124,481,236...124,507,420
|
|
G |
NRROS |
negative regulator of reactive oxygen species |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of NRROS protein |
CTD |
PMID:23811945 |
|
NCBI chr 3:196,639,694...196,662,004
Ensembl chr 3:196,639,694...196,662,004
|
|
G |
NTRK2 |
neurotrophic receptor tyrosine kinase 2 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of NTRK2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
|
|
G |
NUCKS1 |
nuclear casein kinase and cyclin dependent kinase substrate 1 |
decreases phosphorylation affects phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of NUCKS1 protein deoxynivalenol affects the phosphorylation of NUCKS1 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr 1:205,712,822...205,750,182
Ensembl chr 1:205,712,822...205,750,182
|
|
G |
NUDCD1 |
NudC domain containing 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of NUDCD1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 8:109,240,919...109,334,087
Ensembl chr 8:109,240,919...109,334,121
|
|
G |
NUFIP1 |
nuclear FMR1 interacting protein 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of NUFIP1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr13:44,939,249...44,989,471
Ensembl chr13:44,939,249...44,989,471
|
|
G |
NUMA1 |
nuclear mitotic apparatus protein 1 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of NUMA1 protein |
CTD |
PMID:23352502 |
|
NCBI chr11:72,002,864...72,080,542
Ensembl chr11:72,002,864...72,080,693
|
|
G |
NUP155 |
nucleoporin 155 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of NUP155 protein |
CTD |
PMID:23811945 |
|
NCBI chr 5:37,288,137...37,371,106
Ensembl chr 5:37,288,137...37,371,106
|
|
G |
NUP98 |
nucleoporin 98 and 96 precursor |
affects phosphorylation increases phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of NUP98 protein deoxynivalenol results in increased phosphorylation of NUP98 protein |
CTD |
PMID:23811945 |
|
NCBI chr11:3,675,010...3,797,554
Ensembl chr11:3,671,083...3,797,792
|
|
G |
NUSAP1 |
nucleolar and spindle associated protein 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of NUSAP1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:41,332,881...41,381,046
Ensembl chr15:41,320,794...41,381,050
|
|
G |
OAS2 |
2'-5'-oligoadenylate synthetase 2 |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of OAS2 mRNA |
CTD |
PMID:17090620 |
|
NCBI chr12:112,978,519...113,011,723
Ensembl chr12:112,978,395...113,011,723
|
|
G |
OCLN |
occludin |
affects localization decreases expression multiple interactions increases expression |
EXP ISO |
deoxynivalenol affects the localization of OCLN protein deoxynivalenol results in decreased expression of OCLN mRNA; deoxynivalenol results in decreased expression of OCLN protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN mRNA]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN mRNA]]; Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of OCLN mRNA]; Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of OCLN protein]; lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of OCLN protein]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of OCLN mRNA] deoxynivalenol results in increased expression of OCLN mRNA |
CTD |
PMID:20362602 PMID:24568843 PMID:34506767 PMID:35381244 PMID:35817260 |
|
NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
|
|
G |
ODC1 |
ornithine decarboxylase 1 |
increases activity |
ISO |
deoxynivalenol results in increased activity of ODC1 protein |
CTD |
PMID:24937323 |
|
NCBI chr 2:10,439,968...10,448,327
Ensembl chr 2:10,439,968...10,448,327
|
|
G |
OGA |
O-GlcNAcase |
increases expression |
EXP |
deoxynivalenol results in increased expression of OGA mRNA |
CTD |
PMID:31863870 |
|
NCBI chr10:101,784,450...101,818,444
Ensembl chr10:101,784,443...101,818,465
|
|
G |
OGG1 |
8-oxoguanine DNA glycosylase |
increases expression |
EXP |
deoxynivalenol results in increased expression of OGG1 mRNA; deoxynivalenol results in increased expression of OGG1 protein |
CTD |
PMID:24355168 |
|
NCBI chr 3:9,749,952...9,783,108
Ensembl chr 3:9,749,944...9,788,219
|
|
G |
OIP5 |
Opa interacting protein 5 |
increases expression |
EXP |
deoxynivalenol results in increased expression of OIP5 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:41,309,273...41,332,591
Ensembl chr15:41,309,273...41,332,591
|
|
G |
OSER1 |
oxidative stress responsive serine rich 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of OSER1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr20:44,195,939...44,211,810
Ensembl chr20:44,195,939...44,210,771
|
|
G |
OSTF1 |
osteoclast stimulating factor 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of OSTF1 protein |
CTD |
PMID:23811945 |
|
NCBI chr 9:75,088,514...75,147,265
Ensembl chr 9:75,088,514...75,147,265
|
|
G |
P4HA3 |
prolyl 4-hydroxylase subunit alpha 3 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of P4HA3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr11:74,250,146...74,311,640
Ensembl chr11:74,235,801...74,311,640
|
|
G |
PALLD |
palladin, cytoskeletal associated protein |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of PALLD protein |
CTD |
PMID:23811945 |
|
NCBI chr 4:168,497,052...168,928,441
Ensembl chr 4:168,497,052...168,928,457
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases cleavage multiple interactions increases expression |
ISO EXP |
deoxynivalenol results in increased cleavage of PARP1 protein benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone affects the reaction [deoxynivalenol affects the expression of and results in increased cleavage of PARP1 protein]; deoxynivalenol affects the expression of and results in increased cleavage of PARP1 protein benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in decreased expression of and results in increased cleavage of PARP1 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in decreased expression of and results in increased cleavage of PARP1 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased cleavage of PARP1 protein]; deoxynivalenol results in decreased expression of and results in increased cleavage of PARP1 protein; GSDME protein inhibits the reaction [deoxynivalenol results in increased cleavage of PARP1 protein] deoxynivalenol results in increased expression of PARP1 mRNA |
CTD |
PMID:19410639 PMID:34677630 PMID:35925383 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PCK2 |
phosphoenolpyruvate carboxykinase 2, mitochondrial |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of PCK2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr14:24,094,171...24,104,125
Ensembl chr14:24,094,053...24,110,598
|
|
G |
PCNA |
proliferating cell nuclear antigen |
decreases expression multiple interactions |
ISO |
deoxynivalenol results in decreased expression of PCNA protein lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of PCNA protein] |
CTD |
PMID:34506767 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PCOLCE |
procollagen C-endopeptidase enhancer |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of PCOLCE mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 7:100,602,363...100,608,175
Ensembl chr 7:100,602,363...100,608,175
|
|
G |
PCYOX1L |
prenylcysteine oxidase 1 like |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of PCYOX1L mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 5:149,358,046...149,369,653
Ensembl chr 5:149,358,037...149,369,653
|
|
G |
PDCD1 |
programmed cell death 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of PDCD1 mRNA |
CTD |
PMID:27757495 |
|
NCBI chr 2:241,849,884...241,858,894
Ensembl chr 2:241,849,884...241,858,894
|
|
G |
PDCD11 |
programmed cell death 11 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of PDCD11 protein |
CTD |
PMID:23352502 |
|
NCBI chr10:103,396,626...103,446,294
Ensembl chr10:103,396,626...103,446,294
|
|
G |
PDE12 |
phosphodiesterase 12 |
increases expression |
EXP |
deoxynivalenol results in increased expression of PDE12 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 3:57,556,274...57,656,495
Ensembl chr 3:57,556,274...57,566,848
|
|
G |
PDLIM2 |
PDZ and LIM domain 2 |
affects phosphorylation increases phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of PDLIM2 protein deoxynivalenol results in increased phosphorylation of PDLIM2 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr 8:22,578,741...22,598,026
Ensembl chr 8:22,578,279...22,598,025
|
|
G |
PDLIM4 |
PDZ and LIM domain 4 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of PDLIM4 protein |
CTD |
PMID:23811945 |
|
NCBI chr 5:132,257,696...132,273,454
Ensembl chr 5:132,257,696...132,273,454
|
|
G |
PDSS2 |
decaprenyl diphosphate synthase subunit 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of PDSS2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 6:107,152,562...107,459,564
Ensembl chr 6:107,152,562...107,459,564
|
|
G |
PEA15 |
proliferation and apoptosis adaptor protein 15 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of PEA15A protein |
CTD |
PMID:23811945 |
|
NCBI chr 1:160,205,384...160,215,372
Ensembl chr 1:160,205,380...160,215,376
|
|
G |
PER1 |
period circadian regulator 1 |
multiple interactions |
ISO |
deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of PER1 mRNA]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of PER1 protein] |
CTD |
PMID:36602574 |
|
NCBI chr17:8,140,472...8,152,404
Ensembl chr17:8,140,472...8,156,506
|
|
G |
PER2 |
period circadian regulator 2 |
decreases expression multiple interactions |
ISO |
deoxynivalenol results in decreased expression of PER2 mRNA; deoxynivalenol results in decreased expression of PER2 protein BMAL1 protein promotes the reaction [deoxynivalenol results in decreased expression of PER2 protein] |
CTD |
PMID:36602574 |
|
NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102
|
|
G |
PER3 |
period circadian regulator 3 |
multiple interactions decreases expression |
ISO |
BMAL1 protein promotes the reaction [deoxynivalenol results in decreased expression of PER3 protein]; deoxynivalenol inhibits the reaction [BMAL1 protein results in increased expression of PER3 mRNA] |
CTD |
PMID:36602574 |
|
NCBI chr 1:7,784,291...7,845,177
Ensembl chr 1:7,784,291...7,845,177
|
|
G |
PGR |
progesterone receptor |
multiple interactions increases expression |
EXP |
afimoxifene inhibits the reaction [deoxynivalenol results in increased expression of PGR mRNA]; deoxynivalenol promotes the reaction [Estradiol results in increased expression of PGR mRNA]; deoxynivalenol promotes the reaction [Zearalenone results in increased expression of PGR mRNA]; ESR1 promotes the reaction [deoxynivalenol results in increased expression of PGR mRNA] |
CTD |
PMID:35588983 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
G |
PGRMC1 |
progesterone receptor membrane component 1 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of PGRMC1 protein |
CTD |
PMID:23811945 |
|
NCBI chr X:119,236,285...119,244,466
Ensembl chr X:119,236,245...119,244,466
|
|
G |
PHAX |
phosphorylated adaptor for RNA export |
increases expression |
EXP |
deoxynivalenol results in increased expression of PHAX mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 5:126,600,947...126,627,252
Ensembl chr 5:126,600,925...126,627,252
|
|
G |
PHGDH |
phosphoglycerate dehydrogenase |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of PHGDH mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:119,711,934...119,744,215
Ensembl chr 1:119,648,411...119,744,218
|
|
G |
PHLDA1 |
pleckstrin homology like domain family A member 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of PHLDA1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr12:76,025,447...76,031,776
Ensembl chr12:76,025,447...76,031,776
|
|
G |
PHLDA3 |
pleckstrin homology like domain family A member 3 |
increases expression |
EXP |
deoxynivalenol results in increased expression of PHLDA3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:201,464,278...201,469,188
Ensembl chr 1:201,464,278...201,469,237
|
|
G |
PI4KB |
phosphatidylinositol 4-kinase beta |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of PI4KB protein |
CTD |
PMID:23811945 |
|
NCBI chr 1:151,291,797...151,327,715
Ensembl chr 1:151,291,797...151,327,715
|
|
G |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of PIK3CG protein |
CTD |
PMID:23811945 |
|
NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980
|
|
G |
PLEC |
plectin |
affects phosphorylation decreases phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of PLEC protein deoxynivalenol results in decreased phosphorylation of PLEC protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr 8:143,915,153...143,976,745
Ensembl chr 8:143,915,153...143,976,734
|
|
G |
PLEKHA6 |
pleckstrin homology domain containing A6 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of PLEKHA6 protein |
CTD |
PMID:23811945 |
|
NCBI chr 1:204,218,853...204,378,168
Ensembl chr 1:204,218,853...204,378,214
|
|
G |
PLEKHO2 |
pleckstrin homology domain containing O2 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of PLEKHO2 protein |
CTD |
PMID:23811945 |
|
NCBI chr15:64,841,915...64,868,002
Ensembl chr15:64,841,883...64,868,002
|
|
G |
PLIN2 |
perilipin 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of PLIN2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 9:19,108,388...19,127,492
Ensembl chr 9:19,108,375...19,149,290
|
|
G |
PLPP5 |
phospholipid phosphatase 5 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of PLPP5 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 8:38,263,130...38,269,224
Ensembl chr 8:38,263,130...38,269,243
|
|
G |
PLRG1 |
pleiotropic regulator 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of PLRG1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 4:154,535,005...154,550,400
Ensembl chr 4:154,535,005...154,550,400
|
|
G |
PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of PMAIP1 mRNA |
CTD |
PMID:22846391 PMID:24247028 |
|
NCBI chr18:59,899,996...59,904,305
Ensembl chr18:59,899,996...59,904,305
|
|
G |
PML |
PML nuclear body scaffold |
decreases phosphorylation affects phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of PML protein deoxynivalenol affects the phosphorylation of PML protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr15:73,994,716...74,047,827
Ensembl chr15:73,994,673...74,047,827
|
|
G |
PODNL1 |
podocan like 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of PODNL1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr19:13,931,187...13,953,383
Ensembl chr19:13,931,187...13,953,392
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
multiple interactions decreases activity increases expression |
EXP |
15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [deoxynivalenol results in increased expression of PPARG protein]; EGR1 protein promotes the reaction [deoxynivalenol results in increased expression of PPARG mRNA]; lipopolysaccharide, E coli O55-B5 affects the reaction [deoxynivalenol results in increased expression of PPARG mRNA]; MAPK1 protein promotes the reaction [deoxynivalenol results in increased expression of PPARG mRNA]; MAPK3 protein promotes the reaction [deoxynivalenol results in increased expression of PPARG mRNA]; PPARG protein affects the reaction [deoxynivalenol results in decreased degradation of CXCL8 mRNA]; U 0126 inhibits the reaction [deoxynivalenol results in increased expression of PPARG mRNA] deoxynivalenol results in decreased activity of PPARG protein |
CTD |
PMID:18485432 PMID:27481073 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PPM1D |
protein phosphatase, Mg2+/Mn2+ dependent 1D |
increases expression |
EXP |
deoxynivalenol results in increased expression of PPM1D mRNA |
CTD |
PMID:31863870 |
|
NCBI chr17:60,600,193...60,666,280
Ensembl chr17:60,600,193...60,666,280
|
|
G |
PPP2CA |
protein phosphatase 2 catalytic subunit alpha |
increases expression |
EXP |
deoxynivalenol results in increased expression of PPP2CA mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 5:134,194,332...134,226,073
Ensembl chr 5:134,194,035...134,226,073
|
|
G |
PPP3CB |
protein phosphatase 3 catalytic subunit beta |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of PPP3CB mRNA Fatty Acids, Omega-3 promotes the reaction [deoxynivalenol results in increased expression of PPP3CB mRNA] |
CTD |
PMID:15371230 PMID:15681167 |
|
NCBI chr10:73,436,433...73,496,024
Ensembl chr10:73,436,433...73,496,024
|
|
G |
PRC1 |
protein regulator of cytokinesis 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of PRC1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:90,966,040...90,994,535
Ensembl chr15:90,966,040...90,995,629
|
|
G |
PRELP |
proline and arginine rich end leucine rich repeat protein |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of PRELP mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:203,475,806...203,491,352
Ensembl chr 1:203,475,806...203,491,352
|
|
G |
PRKAR1A |
protein kinase cAMP-dependent type I regulatory subunit alpha |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of PRKAR1A protein |
CTD |
PMID:23811945 |
|
NCBI chr17:68,413,623...68,551,316
Ensembl chr17:68,511,780...68,551,319
|
|
G |
PRKAR2A |
protein kinase cAMP-dependent type II regulatory subunit alpha |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of PRKAR2A protein |
CTD |
PMID:23352502 |
|
NCBI chr 3:48,744,591...48,847,874
Ensembl chr 3:48,744,597...48,847,874
|
|
G |
PRKCA |
protein kinase C alpha |
multiple interactions affects localization |
ISO |
Celecoxib inhibits the reaction [deoxynivalenol affects the localization of PRKCA protein]; Ro 31-8220 inhibits the reaction [deoxynivalenol affects the localization of PRKCA protein] |
CTD |
PMID:32416088 |
|
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
|
|
G |
PRKCE |
protein kinase C epsilon |
multiple interactions affects localization |
ISO |
Celecoxib inhibits the reaction [deoxynivalenol affects the localization of PRKCE protein]; Ro 31-8220 inhibits the reaction [deoxynivalenol affects the localization of PRKCE protein] |
CTD |
PMID:32416088 |
|
NCBI chr 2:45,651,279...46,187,990
Ensembl chr 2:45,651,345...46,187,990
|
|
G |
PRKCG |
protein kinase C gamma |
multiple interactions affects localization |
ISO |
Celecoxib inhibits the reaction [deoxynivalenol affects the localization of PRKCG protein]; Ro 31-8220 inhibits the reaction [deoxynivalenol affects the localization of PRKCG protein] |
CTD |
PMID:32416088 |
|
NCBI chr19:53,881,094...53,907,652
Ensembl chr19:53,879,190...53,907,652
|
|
G |
PRKD2 |
protein kinase D2 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of PRKD2 protein |
CTD |
PMID:23811945 |
|
NCBI chr19:46,674,316...46,717,114
Ensembl chr19:46,674,275...46,717,127
|
|
G |
PROS1 |
protein S |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of PROS1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 3:93,873,051...93,973,896
Ensembl chr 3:93,873,051...93,980,003
|
|
G |
PRPF38B |
pre-mRNA processing factor 38B |
increases expression |
EXP |
deoxynivalenol results in increased expression of PRPF38B mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:108,692,310...108,702,928
Ensembl chr 1:108,692,310...108,702,928
|
|
G |
PRR5L |
proline rich 5 like |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of PRR5L mRNA |
CTD |
PMID:26763390 |
|
NCBI chr11:36,296,288...36,465,204
Ensembl chr11:36,296,288...36,465,204
|
|
G |
PSAT1 |
phosphoserine aminotransferase 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of PSAT1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 9:78,297,125...78,330,093
Ensembl chr 9:78,297,125...78,330,093
|
|
G |
PSIP1 |
PC4 and SRSF1 interacting protein 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of PSIP1 protein |
CTD |
PMID:23811945 |
|
NCBI chr 9:15,464,066...15,510,970
Ensembl chr 9:15,464,066...15,510,995
|
|
G |
PSMB8 |
proteasome 20S subunit beta 8 |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of PSMB8 mRNA |
CTD |
PMID:15371230 |
|
NCBI chr 6:32,840,717...32,844,679
Ensembl chr 6:32,840,717...32,844,679
|
|
G |
PSMD12 |
proteasome 26S subunit, non-ATPase 12 |
increases expression |
EXP |
deoxynivalenol results in increased expression of PSMD12 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr17:67,337,916...67,366,577
Ensembl chr17:67,337,916...67,366,605
|
|
G |
PSPC1 |
paraspeckle component 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of PSPC1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr13:19,671,205...19,782,945
Ensembl chr13:19,674,752...19,783,019
|
|
G |
PSTPIP2 |
proline-serine-threonine phosphatase interacting protein 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of PSTPIP2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr18:45,983,536...46,072,260
Ensembl chr18:45,983,536...46,072,272
|
|
G |
PTEN |
phosphatase and tensin homolog |
increases expression |
EXP |
deoxynivalenol results in increased expression of PTEN mRNA |
CTD |
PMID:22846391 |
|
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
|
|
G |
PTGES |
prostaglandin E synthase |
increases expression decreases expression |
ISO |
deoxynivalenol results in increased expression of PTGES mRNA deoxynivalenol results in decreased expression of PTGES mRNA |
CTD |
PMID:21873375 PMID:25549547 |
|
NCBI chr 9:129,738,349...129,753,042
Ensembl chr 9:129,738,331...129,753,042
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
increases expression increases stability multiple interactions |
EXP ISO |
deoxynivalenol results in increased expression of PTGS2 mRNA; deoxynivalenol results in increased expression of PTGS2 protein deoxynivalenol results in increased stability of PTGS2 mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 protein]; Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 protein]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 mRNA]; Indomethacin promotes the reaction [deoxynivalenol results in increased expression of PTGS2 protein]; PTGS2 protein affects the reaction [deoxynivalenol results in increased expression of IL6 mRNA]; PTGS2 protein affects the reaction [deoxynivalenol results in increased expression of IL6 protein]; Ro 31-8220 inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 protein]; SB 203580 inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 mRNA]; SB 203580 inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 protein]; SB 203580 inhibits the reaction [deoxynivalenol results in increased stability of PTGS2 mRNA] Lutein inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 protein] |
CTD |
PMID:11922776 PMID:12377986 PMID:12649040 PMID:14514436 PMID:15570035 PMID:20347963 PMID:20633634 PMID:21873375 PMID:24937323 PMID:27757495 PMID:32416088 More...
|
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTPN14 |
protein tyrosine phosphatase non-receptor type 14 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of PTPN14 protein |
CTD |
PMID:23811945 |
|
NCBI chr 1:214,348,700...214,551,602
Ensembl chr 1:214,348,700...214,552,449
|
|
G |
PTPN22 |
protein tyrosine phosphatase non-receptor type 22 |
increases expression |
ISO |
deoxynivalenol results in increased expression of PTPN22 mRNA |
CTD |
PMID:15371230 |
|
NCBI chr 1:113,813,811...113,871,759
Ensembl chr 1:113,813,811...113,871,753
|
|
G |
PTPRJ |
protein tyrosine phosphatase receptor type J |
increases expression |
ISO |
deoxynivalenol results in increased expression of PTPRJ mRNA |
CTD |
PMID:15371230 |
|
NCBI chr11:47,980,559...48,170,839
Ensembl chr11:47,980,425...48,170,839
|
|
G |
PYCARD |
PYD and CARD domain containing |
multiple interactions |
ISO |
[deoxynivalenol co-treated with fumonisin B1] results in increased expression of PYCARD mRNA; [deoxynivalenol co-treated with fumonisin B1] results in increased expression of PYCARD protein |
CTD |
PMID:36309173 |
|
NCBI chr16:31,201,486...31,202,760
Ensembl chr16:31,201,486...31,203,450
|
|
G |
PYY |
peptide YY |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of PYY protein; deoxynivalenol results in increased expression of PYY protein alternative form [Ruthenium Red co-treated with N-(2-hydroxy-3-(2-cyano-3-chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamine] inhibits the reaction [deoxynivalenol results in increased expression of PYY protein alternative form]; N-(2-hydroxy-3-(2-cyano-3-chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamine inhibits the reaction [deoxynivalenol results in increased expression of PYY protein alternative form]; Ruthenium Red inhibits the reaction [deoxynivalenol results in increased expression of PYY protein alternative form] |
CTD |
PMID:22903826 PMID:26979077 |
|
NCBI chr17:43,952,733...44,004,445
Ensembl chr17:43,952,733...44,004,469
|
|
G |
RAB18 |
RAB18, member RAS oncogene family |
increases expression |
EXP |
deoxynivalenol results in increased expression of RAB18 protein |
CTD |
PMID:33890134 |
|
NCBI chr10:27,504,304...27,542,239
Ensembl chr10:27,504,174...27,543,207
|
|
G |
RAE1 |
ribonucleic acid export 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of RAE1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr20:57,351,255...57,379,202
Ensembl chr20:57,351,223...57,379,211
|
|
G |
RALY |
RALY heterogeneous nuclear ribonucleoprotein |
increases expression |
EXP |
deoxynivalenol results in increased expression of RALY protein |
CTD |
PMID:33890134 |
|
NCBI chr20:33,993,911...34,084,884
Ensembl chr20:33,993,646...34,108,308
|
|
G |
RAMP1 |
receptor activity modifying protein 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of RAMP1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 2:237,858,880...237,912,106
Ensembl chr 2:237,858,893...237,912,106
|
|
G |
RANBP2 |
RAN binding protein 2 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of RANBP2 protein |
CTD |
PMID:23352502 |
|
NCBI chr 2:108,719,482...109,842,301
Ensembl chr 2:108,719,482...108,785,810
|
|
G |
RAVER1 |
ribonucleoprotein, PTB binding 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of RAVER1 protein |
CTD |
PMID:23352502 |
|
NCBI chr19:10,316,212...10,333,529
Ensembl chr19:10,316,212...10,333,529
|
|
G |
RBBP5 |
RB binding protein 5, histone lysine methyltransferase complex subunit |
increases expression |
EXP |
deoxynivalenol results in increased expression of RBBP5 mRNA |
CTD |
PMID:19438726 |
|
NCBI chr 1:205,086,142...205,121,978
Ensembl chr 1:205,086,142...205,122,015
|
|
G |
RBBP6 |
RB binding protein 6, ubiquitin ligase |
increases expression |
EXP |
deoxynivalenol results in increased expression of RBBP6 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr16:24,539,566...24,572,863
Ensembl chr16:24,537,693...24,572,863
|
|
G |
RBM12 |
RNA binding motif protein 12 |
increases expression |
EXP |
deoxynivalenol results in increased expression of RBM12 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr20:35,648,925...35,664,900
Ensembl chr20:35,648,925...35,664,956
|
|
G |
RBM15 |
RNA binding motif protein 15 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of RBM15 protein |
CTD |
PMID:23352502 |
|
NCBI chr 1:110,339,377...110,346,677
Ensembl chr 1:110,338,506...110,346,681
|
|
G |
RBM17 |
RNA binding motif protein 17 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of RBM17 protein |
CTD |
PMID:23352502 |
|
NCBI chr10:6,089,034...6,117,447
Ensembl chr10:6,089,034...6,117,457
|
|
G |
RBM25 |
RNA binding motif protein 25 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of RBM25 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr14:73,058,534...73,123,899
Ensembl chr14:73,058,532...73,123,899
|
|
G |
RBM3 |
RNA binding motif protein 3 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of RBM3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr X:48,574,484...48,581,162
Ensembl chr X:48,574,449...48,581,162
|
|
G |
RBM39 |
RNA binding motif protein 39 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of RBM39 protein |
CTD |
PMID:23811945 |
|
NCBI chr20:35,701,347...35,742,260
Ensembl chr20:35,701,347...35,742,312
|
|
G |
RCC1 |
regulator of chromosome condensation 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of RCC1 protein |
CTD |
PMID:23352502 |
|
NCBI chr 1:28,506,043...28,538,989
Ensembl chr 1:28,505,943...28,539,300
|
|
G |
RCOR1 |
REST corepressor 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of RCOR1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr14:102,592,649...102,730,561
Ensembl chr14:102,592,649...102,730,561
|
|
G |
REL |
REL proto-oncogene, NF-kB subunit |
affects localization increases activity multiple interactions |
ISO |
deoxynivalenol affects the localization of REL protein deoxynivalenol results in increased activity of REL protein 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased activity of REL protein]; deoxynivalenol results in decreased activity of [REL protein binds to NFKB1 protein] |
CTD |
PMID:8887449 PMID:12604842 PMID:15772366 |
|
NCBI chr 2:60,881,574...60,931,612
Ensembl chr 2:60,881,491...60,931,612
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
affects localization increases expression increases phosphorylation multiple interactions increases activity |
EXP ISO |
deoxynivalenol affects the localization of RELA protein deoxynivalenol results in increased expression of RELA mRNA; deoxynivalenol results in increased expression of RELA protein deoxynivalenol results in increased phosphorylation of RELA protein Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased phosphorylation of RELA protein] [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] affects the phosphorylation of RELA protein; ATF3 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] affects the phosphorylation of RELA protein]; deoxynivalenol promotes the reaction [RELA protein binds to CXCL8 promoter]; EIF2AK2 protein affects the reaction [deoxynivalenol results in increased activity of RELA protein]; Lutein inhibits the reaction [deoxynivalenol affects the localization of RELA protein]; Lutein inhibits the reaction [deoxynivalenol results in increased expression of RELA protein]; RELA protein promotes the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA]; SB 203580 inhibits the reaction [deoxynivalenol results in increased activity of RELA protein] |
CTD |
PMID:16424113 PMID:17636245 PMID:18599499 PMID:20347963 PMID:22003189 PMID:22846391 PMID:24937323 PMID:34400200 More...
|
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RELB |
RELB proto-oncogene, NF-kB subunit |
increases expression |
EXP |
deoxynivalenol results in increased expression of RELB mRNA |
CTD |
PMID:22846391 |
|
NCBI chr19:45,001,464...45,038,192
Ensembl chr19:45,001,461...45,038,192
|
|
G |
RGCC |
regulator of cell cycle |
increases expression |
EXP |
deoxynivalenol results in increased expression of RGCC mRNA |
CTD |
PMID:31863870 |
|
NCBI chr13:41,457,550...41,470,871
Ensembl chr13:41,457,550...41,470,871
|
|
G |
RGS4 |
regulator of G protein signaling 4 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of RGS4 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:163,068,871...163,076,802
Ensembl chr 1:163,068,775...163,076,802
|
|
G |
RGS5 |
regulator of G protein signaling 5 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of RGS5 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:163,142,299...163,321,735
Ensembl chr 1:163,111,121...163,321,791
|
|
G |
RHOH |
ras homolog family member H |
increases expression |
EXP |
deoxynivalenol results in increased expression of RHOH mRNA |
CTD |
PMID:24247028 |
|
NCBI chr 4:40,191,080...40,246,967
Ensembl chr 4:40,191,011...40,246,967
|
|
G |
RICTOR |
RPTOR independent companion of MTOR complex 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of RICTOR mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 5:38,937,920...39,074,399
Ensembl chr 5:38,937,920...39,074,402
|
|
G |
RIPK2 |
receptor interacting serine/threonine kinase 2 |
increases expression |
ISO |
deoxynivalenol results in increased expression of RIPK2 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 8:89,757,816...89,791,064
Ensembl chr 8:89,757,806...89,791,064
|
|
G |
RNASET2 |
ribonuclease T2 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of RNASET2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 6:166,922,113...166,956,550
Ensembl chr 6:166,922,113...166,957,191
|
|
G |
RNF111 |
ring finger protein 111 |
increases expression |
EXP |
deoxynivalenol results in increased expression of RNF111 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr15:58,987,663...59,097,419
Ensembl chr15:58,865,175...59,097,419
|
|
G |
RNPS1 |
RNA binding protein with serine rich domain 1 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of RNPS1 protein |
CTD |
PMID:23811945 |
|
NCBI chr16:2,253,116...2,268,126
Ensembl chr16:2,253,116...2,268,397
|
|
G |
RORA |
RAR related orphan receptor A |
increases expression |
EXP |
deoxynivalenol results in increased expression of RORA mRNA |
CTD |
PMID:24247028 |
|
NCBI chr15:60,488,284...61,229,302
Ensembl chr15:60,488,284...61,229,302
|
|
G |
RPL22L1 |
ribosomal protein L22 like 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of RPL22L1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 3:170,864,875...170,870,195
Ensembl chr 3:170,864,875...170,870,208
|
|
G |
RPL27A |
ribosomal protein L27a |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of RPL27A mRNA |
CTD |
PMID:24247028 |
|
NCBI chr11:8,682,792...8,689,872
Ensembl chr11:8,682,788...8,714,759
|
|
G |
RPL31 |
ribosomal protein L31 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of RPL31 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 2:101,002,289...101,019,724
Ensembl chr 2:101,002,229...101,024,032
|
|
G |
RPL4 |
ribosomal protein L4 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of RPL4 protein |
CTD |
PMID:23352502 |
|
NCBI chr15:66,498,015...66,504,855
Ensembl chr15:66,498,015...66,524,532
|
|
G |
RPLP0 |
ribosomal protein lateral stalk subunit P0 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of RPLP0 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr12:120,196,699...120,201,111
Ensembl chr12:120,196,699...120,201,235
|
|
G |
RPLP1 |
ribosomal protein lateral stalk subunit P1 |
decreases phosphorylation increases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of RPLP1 protein deoxynivalenol results in increased phosphorylation of RPLP1 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr15:69,452,818...69,456,205
Ensembl chr15:69,452,814...69,456,205
|
|
G |
RPLP2 |
ribosomal protein lateral stalk subunit P2 |
decreases phosphorylation increases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of RPLP2 protein deoxynivalenol results in increased phosphorylation of RPLP2 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr11:809,967...812,876
Ensembl chr11:809,965...812,880
|
|
G |
RPP30 |
ribonuclease P/MRP subunit p30 |
increases expression |
EXP |
deoxynivalenol results in increased expression of RPP30 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr10:90,871,974...90,908,556
Ensembl chr10:90,871,952...90,908,553
|
|
G |
RPS29 |
ribosomal protein S29 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of RPS29 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr14:49,570,988...49,598,710
Ensembl chr14:49,570,984...49,599,164
|
|
G |
RPS6 |
ribosomal protein S6 |
multiple interactions decreases phosphorylation |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased phosphorylation of RPS6 protein] |
CTD |
PMID:34506767 |
|
NCBI chr 9:19,375,715...19,380,236
Ensembl chr 9:19,375,715...19,380,236
|
|
G |
RPS6KA1 |
ribosomal protein S6 kinase A1 |
multiple interactions increases phosphorylation |
ISO |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of RPS6KA1 protein]; deoxynivalenol results in increased phosphorylation of and results in increased activity of RPS6KA1 protein |
CTD |
PMID:15772366 PMID:15976193 |
|
NCBI chr 1:26,529,761...26,575,025
Ensembl chr 1:26,529,761...26,575,030
|
|
G |
RPS6KA2 |
ribosomal protein S6 kinase A2 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of RPS6KA2 protein |
CTD |
PMID:16424113 |
|
NCBI chr 6:166,409,364...166,862,773
Ensembl chr 6:166,409,364...166,906,451
|
|
G |
RPS6KA5 |
ribosomal protein S6 kinase A5 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of RPS6KA5 protein |
CTD |
PMID:16424113 |
|
NCBI chr14:90,847,861...91,060,641
Ensembl chr14:90,847,861...91,060,641
|
|
G |
RPS6KB1 |
ribosomal protein S6 kinase B1 |
decreases phosphorylation multiple interactions |
ISO |
deoxynivalenol results in decreased phosphorylation of RPS6KB1 protein lauric acid inhibits the reaction [deoxynivalenol results in decreased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:34506767 |
|
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
|
|
G |
RRM2B |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
increases expression |
EXP |
deoxynivalenol results in increased expression of RRM2B mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 8:102,204,501...102,238,961
Ensembl chr 8:102,204,502...102,238,961
|
|
G |
RSL1D1 |
ribosomal L1 domain containing 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of RSL1D1 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr16:11,833,850...11,851,542
Ensembl chr16:11,833,850...11,851,580
|
|
G |
RUVBL2 |
RuvB like AAA ATPase 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of RUVBL2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr19:48,993,448...49,015,995
Ensembl chr19:48,993,562...49,015,970
|
|
G |
S100A4 |
S100 calcium binding protein A4 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of S100A4 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:153,543,621...153,545,806
Ensembl chr 1:153,543,613...153,550,136
|
|
G |
SAFB |
scaffold attachment factor B |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of SAFB protein |
CTD |
PMID:23352502 |
|
NCBI chr19:5,623,083...5,668,478
Ensembl chr19:5,623,035...5,668,478
|
|
G |
SAMHD1 |
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of SAMHD1 protein |
CTD |
PMID:23811945 |
|
NCBI chr20:36,889,773...36,951,708
Ensembl chr20:36,890,229...36,951,893
|
|
G |
SCARA5 |
scavenger receptor class A member 5 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SCARA5 mRNA |
CTD |
PMID:26763390 |
|
NCBI chr 8:27,869,883...27,992,673
Ensembl chr 8:27,869,883...27,992,673
|
|
G |
SCLT1 |
sodium channel and clathrin linker 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of SCLT1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 4:128,873,241...129,093,539
Ensembl chr 4:128,864,921...129,093,600
|
|
G |
SDC1 |
syndecan 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SDC1 protein |
CTD |
PMID:33890134 |
|
NCBI chr 2:20,200,797...20,225,475
Ensembl chr 2:20,200,797...20,225,433
|
|
G |
SEC61B |
SEC61 translocon subunit beta |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of SEC61B protein |
CTD |
PMID:23352502 |
|
NCBI chr 9:99,222,282...99,230,615
Ensembl chr 9:99,222,064...99,230,615
|
|
G |
SEMA3A |
semaphorin 3A |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SEMA3A mRNA |
CTD |
PMID:26763390 |
|
NCBI chr 7:83,955,777...84,492,725
Ensembl chr 7:83,955,777...84,492,724
|
|
G |
SERPINA3 |
serpin family A member 3 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SERPINA3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr14:94,612,391...94,624,053
Ensembl chr14:94,612,384...94,624,055
|
|
G |
SERPINE2 |
serpin family E member 2 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SERPINE2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 2:223,975,045...224,039,286
Ensembl chr 2:223,975,045...224,039,318
|
|
G |
SETD1A |
SET domain containing 1A, histone lysine methyltransferase |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of SETD1A protein |
CTD |
PMID:23352502 |
|
NCBI chr16:30,957,754...30,984,664
Ensembl chr16:30,957,294...30,984,664
|
|
G |
SF1 |
splicing factor 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of SF1 protein |
CTD |
PMID:23811945 |
|
NCBI chr11:64,764,606...64,778,542
Ensembl chr11:64,764,606...64,778,786
|
|
G |
SF3A1 |
splicing factor 3a subunit 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of SF3A1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr22:30,331,988...30,356,894
Ensembl chr22:30,331,988...30,356,919
|
|
G |
SFT2D2 |
SFT2 domain containing 2 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SFT2D2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:168,226,004...168,253,021
Ensembl chr 1:168,225,938...168,253,021
|
|
G |
SGPP1 |
sphingosine-1-phosphate phosphatase 1 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of SGPP1 protein |
CTD |
PMID:23811945 |
|
NCBI chr14:63,684,216...63,728,065
Ensembl chr14:63,684,216...63,728,065
|
|
G |
SH2D3C |
SH2 domain containing 3C |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of SH2D3C protein |
CTD |
PMID:23811945 |
|
NCBI chr 9:127,738,317...127,778,666
Ensembl chr 9:127,738,317...127,778,710
|
|
G |
SH3BP1 |
SH3 domain binding protein 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of SH3BP1 protein |
CTD |
PMID:23352502 |
|
NCBI chr22:37,639,669...37,656,117
Ensembl chr22:37,634,654...37,656,117
|
|
G |
SH3KBP1 |
SH3 domain containing kinase binding protein 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of SH3KBP1 protein |
CTD |
PMID:23811945 |
|
NCBI chr X:19,533,977...19,887,600
Ensembl chr X:19,533,977...19,887,600
|
|
G |
SHCBP1 |
SHC binding and spindle associated 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of SHCBP1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr16:46,578,591...46,621,379
Ensembl chr16:46,578,591...46,621,379
|
|
G |
SHOX |
SHOX homeobox |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SHOX mRNA |
CTD |
PMID:26763390 |
|
NCBI chr Y:624,344...659,411 NCBI chr X:624,344...659,411
Ensembl chr Y:624,344...659,411 Ensembl chr X:624,344...659,411
|
|
G |
SIRT1 |
sirtuin 1 |
multiple interactions increases expression |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased expression of SIRT1 mRNA] |
CTD |
PMID:34677630 |
|
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
|
|
G |
SLC10A2 |
solute carrier family 10 member 2 |
decreases expression multiple interactions |
EXP |
deoxynivalenol results in decreased expression of SLC10A2 mRNA GW 4064 inhibits the reaction [deoxynivalenol results in decreased expression of SLC10A2 mRNA]; SB 203580 inhibits the reaction [deoxynivalenol results in decreased expression of SLC10A2 mRNA] |
CTD |
PMID:35224661 PMID:37315771 |
|
NCBI chr13:103,043,998...103,066,417
Ensembl chr13:103,043,998...103,066,417
|
|
G |
SLC16A1 |
solute carrier family 16 member 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of SLC16A1 protein |
CTD |
PMID:23811945 |
|
NCBI chr 1:112,911,847...112,956,196
Ensembl chr 1:112,911,847...112,957,593
|
|
G |
SLC1A3 |
solute carrier family 1 member 3 |
affects localization |
ISO |
deoxynivalenol affects the localization of SLC1A3 protein |
CTD |
PMID:21748807 |
|
NCBI chr 5:36,606,606...36,688,334
Ensembl chr 5:36,596,588...36,688,334
|
|
G |
SLC1A5 |
solute carrier family 1 member 5 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SLC1A5 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr19:46,774,883...46,788,594
Ensembl chr19:46,774,883...46,788,594
|
|
G |
SLC25A6 |
solute carrier family 25 member 6 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SLC25A6 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr X:1,386,152...1,392,113 NCBI chr Y:1,386,152...1,392,113
Ensembl chr X:1,386,152...1,392,113 Ensembl chr Y:1,386,152...1,392,113
|
|
G |
SLC4A1AP |
solute carrier family 4 member 1 adaptor protein |
increases expression |
EXP |
deoxynivalenol results in increased expression of SLC4A1AP mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 2:27,663,889...27,694,969
Ensembl chr 2:27,663,426...27,695,366
|
|
G |
SLC4A7 |
solute carrier family 4 member 7 |
increases expression |
EXP |
deoxynivalenol results in increased expression of SLC4A7 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 3:27,372,723...27,484,384
Ensembl chr 3:27,372,723...27,484,420
|
|
G |
SLC51A |
solute carrier family 51 member A |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SLC51A mRNA |
CTD |
PMID:35224661 |
|
NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178
|
|
G |
SLC7A11 |
solute carrier family 7 member 11 |
decreases expression multiple interactions |
EXP |
deoxynivalenol results in decreased expression of SLC7A11 mRNA Resveratrol inhibits the reaction [deoxynivalenol results in decreased expression of SLC7A11 protein] |
CTD |
PMID:31863870 PMID:37419272 |
|
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
|
|
G |
SMARCC2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of SMARCC2 protein |
CTD |
PMID:23352502 |
|
NCBI chr12:56,162,359...56,189,483
Ensembl chr12:56,162,359...56,189,567
|
|
G |
SMOX |
spermine oxidase |
increases expression |
EXP |
deoxynivalenol results in increased expression of SMOX mRNA |
CTD |
PMID:26763390 |
|
NCBI chr20:4,148,828...4,187,727
Ensembl chr20:4,120,980...4,187,747
|
|
G |
SNIP1 |
Smad nuclear interacting protein 1 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of SNIP1 protein |
CTD |
PMID:23352502 |
|
NCBI chr 1:37,534,449...37,554,293
Ensembl chr 1:37,534,449...37,554,293
|
|
G |
SNW1 |
SNW domain containing 1 |
decreases phosphorylation increases expression |
ISO EXP |
deoxynivalenol results in decreased phosphorylation of SNW1 protein deoxynivalenol results in increased expression of SNW1 mRNA |
CTD |
PMID:23352502 PMID:31863870 |
|
NCBI chr14:77,717,599...77,761,156
Ensembl chr14:77,717,599...77,761,207
|
|
G |
SOCS1 |
suppressor of cytokine signaling 1 |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of SOCS1 mRNA deoxynivalenol inhibits the reaction [Antigens results in increased expression of SOCS1 mRNA] |
CTD |
PMID:19625342 PMID:28935500 |
|
NCBI chr16:11,254,417...11,256,204
Ensembl chr16:11,254,417...11,256,204
|
|
G |
SOCS2 |
suppressor of cytokine signaling 2 |
increases expression multiple interactions |
ISO |
deoxynivalenol results in increased expression of SOCS2 mRNA deoxynivalenol inhibits the reaction [Antigens results in increased expression of SOCS2 mRNA] |
CTD |
PMID:19625342 PMID:28935500 |
|
NCBI chr12:93,569,969...93,626,236
Ensembl chr12:93,569,814...93,583,487
|
|
G |
SOCS3 |
suppressor of cytokine signaling 3 |
increases expression |
ISO |
deoxynivalenol results in increased expression of SOCS3 mRNA; deoxynivalenol results in increased expression of SOCS3 protein |
CTD |
PMID:19625342 PMID:19805407 |
|
NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions decreases expression |
ISO |
Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of SOD1 mRNA] |
CTD |
PMID:35817260 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SOD2 |
superoxide dismutase 2 |
decreases expression increases expression |
EXP |
deoxynivalenol results in decreased expression of SOD2 mRNA deoxynivalenol results in increased expression of SOD2 mRNA |
CTD |
PMID:20702593 PMID:35314294 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SORBS2 |
sorbin and SH3 domain containing 2 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of SORBS2 protein |
CTD |
PMID:23811945 |
|
NCBI chr 4:185,585,523...185,956,372
Ensembl chr 4:185,585,444...185,956,652
|
|
G |
SOX4 |
SRY-box transcription factor 4 |
increases expression |
EXP |
deoxynivalenol results in increased expression of SOX4 mRNA |
CTD |
PMID:22846391 |
|
NCBI chr 6:21,593,751...21,598,619
Ensembl chr 6:21,593,751...21,598,619
|
|
G |
SOX5 |
SRY-box transcription factor 5 |
increases expression |
EXP |
deoxynivalenol results in increased expression of SOX5 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr12:23,529,504...24,562,650
Ensembl chr12:23,529,504...24,562,544
|
|
G |
SP1 |
Sp1 transcription factor |
multiple interactions affects expression increases phosphorylation |
EXP |
deoxynivalenol promotes the reaction [SP1 protein binds to KMT2A promoter]; SP1 protein promotes the reaction [deoxynivalenol results in increased expression of KMT2A mRNA] deoxynivalenol affects the expression of SP1 protein deoxynivalenol results in increased phosphorylation of SP1 protein |
CTD |
PMID:19438726 PMID:33890134 |
|
NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446
|
|
G |
SP100 |
SP100 nuclear antigen |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of SP100 protein |
CTD |
PMID:23811945 |
|
NCBI chr 2:230,416,201...230,545,606
Ensembl chr 2:230,415,942...230,545,606
|
|
G |
SPAG5 |
sperm associated antigen 5 |
increases expression |
EXP |
deoxynivalenol results in increased expression of SPAG5 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr17:28,577,574...28,599,025
Ensembl chr17:28,577,565...28,599,025
|
|
G |
SPP1 |
secreted phosphoprotein 1 |
decreases phosphorylation increases expression |
ISO EXP |
deoxynivalenol results in decreased phosphorylation of SPP1 protein deoxynivalenol results in increased expression of SPP1 mRNA |
CTD |
PMID:23352502 PMID:27757495 |
|
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
|
|
G |
SPRR1A |
small proline rich protein 1A |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SPRR1A protein |
CTD |
PMID:33890134 |
|
NCBI chr 1:152,984,081...152,985,814
Ensembl chr 1:152,984,081...152,985,814
|
|
G |
SPRR3 |
small proline rich protein 3 |
increases expression |
EXP |
deoxynivalenol results in increased expression of SPRR3 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 1:153,001,749...153,003,856
Ensembl chr 1:153,001,747...153,003,856
|
|
G |
SPTLC2 |
serine palmitoyltransferase long chain base subunit 2 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SPTLC2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr14:77,505,997...77,616,637
Ensembl chr14:77,505,997...77,616,637
|
|
G |
SQSTM1 |
sequestosome 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of SQSTM1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
SRFBP1 |
serum response factor binding protein 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of SRFBP1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 5:121,961,975...122,078,935
Ensembl chr 5:121,961,975...122,075,570
|
|
G |
SRP14-DT |
SRP14 divergent transcript |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SRP14-DT mRNA |
CTD |
PMID:26763390 |
|
NCBI chr15:40,039,311...40,067,509
Ensembl chr15:40,039,242...40,080,614
|
|
G |
SRRM1 |
serine and arginine repetitive matrix 1 |
increases phosphorylation affects phosphorylation decreases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of SRRM1 protein deoxynivalenol affects the phosphorylation of SRRM1 protein deoxynivalenol results in decreased phosphorylation of SRRM1 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr 1:24,643,302...24,673,281
Ensembl chr 1:24,631,716...24,673,281
|
|
G |
SRRM2 |
serine/arginine repetitive matrix 2 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of SRRM2 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr16:2,752,638...2,771,412
Ensembl chr16:2,752,626...2,772,538
|
|
G |
SRSF1 |
serine and arginine rich splicing factor 1 |
decreases phosphorylation increases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of SRSF1 protein deoxynivalenol results in increased phosphorylation of SRSF1 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr17:57,989,038...58,007,246
Ensembl chr17:58,000,919...58,007,346
|
|
G |
SRSF2 |
serine and arginine rich splicing factor 2 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of SRSF2 protein |
CTD |
PMID:23811945 |
|
NCBI chr17:76,734,115...76,737,411
Ensembl chr17:76,734,115...76,737,333
|
|
G |
SRSF9 |
serine and arginine rich splicing factor 9 |
decreases phosphorylation increases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of SRSF9 protein deoxynivalenol results in increased phosphorylation of SRSF9 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr12:120,461,672...120,469,748
Ensembl chr12:120,461,672...120,495,946
|
|
G |
SSRP1 |
structure specific recognition protein 1 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of SSRP1 protein |
CTD |
PMID:23811945 |
|
NCBI chr11:57,325,988...57,335,892
Ensembl chr11:57,325,986...57,335,892
|
|
G |
STAR |
steroidogenic acute regulatory protein |
multiple interactions |
ISO |
[Colforsin co-treated with deoxynivalenol] results in increased expression of STAR mRNA |
CTD |
PMID:26783879 |
|
NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
|
|
G |
STAT1 |
signal transducer and activator of transcription 1 |
multiple interactions increases expression increases phosphorylation |
ISO |
[deoxynivalenol results in increased susceptibility to Antigens] which results in increased expression of STAT1 mRNA; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [deoxynivalenol results in increased expression of STAT1 mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [deoxynivalenol results in increased phosphorylation of STAT1 protein]; stattic inhibits the reaction [deoxynivalenol results in increased expression of STAT1 mRNA]; stattic inhibits the reaction [deoxynivalenol results in increased phosphorylation of STAT1 protein] |
CTD |
PMID:22454431 PMID:28935500 |
|
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
|
|
G |
STAT2 |
signal transducer and activator of transcription 2 |
increases expression |
ISO |
deoxynivalenol results in increased expression of STAT2 mRNA |
CTD |
PMID:22454431 |
|
NCBI chr12:56,341,597...56,360,107
Ensembl chr12:56,341,597...56,360,203
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
multiple interactions increases phosphorylation increases expression |
ISO |
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [deoxynivalenol results in increased expression of STAT3 mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [deoxynivalenol results in increased phosphorylation of STAT3 protein]; stattic inhibits the reaction [deoxynivalenol results in increased expression of STAT3 mRNA]; stattic inhibits the reaction [deoxynivalenol results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:22454431 PMID:36602574 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
STAT4 |
signal transducer and activator of transcription 4 |
multiple interactions |
ISO |
[deoxynivalenol results in increased susceptibility to Antigens] which results in increased expression of STAT4 mRNA |
CTD |
PMID:28935500 |
|
NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,178,435
|
|
G |
STEAP3 |
STEAP3 metalloreductase |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of STEAP3 protein |
CTD |
PMID:23811945 |
|
NCBI chr 2:119,223,834...119,265,652
Ensembl chr 2:119,223,831...119,265,652
|
|
G |
STMN1 |
stathmin 1 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of STMN1 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr 1:25,884,179...25,906,880
Ensembl chr 1:25,884,181...25,906,991
|
|
G |
STRBP |
spermatid perinuclear RNA binding protein |
increases expression |
EXP |
deoxynivalenol results in increased expression of STRBP mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 9:123,109,494...123,268,586
Ensembl chr 9:123,109,500...123,268,586
|
|
G |
STRIP1 |
striatin interacting protein 1 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of STRIP1 protein |
CTD |
PMID:23811945 |
|
NCBI chr 1:110,031,577...110,054,641
Ensembl chr 1:110,031,577...110,074,641
|
|
G |
SULF1 |
sulfatase 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SULF1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 8:69,466,781...69,660,912
Ensembl chr 8:69,466,624...69,660,915
|
|
G |
SYBU |
syntabulin |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of SYBU mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 8:109,573,978...109,691,600
Ensembl chr 8:109,573,978...109,691,791
|
|
G |
SYNM |
synemin |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of SYNM protein |
CTD |
PMID:23811945 |
|
NCBI chr15:99,105,080...99,141,767
Ensembl chr15:99,098,217...99,135,593
|
|
G |
SYNPO2 |
synaptopodin 2 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of SYNPO2 protein |
CTD |
PMID:23811945 |
|
NCBI chr 4:118,850,681...119,061,247
Ensembl chr 4:118,850,688...119,061,247
|
|
G |
TAP1 |
transporter 1, ATP binding cassette subfamily B member |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of TAP1 mRNA; deoxynivalenol results in decreased expression of TAP1 protein |
CTD |
PMID:15766417 |
|
NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816
|
|
G |
TBC1D15 |
TBC1 domain family member 15 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of TBC1D15 protein |
CTD |
PMID:23352502 |
|
NCBI chr12:71,839,759...71,924,313
Ensembl chr12:71,839,707...71,927,248
|
|
G |
TBP |
TATA-box binding protein |
increases expression |
EXP |
deoxynivalenol results in increased expression of TBP protein |
CTD |
PMID:33890134 |
|
NCBI chr 6:170,554,369...170,572,859
Ensembl chr 6:170,554,302...170,572,870
|
|
G |
TCOF1 |
treacle ribosome biogenesis factor 1 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of TCOF1 protein |
CTD |
PMID:23811945 |
|
NCBI chr 5:150,357,697...150,400,293
Ensembl chr 5:150,357,629...150,400,308
|
|
G |
TF |
transferrin |
multiple interactions decreases expression |
EXP |
[deoxynivalenol co-treated with Zearalenone] affects the expression of TF mRNA; [deoxynivalenol co-treated with Zearalenone] results in increased expression of TF mRNA deoxynivalenol results in decreased expression of TF mRNA |
CTD |
PMID:28865950 PMID:28935499 |
|
NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
|
|
G |
TFAP4 |
transcription factor AP-4 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of TFAP4 protein |
CTD |
PMID:23352502 |
|
NCBI chr16:4,257,186...4,273,023
Ensembl chr16:4,257,186...4,273,075
|
|
G |
TFCP2L1 |
transcription factor CP2 like 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of TFCP2L1 protein |
CTD |
PMID:33890134 |
|
NCBI chr 2:121,216,587...121,285,202
Ensembl chr 2:121,216,587...121,285,202
|
|
G |
TFF1 |
trefoil factor 1 |
affects expression increases expression decreases secretion multiple interactions |
EXP |
deoxynivalenol affects the expression of TFF1 mRNA deoxynivalenol results in increased expression of TFF1 mRNA deoxynivalenol results in decreased secretion of TFF1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the reaction [deoxynivalenol affects the expression of TFF1 mRNA]; Adenine affects the reaction [deoxynivalenol affects the expression of TFF1 mRNA]; afimoxifene inhibits the reaction [deoxynivalenol results in increased expression of TFF1 mRNA]; deoxynivalenol promotes the reaction [Estradiol results in increased expression of TFF1 mRNA]; deoxynivalenol promotes the reaction [Zearalenone results in increased expression of TFF1 mRNA]; ESR1 promotes the reaction [deoxynivalenol results in increased expression of TFF1 mRNA]; SB 203580 affects the reaction [deoxynivalenol affects the expression of TFF1 mRNA] |
CTD |
PMID:30854615 PMID:35588983 |
|
NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
|
|
G |
TFF2 |
trefoil factor 2 |
decreases secretion affects expression multiple interactions |
EXP |
deoxynivalenol results in decreased secretion of TFF2 protein deoxynivalenol affects the expression of TFF2 mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the reaction [deoxynivalenol affects the expression of TFF2 mRNA]; Adenine affects the reaction [deoxynivalenol affects the expression of TFF2 mRNA]; SB 203580 affects the reaction [deoxynivalenol affects the expression of TFF2 mRNA] |
CTD |
PMID:30854615 |
|
NCBI chr21:42,346,357...42,350,994
Ensembl chr21:42,346,357...42,350,997
|
|
G |
TFF3 |
trefoil factor 3 |
affects expression multiple interactions decreases secretion |
EXP |
deoxynivalenol affects the expression of TFF3 mRNA 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one affects the reaction [deoxynivalenol affects the expression of TFF3 mRNA]; Adenine affects the reaction [deoxynivalenol affects the expression of TFF3 mRNA]; SB 203580 affects the reaction [deoxynivalenol affects the expression of TFF3 mRNA] deoxynivalenol results in decreased secretion of TFF3 protein |
CTD |
PMID:30854615 |
|
NCBI chr21:42,311,667...42,315,409
Ensembl chr21:42,311,667...42,315,409
|
|
G |
TFRC |
transferrin receptor |
increases expression |
EXP |
deoxynivalenol results in increased expression of TFRC mRNA |
CTD |
PMID:37419272 |
|
NCBI chr 3:196,049,284...196,082,090
Ensembl chr 3:196,012,511...196,082,153
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions increases expression |
ISO |
deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of TGFB1 mRNA] deoxynivalenol results in increased expression of TGFB1 mRNA |
CTD |
PMID:14644621 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TGFB3 |
transforming growth factor beta 3 |
multiple interactions increases expression |
ISO |
deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of TGFB3 mRNA] deoxynivalenol results in increased expression of TGFB3 mRNA |
CTD |
PMID:14644621 |
|
NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011
|
|
G |
THRAP3 |
thyroid hormone receptor associated protein 3 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of THRAP3 protein |
CTD |
PMID:23352502 PMID:23811945 |
|
NCBI chr 1:36,207,637...36,305,357
Ensembl chr 1:36,224,432...36,305,357
|
|
G |
THRB |
thyroid hormone receptor beta |
decreases activity multiple interactions |
EXP |
deoxynivalenol results in decreased activity of THRB protein [15-acetyldeoxynivalenol co-treated with 3-acetyldeoxynivalenol co-treated with deoxynivalenol co-treated with zearalenol co-treated with Zearalenone] results in decreased activity of THRB protein; deoxynivalenol inhibits the reaction [Triiodothyronine results in increased activity of THRB protein] |
CTD |
PMID:27481073 PMID:31077750 |
|
NCBI chr 3:24,117,153...24,495,708
Ensembl chr 3:24,117,153...24,495,756
|
|
G |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of TIMP3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr22:32,801,705...32,863,041
Ensembl chr22:32,801,705...32,863,041
|
|
G |
TJP1 |
tight junction protein 1 |
affects localization multiple interactions decreases expression increases expression |
EXP ISO |
deoxynivalenol affects the localization of TJP1 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 protein]]; Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of and affects the localization of TJP1 protein]; Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]; deoxynivalenol results in decreased expression of and affects the localization of TJP1 protein; lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of TJP1 protein]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 protein] deoxynivalenol results in decreased expression of TJP1 mRNA; deoxynivalenol results in decreased expression of TJP1 protein deoxynivalenol results in increased expression of TJP1 mRNA |
CTD |
PMID:24568843 PMID:34506767 PMID:35381244 PMID:35817260 |
|
NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
|
|
G |
TLR1 |
toll like receptor 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of TLR1 mRNA |
CTD |
PMID:26763390 |
|
NCBI chr 4:38,787,569...38,805,644
Ensembl chr 4:38,790,677...38,856,817
|
|
G |
TLR2 |
toll like receptor 2 |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of TLR2 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
|
|
G |
TLR3 |
toll like receptor 3 |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of TLR3 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 4:186,069,156...186,088,073
Ensembl chr 4:186,068,911...186,088,073
|
|
G |
TLR4 |
toll like receptor 4 |
increases expression |
ISO |
deoxynivalenol results in increased expression of TLR4 mRNA; deoxynivalenol results in increased expression of TLR4 protein |
CTD |
PMID:34400200 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TLR5 |
toll like receptor 5 |
increases expression |
ISO |
deoxynivalenol results in increased expression of TLR5 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr 1:223,109,404...223,143,248
Ensembl chr 1:223,109,404...223,143,292
|
|
G |
TM9SF3 |
transmembrane 9 superfamily member 3 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of TM9SF3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr10:96,518,110...96,587,012
Ensembl chr10:96,518,110...96,587,452
|
|
G |
TMBIM6 |
transmembrane BAX inhibitor motif containing 6 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of TMBIM6 protein |
CTD |
PMID:33890134 |
|
NCBI chr12:49,741,557...49,764,934
Ensembl chr12:49,707,725...49,764,934
|
|
G |
TMPO |
thymopoietin |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of TMPO protein |
CTD |
PMID:23811945 |
|
NCBI chr12:98,515,573...98,550,351
Ensembl chr12:98,515,579...98,550,351
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions increases secretion increases expression increases stability |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased expression of TNF mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol results in increased secretion of TNF protein]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of TNF mRNA]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased expression of TNF protein]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of TNF mRNA]]; [deoxynivalenol results in increased susceptibility to Antigens] which results in increased expression of TNF protein; [Lipopolysaccharides co-treated with deoxynivalenol] results in increased expression of TNF protein; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [deoxynivalenol results in increased expression of TNF mRNA]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [deoxynivalenol results in increased expression of TNF mRNA]; BMAL1 protein inhibits the reaction [deoxynivalenol results in increased expression of TNF protein]; Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of TNF protein]; Curcumin inhibits the reaction [deoxynivalenol results in increased expression of TNF mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; Dichlororibofuranosylbenzimidazole inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; HCK protein affects the reaction [deoxynivalenol results in increased expression of TNF protein]; HMOX1 protein inhibits the reaction [deoxynivalenol results in increased expression of TNF protein]; Lipopolysaccharides promotes the reaction [deoxynivalenol results in increased expression of TNF mRNA]; Lipopolysaccharides promotes the reaction [deoxynivalenol results in increased expression of TNF protein]; Poly I-C promotes the reaction [deoxynivalenol results in increased expression of TNF mRNA]; pyrazolanthrone inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; resiquimod promotes the reaction [deoxynivalenol results in increased expression of TNF mRNA]; Rolipram inhibits the reaction [[Lipopolysaccharides co-treated with deoxynivalenol] results in increased expression of TNF protein]; SB 203580 inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; SB 203580 inhibits the reaction [deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; SB 203580 inhibits the reaction [deoxynivalenol results in increased expression of TNF mRNA]; SB 203580 inhibits the reaction [deoxynivalenol results in increased secretion of TNF protein]; sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of TNF mRNA]; stattic inhibits the reaction [deoxynivalenol results in increased expression of TNF mRNA]; Zymosan promotes the reaction [deoxynivalenol results in increased expression of TNF mRNA] deoxynivalenol results in increased expression of TNF mRNA; deoxynivalenol results in increased expression of TNF protein Bentonite inhibits the reaction [deoxynivalenol results in increased expression of TNF mRNA]; Bentonite inhibits the reaction [deoxynivalenol results in increased expression of TNF protein]; Charcoal inhibits the reaction [deoxynivalenol results in increased expression of TNF mRNA]; Charcoal inhibits the reaction [deoxynivalenol results in increased expression of TNF protein]; deoxynivalenol inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; Adenine inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased abundance of Nitric Oxide]; deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]; lactacystin inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; pyrrolidine dithiocarbamic acid inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]]; SB 203580 inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]] deoxynivalenol results in increased stability of TNF mRNA |
CTD |
PMID:9194413 PMID:9707511 PMID:10344227 PMID:11295263 PMID:11922776 PMID:12604842 PMID:14644621 PMID:15772366 PMID:16009389 PMID:16687389 PMID:17090620 PMID:18433975 PMID:18614267 PMID:19625342 PMID:21748807 PMID:21873375 PMID:22454431 PMID:22968694 PMID:24793808 PMID:24937323 PMID:25392278 PMID:25549547 PMID:25766886 PMID:26115597 PMID:27757495 PMID:28935500 PMID:31034930 PMID:32416088 PMID:32738333 PMID:33170220 PMID:34400200 PMID:35314294 PMID:35381244 PMID:35817260 PMID:35925383 PMID:36602574 More...
|
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFSF14 |
TNF superfamily member 14 |
increases expression |
ISO |
deoxynivalenol results in increased expression of TNFSF14 mRNA |
CTD |
PMID:22968694 |
|
NCBI chr19:6,661,253...6,670,588
Ensembl chr19:6,661,253...6,670,588
|
|
G |
TNFSF9 |
TNF superfamily member 9 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of TNFSF9 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr19:6,531,026...6,535,924
Ensembl chr19:6,531,026...6,535,924
|
|
G |
TNS1 |
tensin 1 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of TNS1 protein |
CTD |
PMID:23811945 |
|
NCBI chr 2:217,799,791...218,033,982
Ensembl chr 2:217,799,588...218,033,982
|
|
G |
TOMM20 |
translocase of outer mitochondrial membrane 20 |
increases phosphorylation affects localization |
EXP |
deoxynivalenol results in increased phosphorylation of TOMM20 protein deoxynivalenol affects the localization of TOMM20 protein |
CTD |
PMID:33890134 |
|
NCBI chr 1:235,109,341...235,128,837
Ensembl chr 1:235,109,341...235,128,837
|
|
G |
TOMM22 |
translocase of outer mitochondrial membrane 22 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of TOMM22 protein |
CTD |
PMID:33890134 |
|
NCBI chr22:38,681,957...38,685,421
Ensembl chr22:38,681,957...38,685,421
|
|
G |
TOMM40 |
translocase of outer mitochondrial membrane 40 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of TOMM40 protein |
CTD |
PMID:33890134 |
|
NCBI chr19:44,891,254...44,903,689
Ensembl chr19:44,890,569...44,903,689
|
|
G |
TOMM70 |
translocase of outer mitochondrial membrane 70 |
increases phosphorylation decreases expression |
ISO EXP |
deoxynivalenol results in increased phosphorylation of TOMM70A protein deoxynivalenol results in decreased expression of TOMM70A protein |
CTD |
PMID:23352502 PMID:33890134 |
|
NCBI chr 3:100,363,431...100,401,089
Ensembl chr 3:100,363,431...100,401,089
|
|
G |
TOP2B |
DNA topoisomerase II beta |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of TOP2B protein |
CTD |
PMID:23811945 |
|
NCBI chr 3:25,597,905...25,664,907
Ensembl chr 3:25,597,978...25,664,909
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions increases expression decreases expression increases activity |
ISO EXP |
[pifithrin results in decreased activity of TP53 protein] which results in decreased susceptibility to deoxynivalenol; Curcumin inhibits the reaction [deoxynivalenol results in increased expression of TRP53 protein]; deoxynivalenol results in increased phosphorylation of and results in increased activity of TRP53 protein; pifithrin inhibits the reaction [deoxynivalenol results in increased phosphorylation of and results in increased activity of TRP53 protein]; SB 203580 inhibits the reaction [deoxynivalenol results in increased phosphorylation of and results in increased activity of TRP53 protein] deoxynivalenol results in decreased expression of TP53 protein deoxynivalenol results in increased expression of TP53 mRNA [Zearalenone co-treated with Aflatoxin B1] promotes the reaction [deoxynivalenol results in increased expression of TP53 mRNA]; Aflatoxin B1 promotes the reaction [deoxynivalenol results in increased expression of TP53 mRNA] deoxynivalenol results in increased activity of TP53 protein |
CTD |
PMID:15976193 PMID:19664677 PMID:22491426 PMID:30668976 PMID:33890134 PMID:35817260 More...
|
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
|
|
G |
TP53INP1 |
tumor protein p53 inducible nuclear protein 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of TP53INP1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 8:94,925,972...94,949,378
Ensembl chr 8:94,925,972...94,949,378
|
|
G |
TRAF1 |
TNF receptor associated factor 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of TRAF1 mRNA |
CTD |
PMID:22846391 |
|
NCBI chr 9:120,902,393...120,929,171
Ensembl chr 9:120,902,393...120,929,173
|
|
G |
TRAF6 |
TNF receptor associated factor 6 |
increases expression |
EXP ISO |
deoxynivalenol results in increased expression of TRAF6 mRNA |
CTD |
PMID:22846391 PMID:34400200 |
|
NCBI chr11:36,483,769...36,510,272
Ensembl chr11:36,483,769...36,510,272
|
|
G |
TRIB3 |
tribbles pseudokinase 3 |
decreases expression |
ISO EXP |
deoxynivalenol results in decreased expression of TRIB3 mRNA |
CTD |
PMID:23253260 PMID:31863870 |
|
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
|
|
G |
TRIM28 |
tripartite motif containing 28 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of TRIM28 protein |
CTD |
PMID:23352502 |
|
NCBI chr19:58,544,064...58,550,715
Ensembl chr19:58,544,064...58,550,722
|
|
G |
TRMT13 |
tRNA methyltransferase 13 homolog |
increases expression |
EXP |
deoxynivalenol results in increased expression of TRMT13 mRNA |
CTD |
PMID:22846391 |
|
NCBI chr 1:100,133,163...100,150,496
Ensembl chr 1:100,133,150...100,150,496
|
|
G |
TRPA1 |
transient receptor potential cation channel subfamily A member 1 |
multiple interactions |
ISO |
TRPA1 affects the reaction [deoxynivalenol results in increased secretion of CCK protein] |
CTD |
PMID:25787141 |
|
NCBI chr 8:72,021,250...72,090,010
Ensembl chr 8:72,019,917...72,075,584
|
|
G |
TSLP |
thymic stromal lymphopoietin |
multiple interactions |
ISO |
deoxynivalenol promotes the reaction [Antigens, Dermatophagoides results in increased expression of TSLP protein] |
CTD |
PMID:33170220 |
|
NCBI chr 5:111,070,062...111,078,026
Ensembl chr 5:111,070,062...111,078,026
|
|
G |
TTK |
TTK protein kinase |
increases expression |
EXP |
deoxynivalenol results in increased expression of TTK mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 6:80,004,649...80,042,527
Ensembl chr 6:80,003,887...80,042,527
|
|
G |
TXNDC11 |
thioredoxin domain containing 11 |
decreases expression |
ISO |
deoxynivalenol results in decreased expression of TXNDC11 mRNA |
CTD |
PMID:23253260 |
|
NCBI chr16:11,679,083...11,742,857
Ensembl chr16:11,679,083...11,742,857
|
|
G |
TXNDC16 |
thioredoxin domain containing 16 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of TXNDC16 protein |
CTD |
PMID:23352502 |
|
NCBI chr14:52,430,596...52,552,505
Ensembl chr14:52,430,596...52,552,522
|
|
G |
UBE2C |
ubiquitin conjugating enzyme E2 C |
increases expression |
EXP |
deoxynivalenol results in increased expression of UBE2C mRNA |
CTD |
PMID:31863870 |
|
NCBI chr20:45,812,644...45,816,952
Ensembl chr20:45,812,576...45,816,957
|
|
G |
UGT2B4 |
UDP glucuronosyltransferase family 2 member B4 |
increases glucuronidation |
EXP |
UGT2B4 protein results in increased glucuronidation of deoxynivalenol |
CTD |
PMID:24927789 |
|
NCBI chr 4:69,480,165...69,526,014
Ensembl chr 4:69,480,165...69,526,014
|
|
G |
UGT2B7 |
UDP glucuronosyltransferase family 2 member B7 |
increases glucuronidation |
EXP |
UGT2B7 protein results in increased glucuronidation of deoxynivalenol |
CTD |
PMID:24927789 |
|
NCBI chr 4:69,051,375...69,112,987
Ensembl chr 4:69,051,363...69,112,987
|
|
G |
UHRF1 |
ubiquitin like with PHD and ring finger domains 1 |
affects phosphorylation |
ISO |
deoxynivalenol affects the phosphorylation of UHRF1 protein |
CTD |
PMID:23352502 |
|
NCBI chr19:4,903,080...4,962,154
Ensembl chr19:4,903,080...4,962,154
|
|
G |
UNC13D |
unc-13 homolog D |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of UNC13D protein |
CTD |
PMID:23811945 |
|
NCBI chr17:75,827,225...75,844,404
Ensembl chr17:75,827,225...75,844,785
|
|
G |
UPF2 |
UPF2 regulator of nonsense mediated mRNA decay |
increases expression |
EXP |
deoxynivalenol results in increased expression of UPF2 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr10:11,920,022...12,043,170
Ensembl chr10:11,920,022...12,043,170
|
|
G |
UPF3B |
UPF3B regulator of nonsense mediated mRNA decay |
increases expression |
EXP |
deoxynivalenol results in increased expression of UPF3B mRNA |
CTD |
PMID:31863870 |
|
NCBI chr X:119,805,311...119,852,963
Ensembl chr X:119,834,022...119,852,998
|
|
G |
UQCRC1 |
ubiquinol-cytochrome c reductase core protein 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of UQCRC1 protein |
CTD |
PMID:33890134 |
|
NCBI chr 3:48,599,002...48,609,646
Ensembl chr 3:48,599,002...48,610,976
|
|
G |
UQCRFS1 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of UQCRFS1 protein |
CTD |
PMID:33890134 |
|
NCBI chr19:29,205,320...29,213,151
Ensembl chr19:29,205,320...29,213,151
|
|
G |
USP15 |
ubiquitin specific peptidase 15 |
increases expression |
EXP |
deoxynivalenol results in increased expression of USP15 mRNA |
CTD |
PMID:22846391 |
|
NCBI chr12:62,260,404...62,416,389
Ensembl chr12:62,260,338...62,417,431
|
|
G |
USP24 |
ubiquitin specific peptidase 24 |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of USP24 protein |
CTD |
PMID:23811945 |
|
NCBI chr 1:55,066,359...55,215,364
Ensembl chr 1:55,066,359...55,215,378
|
|
G |
USP30 |
ubiquitin specific peptidase 30 |
increases expression |
EXP |
deoxynivalenol results in increased expression of USP30 mRNA |
CTD |
PMID:24247028 |
|
NCBI chr12:109,023,089...109,088,023
Ensembl chr12:109,023,089...109,088,023
|
|
G |
USP39 |
ubiquitin specific peptidase 39 |
decreases phosphorylation |
ISO |
deoxynivalenol results in decreased phosphorylation of USP39 protein |
CTD |
PMID:23352502 |
|
NCBI chr 2:85,602,861...85,649,283
Ensembl chr 2:85,602,856...85,649,283
|
|
G |
UTP3 |
UTP3 small subunit processome component |
increases expression |
EXP |
deoxynivalenol results in increased expression of UTP3 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 4:70,688,532...70,690,551
Ensembl chr 4:70,688,532...70,690,551
|
|
G |
VAMP4 |
vesicle associated membrane protein 4 |
increases expression |
EXP |
deoxynivalenol results in increased expression of VAMP4 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 1:171,700,160...171,742,065
Ensembl chr 1:171,700,160...171,742,074
|
|
G |
VCAN |
versican |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of VCAN mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 5:83,471,744...83,582,302
Ensembl chr 5:83,471,618...83,582,303
|
|
G |
VIL1 |
villin 1 |
multiple interactions decreases expression |
ISO |
lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of VIL1 protein] |
CTD |
PMID:34506767 |
|
NCBI chr 2:218,419,123...218,453,295
Ensembl chr 2:218,419,121...218,453,295
|
|
G |
VLDLR-AS1 |
VLDLR antisense RNA 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of VLDLR-AS1 mRNA |
CTD |
PMID:26763390 |
|
NCBI chr 9:2,535,652...2,622,373
Ensembl chr 9:2,421,597...2,622,457
|
|
G |
WARS1 |
tryptophanyl-tRNA synthetase 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of WARS1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr14:100,333,790...100,376,327
Ensembl chr14:100,333,790...100,376,805
|
|
G |
WASHC2C |
WASH complex subunit 2C |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of WASHC2 protein |
CTD |
PMID:23352502 |
|
NCBI chr10:45,727,043...45,792,964
Ensembl chr10:45,727,200...45,792,964
|
|
G |
WBP4 |
WW domain binding protein 4 |
increases expression |
EXP |
deoxynivalenol results in increased expression of WBP4 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr13:41,061,509...41,084,006
Ensembl chr13:41,061,509...41,084,006
|
|
G |
WDR20 |
WD repeat domain 20 |
increases expression |
EXP |
deoxynivalenol results in increased expression of WDR20 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr14:102,139,423...102,224,839
Ensembl chr14:102,139,503...102,224,847
|
|
G |
WDR5 |
WD repeat domain 5 |
increases expression |
EXP |
deoxynivalenol results in increased expression of WDR5 mRNA |
CTD |
PMID:19438726 |
|
NCBI chr 9:134,135,199...134,159,968
Ensembl chr 9:134,135,365...134,159,968
|
|
G |
WDR74 |
WD repeat domain 74 |
increases expression |
EXP |
deoxynivalenol results in increased expression of WDR74 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr11:62,832,905...62,841,809
Ensembl chr11:62,832,342...62,841,809
|
|
G |
WFDC1 |
WAP four-disulfide core domain 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of WFDC1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr16:84,294,878...84,329,844
Ensembl chr16:84,294,846...84,329,844
|
|
G |
WIPI1 |
WD repeat domain, phosphoinositide interacting 1 |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of WIPI1 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr17:68,421,281...68,457,496
Ensembl chr17:68,420,948...68,457,513
|
|
G |
WRAP53 |
WD repeat containing antisense to TP53 |
increases expression |
EXP |
deoxynivalenol results in increased expression of WRAP53 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr17:7,686,071...7,703,502
Ensembl chr17:7,686,071...7,703,502
|
|
G |
WWTR1 |
WW domain containing transcription regulator 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of WWTR1 protein |
CTD |
PMID:33890134 |
|
NCBI chr 3:149,517,235...149,724,788
Ensembl chr 3:149,517,235...149,736,714
|
|
G |
XBP1 |
X-box binding protein 1 |
increases expression increases splicing |
ISO |
deoxynivalenol results in increased expression of XBP1 protein deoxynivalenol results in increased splicing of XBP1 mRNA |
CTD |
PMID:19336499 |
|
NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597
|
|
G |
XRCC1 |
X-ray repair cross complementing 1 |
increases expression |
EXP |
deoxynivalenol results in increased expression of XRCC1 mRNA; deoxynivalenol results in increased expression of XRCC1 protein |
CTD |
PMID:24355168 |
|
NCBI chr19:43,543,311...43,575,527
Ensembl chr19:43,543,311...43,580,473
|
|
G |
YAP1 |
Yes1 associated transcriptional regulator |
decreases phosphorylation |
EXP |
deoxynivalenol results in decreased phosphorylation of YAP1 protein |
CTD |
PMID:33890134 |
|
NCBI chr11:102,110,447...102,233,424
Ensembl chr11:102,110,447...102,233,424
|
|
G |
ZBTB11 |
zinc finger and BTB domain containing 11 |
increases expression |
EXP |
deoxynivalenol results in increased expression of ZBTB11 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 3:101,648,889...101,677,132
Ensembl chr 3:101,648,889...101,677,135
|
|
G |
ZBTB18 |
zinc finger and BTB domain containing 18 |
increases expression |
EXP |
deoxynivalenol results in increased expression of ZBTB18 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 1:244,048,491...244,057,476
Ensembl chr 1:244,048,547...244,057,476
|
|
G |
ZBTB21 |
zinc finger and BTB domain containing 21 |
increases expression |
EXP |
deoxynivalenol results in increased expression of ZBTB21 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr21:41,986,831...42,010,360
Ensembl chr21:41,986,831...42,010,387
|
|
G |
ZBTB33 |
zinc finger and BTB domain containing 33 |
increases expression |
EXP |
deoxynivalenol results in increased expression of ZBTB33 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr X:120,250,812...120,258,398
Ensembl chr X:120,250,752...120,258,398
|
|
G |
ZC3H11A |
zinc finger CCCH-type containing 11A |
increases phosphorylation |
ISO |
deoxynivalenol results in increased phosphorylation of ZC3H11A protein |
CTD |
PMID:23352502 |
|
NCBI chr 1:203,795,623...203,854,124
Ensembl chr 1:203,795,623...203,854,999
|
|
G |
ZCCHC4 |
zinc finger CCHC-type containing 4 |
increases expression |
EXP |
deoxynivalenol results in increased expression of ZCCHC4 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 4:25,312,774...25,370,383
Ensembl chr 4:25,312,774...25,370,383
|
|
G |
ZEB1 |
zinc finger E-box binding homeobox 1 |
decreases activity multiple interactions |
ISO |
deoxynivalenol results in decreased activity of ZEB1 protein [Tetradecanoylphorbol Acetate co-treated with Ionomycin] promotes the reaction [deoxynivalenol results in decreased expression of ZEB1 protein] |
CTD |
PMID:11893416 |
|
NCBI chr10:31,318,417...31,529,804
Ensembl chr10:31,318,495...31,529,814
|
|
G |
ZEB2 |
zinc finger E-box binding homeobox 2 |
increases expression |
EXP |
deoxynivalenol results in increased expression of ZEB2 mRNA |
CTD |
PMID:26763390 |
|
NCBI chr 2:144,384,081...144,520,119
Ensembl chr 2:144,364,364...144,521,057
|
|
G |
ZNF354C |
zinc finger protein 354C |
decreases expression |
EXP |
deoxynivalenol results in decreased expression of ZNF354C protein |
CTD |
PMID:33890134 |
|
NCBI chr 5:179,060,373...179,083,977
Ensembl chr 5:179,060,373...179,083,977
|
|
G |
ZNF777 |
zinc finger protein 777 |
increases expression |
EXP |
deoxynivalenol results in increased expression of ZNF777 mRNA |
CTD |
PMID:31863870 |
|
NCBI chr 7:149,431,363...149,461,062
Ensembl chr 7:149,431,363...149,461,062
|
|
|
G |
ADRB2 |
adrenoceptor beta 2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of ADRB2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
|
|
G |
ANGPTL4 |
angiopoietin like 4 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr19:8,364,155...8,374,370
Ensembl chr19:8,363,289...8,374,370
|
|
G |
AR |
androgen receptor |
multiple interactions decreases activity |
EXP |
[15-acetyldeoxynivalenol co-treated with 3-acetyldeoxynivalenol co-treated with deoxynivalenol co-treated with zearalenol co-treated with Zearalenone] results in decreased activity of AR protein; [15-acetyldeoxynivalenol co-treated with 3-acetyldeoxynivalenol co-treated with deoxynivalenol] results in decreased activity of AR protein 15-acetyldeoxynivalenol results in decreased activity of AR protein |
CTD |
PMID:27481073 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
ARC |
activity regulated cytoskeleton associated protein |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of ARC mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 8:142,611,049...142,614,479
Ensembl chr 8:142,611,049...142,614,479
|
|
G |
AREG |
amphiregulin |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of AREG mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 4:74,445,136...74,455,005
Ensembl chr 4:74,445,136...74,455,005
|
|
G |
ARID5A |
AT-rich interaction domain 5A |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of ARID5A mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 2:96,536,752...96,552,638
Ensembl chr 2:96,536,743...96,552,634
|
|
G |
ARL5B |
ADP ribosylation factor like GTPase 5B |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of ARL5B mRNA |
CTD |
PMID:23792671 |
|
NCBI chr10:18,659,431...18,681,639
Ensembl chr10:18,659,431...18,681,639
|
|
G |
ARRDC4 |
arrestin domain containing 4 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of ARRDC4 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr15:97,960,703...97,973,833
Ensembl chr15:97,960,703...97,973,833
|
|
G |
ATF3 |
activating transcription factor 3 |
increases expression multiple interactions |
EXP |
15-acetyldeoxynivalenol results in increased expression of ATF3 mRNA [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [15-acetyldeoxynivalenol results in increased expression of ATF3 mRNA] |
CTD |
PMID:19101521 PMID:22003189 PMID:23792671 |
|
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
|
|
G |
ATF6 |
activating transcription factor 6 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of ATF6 mRNA |
CTD |
PMID:20682335 |
|
NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
|
|
G |
ATOSB |
atos homolog B |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of ATOSB mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 9:35,104,117...35,116,380
Ensembl chr 9:35,104,112...35,116,341
|
|
G |
BDKRB1 |
bradykinin receptor B1 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of BDKRB1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr14:96,256,210...96,264,763
Ensembl chr14:96,256,210...96,268,967
|
|
G |
BDKRB2 |
bradykinin receptor B2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of BDKRB2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
|
|
G |
BHLHE40 |
basic helix-loop-helix family member e40 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of BHLHE40 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 3:4,979,437...4,985,323
Ensembl chr 3:4,979,437...4,985,323
|
|
G |
BTG2 |
BTG anti-proliferation factor 2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of BTG2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602
|
|
G |
C11orf96 |
chromosome 11 open reading frame 96 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of C11ORF96 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr11:43,942,637...43,943,878
Ensembl chr11:43,942,637...43,943,878
|
|
G |
CCDC116 |
coiled-coil domain containing 116 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of CCDC116 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr22:21,632,760...21,637,329
Ensembl chr22:21,632,716...21,637,329
|
|
G |
CCK |
cholecystokinin |
increases expression |
ISO |
15-acetyldeoxynivalenol results in increased expression of CCK protein |
CTD |
PMID:24385417 |
|
NCBI chr 3:42,257,826...42,266,185
Ensembl chr 3:42,257,825...42,266,185
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
15-acetyldeoxynivalenol results in increased expression of CCL2 mRNA |
CTD |
PMID:24793808 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL3 |
C-C motif chemokine ligand 3 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of CCL3 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
|
|
G |
CCL3L3 |
C-C motif chemokine ligand 3 like 3 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of CCL3L3 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr17:36,194,869...36,196,758
Ensembl chr17:36,194,869...36,196,758
|
|
G |
CCL4 |
C-C motif chemokine ligand 4 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of CCL4 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
increases expression |
ISO |
15-acetyldeoxynivalenol results in increased expression of CCL7 mRNA |
CTD |
PMID:24793808 |
|
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
|
|
G |
CCR7 |
C-C motif chemokine receptor 7 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of CCR7 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,553,769...40,565,472
|
|
G |
CFL1P1 |
cofilin 1 pseudogene 1 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of CFL1P1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr10:87,818,313...87,845,612
Ensembl chr10:87,843,870...87,844,280 Ensembl chr10:87,843,870...87,844,280
|
|
G |
CREM |
cAMP responsive element modulator |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of CREM mRNA |
CTD |
PMID:23792671 |
|
NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
15-acetyldeoxynivalenol results in increased expression of CXCL2 mRNA |
CTD |
PMID:24793808 |
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
increases expression increases secretion |
EXP |
15-acetyldeoxynivalenol results in increased expression of CXCL8 mRNA 15-acetyldeoxynivalenol results in increased secretion of CXCL8 protein |
CTD |
PMID:23792671 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
CXCR4 |
C-X-C motif chemokine receptor 4 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of CXCR4 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of DDIT3 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DIXDC1 |
DIX domain containing 1 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of DIXDC1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr11:111,927,315...112,022,653
Ensembl chr11:111,927,144...112,022,653
|
|
G |
DLX1 |
distal-less homeobox 1 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of DLX1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 2:172,085,507...172,089,674
Ensembl chr 2:172,084,740...172,089,677
|
|
G |
DLX2 |
distal-less homeobox 2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of DLX2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 2:172,099,438...172,102,900
Ensembl chr 2:172,099,438...172,102,900
|
|
G |
DMRT2 |
doublesex and mab-3 related transcription factor 2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of DMRT2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 9:1,050,357...1,057,552
Ensembl chr 9:1,049,858...1,057,552
|
|
G |
DNAJB5 |
DnaJ heat shock protein family (Hsp40) member B5 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of DNAJB5 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 9:34,989,745...34,998,900
Ensembl chr 9:34,989,641...34,998,900
|
|
G |
DUSP10 |
dual specificity phosphatase 10 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of DUSP10 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 1:221,701,424...221,742,089
Ensembl chr 1:221,701,424...221,742,089
|
|
G |
DUSP8 |
dual specificity phosphatase 8 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of DUSP8 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr11:1,554,051...1,572,848
Ensembl chr11:1,554,051...1,572,271
|
|
G |
EGR3 |
early growth response 3 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of EGR3 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 8:22,687,659...22,693,480
Ensembl chr 8:22,687,659...22,693,480
|
|
G |
EIF2A |
eukaryotic translation initiation factor 2A |
increases phosphorylation |
EXP |
15-acetyldeoxynivalenol results in increased phosphorylation of EIF2A protein |
CTD |
PMID:20682335 |
|
NCBI chr 3:150,546,787...150,586,016
Ensembl chr 3:150,546,678...150,586,016
|
|
G |
EMX2 |
empty spiracles homeobox 2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of EMX2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr10:117,542,746...117,549,546
Ensembl chr10:117,542,445...117,549,546
|
|
G |
EPHB3 |
EPH receptor B3 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of EPHB3 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 3:184,561,785...184,582,408
Ensembl chr 3:184,561,785...184,582,408
|
|
G |
EREG |
epiregulin |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of EREG mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 4:74,365,145...74,388,749
Ensembl chr 4:74,365,145...74,388,749
|
|
G |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
decreases expression |
EXP |
15-acetyldeoxynivalenol results in decreased expression of ERN1 mRNA |
CTD |
PMID:20682335 |
|
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
|
|
G |
FAM43A |
family with sequence similarity 43 member A |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of FAM43A mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 3:194,685,883...194,689,037
Ensembl chr 3:194,685,883...194,689,037
|
|
G |
FAM90A7 |
family with sequence similarity 90 member A7 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of FAM90A7 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 8:7,556,700...7,559,712
Ensembl chr 8:7,556,700...7,559,712
|
|
G |
FBP2 |
fructose-bisphosphatase 2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of FBP2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 9:94,558,720...94,593,824
Ensembl chr 9:94,558,720...94,593,824
|
|
G |
FGF9 |
fibroblast growth factor 9 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of FGF9 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr13:21,671,073...21,704,498
Ensembl chr13:21,671,073...21,704,498
|
|
G |
FJX1 |
four-jointed box kinase 1 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of FJX1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr11:35,618,460...35,620,865
Ensembl chr11:35,618,460...35,620,865
|
|
G |
GEM |
GTP binding protein overexpressed in skeletal muscle |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of GEM mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 8:94,249,253...94,262,319
Ensembl chr 8:94,249,253...94,262,350
|
|
G |
GFOD1 |
Gfo/Idh/MocA-like oxidoreductase domain containing 1 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of GFOD1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 6:13,357,830...13,487,600
Ensembl chr 6:13,357,830...13,487,662
|
|
G |
GTF2IRD2 |
GTF2I repeat domain containing 2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of GTF2IRD2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 7:74,796,151...74,851,605
Ensembl chr 7:74,796,151...74,851,605
|
|
G |
HAS2 |
hyaluronan synthase 2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of HAS2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 8:121,612,116...121,641,440
Ensembl chr 8:121,612,116...121,641,440
|
|
G |
HOXB2 |
homeobox B2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of HOXB2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr17:48,542,655...48,545,109
Ensembl chr17:48,540,894...48,545,109
|
|
G |
HPSE2 |
heparanase 2 (inactive) |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of HPSE2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr10:98,457,077...99,315,951
Ensembl chr10:98,457,077...99,235,862
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression |
EXP |
15-acetyldeoxynivalenol results in decreased expression of HSPA5 mRNA |
CTD |
PMID:20682335 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
IL10RA |
interleukin 10 receptor subunit alpha |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of IL10RA mRNA |
CTD |
PMID:23792671 |
|
NCBI chr11:117,986,394...118,003,037
Ensembl chr11:117,986,370...118,003,037
|
|
G |
IL1B |
interleukin 1 beta |
increases expression |
EXP ISO |
15-acetyldeoxynivalenol results in increased expression of IL1B mRNA |
CTD |
PMID:23792671 PMID:24793808 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL2 |
interleukin 2 |
affects secretion increases expression |
ISO |
15-acetyldeoxynivalenol affects the secretion of IL2 protein 15-acetyldeoxynivalenol results in increased expression of IL2 mRNA |
CTD |
PMID:8560498 |
|
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL4 |
interleukin 4 |
affects secretion |
ISO |
15-acetyldeoxynivalenol affects the secretion of IL4 protein |
CTD |
PMID:8560498 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL5 |
interleukin 5 |
affects secretion |
ISO |
15-acetyldeoxynivalenol affects the secretion of IL5 protein |
CTD |
PMID:8560498 |
|
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
|
|
G |
IL6 |
interleukin 6 |
increases expression |
ISO |
15-acetyldeoxynivalenol results in increased expression of IL6 mRNA |
CTD |
PMID:8560498 PMID:24793808 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
IQCN |
IQ motif containing N |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of IQCN mRNA |
CTD |
PMID:23792671 |
|
NCBI chr19:18,257,098...18,274,452
Ensembl chr19:18,257,098...18,274,500
|
|
G |
IRGM |
immunity related GTPase M |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of IRGM mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 5:150,846,521...150,902,402
Ensembl chr 5:150,846,521...150,900,736
|
|
G |
KCNJ2 |
potassium inwardly rectifying channel subfamily J member 2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of KCNJ2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr17:70,169,532...70,180,044
Ensembl chr17:70,168,673...70,180,044
|
|
G |
KLF10 |
KLF transcription factor 10 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of KLF10 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 8:102,648,784...102,655,725
Ensembl chr 8:102,648,784...102,655,725
|
|
G |
LINC00312 |
long intergenic non-protein coding RNA 312 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of LINC00312 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 3:8,571,782...8,574,668
|
|
G |
MAN1B1 |
mannosidase alpha class 1B member 1 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of MAN1B1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 9:137,086,985...137,109,183
Ensembl chr 9:137,086,857...137,109,189
|
|
G |
MFSD2A |
MFSD2 lysolipid transporter A, lysophospholipid |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of MFSD2A mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 1:39,955,145...39,969,956
Ensembl chr 1:39,955,112...39,969,968
|
|
G |
MIR7-3HG |
MIR7-3 host gene |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of MIR7-3HG mRNA |
CTD |
PMID:23792671 |
|
NCBI chr19:4,769,105...4,772,556
Ensembl chr19:4,769,031...4,785,077
|
|
G |
MRAS |
muscle RAS oncogene homolog |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of MRAS mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 3:138,347,648...138,405,535
Ensembl chr 3:138,347,648...138,405,534
|
|
G |
MROH3P |
maestro heat like repeat family member 3, pseudogene |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of MROH3P mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 1:200,928,944...200,966,668
Ensembl chr 1:200,917,460...200,966,536
|
|
G |
MXD1 |
MAX dimerization protein 1 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of MXD1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 2:69,915,109...69,942,945
Ensembl chr 2:69,897,688...69,942,945
|
|
G |
NEURL3 |
neuralized E3 ubiquitin protein ligase 3 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of NEURL3 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 2:96,497,646...96,508,109
Ensembl chr 2:96,497,646...96,508,109
|
|
G |
NOD2 |
nucleotide binding oligomerization domain containing 2 |
multiple interactions |
EXP |
[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [15-acetyldeoxynivalenol results in increased expression of ATF3 mRNA] |
CTD |
PMID:22003189 |
|
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
|
|
G |
NR4A3 |
nuclear receptor subfamily 4 group A member 3 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of NR4A3 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 9:99,821,885...99,866,891
Ensembl chr 9:99,821,855...99,866,891
|
|
G |
NWD2 |
NACHT and WD repeat domain containing 2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of NWD2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 4:37,244,743...37,449,463
Ensembl chr 4:37,244,743...37,449,463
|
|
G |
PCDH9 |
protocadherin 9 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of PCDH9 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr13:66,302,834...67,230,336
Ensembl chr13:66,302,834...67,230,445
|
|
G |
PER1 |
period circadian regulator 1 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of PER1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr17:8,140,472...8,152,404
Ensembl chr17:8,140,472...8,156,506
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
decreases activity |
EXP |
15-acetyldeoxynivalenol results in decreased activity of PPARG protein |
CTD |
PMID:27481073 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PRECSIT |
p53 regulated carcinoma associated Stat3 activating long intergenic non-protein coding transcript |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of PRECSIT mRNA |
CTD |
PMID:23792671 |
|
NCBI chr13:110,863,987...110,870,308
Ensembl chr13:110,863,987...110,870,330
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
15-acetyldeoxynivalenol results in increased expression of PTGS2 mRNA |
CTD |
PMID:14514436 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RCAN1 |
regulator of calcineurin 1 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of RCAN1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr21:34,516,442...34,615,113
Ensembl chr21:34,513,142...34,615,113
|
|
G |
REM2 |
RRAD and GEM like GTPase 2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of REM2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr14:22,883,222...22,887,678
Ensembl chr14:22,883,222...22,887,678
|
|
G |
RGS16 |
regulator of G protein signaling 16 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of RGS16 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 1:182,598,623...182,604,389
Ensembl chr 1:182,598,623...182,604,389
|
|
G |
RHOH |
ras homolog family member H |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of RHOH mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 4:40,191,080...40,246,967
Ensembl chr 4:40,191,011...40,246,967
|
|
G |
RND1 |
Rho family GTPase 1 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of RND1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr12:48,857,145...48,865,870
Ensembl chr12:48,857,145...48,865,870
|
|
G |
SIX1 |
SIX homeobox 1 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of SIX1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr14:60,643,421...60,649,477
Ensembl chr14:60,643,421...60,658,259
|
|
G |
SLC34A1 |
solute carrier family 34 member 1 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of SLC34A1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 5:177,384,434...177,398,848
Ensembl chr 5:177,379,235...177,398,848
|
|
G |
SPANXN5 |
SPANX family member N5 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of SPANXN5 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr X:52,796,144...52,797,427
Ensembl chr X:52,796,144...52,797,427
|
|
G |
STMN4 |
stathmin 4 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of STMN4 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 8:27,235,308...27,258,404
Ensembl chr 8:27,235,308...27,258,420
|
|
G |
STOX2 |
storkhead box 2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of STOX2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 4:183,798,022...184,023,530
Ensembl chr 4:183,797,692...184,023,526
|
|
G |
TFAP2A |
transcription factor AP-2 alpha |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of TFAP2A mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 6:10,396,677...10,419,659
Ensembl chr 6:10,393,186...10,419,659
|
|
G |
THRB |
thyroid hormone receptor beta |
multiple interactions |
EXP |
[15-acetyldeoxynivalenol co-treated with 3-acetyldeoxynivalenol co-treated with deoxynivalenol co-treated with zearalenol co-treated with Zearalenone] results in decreased activity of THRB protein |
CTD |
PMID:27481073 |
|
NCBI chr 3:24,117,153...24,495,708
Ensembl chr 3:24,117,153...24,495,756
|
|
G |
TMCC2 |
transmembrane and coiled-coil domain family 2 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of TMCC2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 1:205,227,946...205,273,343
Ensembl chr 1:205,227,946...205,285,632
|
|
G |
TMEM88 |
transmembrane protein 88 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of TMEM88 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr17:7,855,066...7,856,099
Ensembl chr17:7,855,066...7,856,099
|
|
G |
TNF |
tumor necrosis factor |
increases expression |
EXP ISO |
15-acetyldeoxynivalenol results in increased expression of TNF mRNA |
CTD |
PMID:23792671 PMID:24793808 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
UCP1 |
uncoupling protein 1 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of UCP1 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 4:140,559,431...140,568,961
Ensembl chr 4:140,559,431...140,568,961
|
|
G |
ZBTB21 |
zinc finger and BTB domain containing 21 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of ZBTB21 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr21:41,986,831...42,010,360
Ensembl chr21:41,986,831...42,010,387
|
|
G |
ZC3H12D |
zinc finger CCCH-type containing 12D |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of ZC3H12D mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 6:149,446,795...149,485,014
Ensembl chr 6:149,446,795...149,485,014
|
|
G |
ZFP2 |
ZFP2 zinc finger protein |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of ZFP2 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 5:178,895,913...178,933,212
Ensembl chr 5:178,895,898...178,933,212
|
|
G |
ZNF77 |
zinc finger protein 77 |
increases expression |
EXP |
15-acetyldeoxynivalenol results in increased expression of ZNF77 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr19:2,933,218...2,950,625
Ensembl chr19:2,933,218...2,944,971
|
|
|
G |
AR |
androgen receptor |
multiple interactions decreases activity |
EXP |
[15-acetyldeoxynivalenol co-treated with 3-acetyldeoxynivalenol co-treated with deoxynivalenol co-treated with zearalenol co-treated with Zearalenone] results in decreased activity of AR protein; [15-acetyldeoxynivalenol co-treated with 3-acetyldeoxynivalenol co-treated with deoxynivalenol] results in decreased activity of AR protein 3-acetyldeoxynivalenol results in decreased activity of AR protein |
CTD |
PMID:27481073 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
ATF4 |
activating transcription factor 4 |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of ATF4 mRNA 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ATF4 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
|
|
G |
ATF6 |
activating transcription factor 6 |
increases expression multiple interactions |
EXP ISO |
3-acetyldeoxynivalenol results in increased expression of ATF6 mRNA 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ATF6 mRNA] |
CTD |
PMID:20682335 PMID:35413383 |
|
NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
|
|
G |
CCK |
cholecystokinin |
increases expression |
ISO |
3-acetyldeoxynivalenol results in increased expression of CCK protein |
CTD |
PMID:24385417 |
|
NCBI chr 3:42,257,826...42,266,185
Ensembl chr 3:42,257,825...42,266,185
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of CCL2 mRNA 3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of CCL2 protein; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of CCL2 protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of CCL2 mRNA] |
CTD |
PMID:24793808 PMID:35413383 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CCL7 |
C-C motif chemokine ligand 7 |
increases expression |
ISO |
3-acetyldeoxynivalenol results in increased expression of CCL7 mRNA |
CTD |
PMID:24793808 |
|
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
|
|
G |
CCL8 |
C-C motif chemokine ligand 8 |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of CCL8 mRNA 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of CCL8 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr17:34,319,435...34,321,402
Ensembl chr17:34,319,435...34,321,402
|
|
G |
CSF1 |
colony stimulating factor 1 |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of CSF1 mRNA 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of CSF1 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992
|
|
G |
CSF2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of CSF2 protein; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of CSF2 protein] |
CTD |
PMID:35413383 |
|
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
|
|
G |
CSF3 |
colony stimulating factor 3 |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of CSF3 mRNA 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of CSF3 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
3-acetyldeoxynivalenol results in increased expression of CXCL2 mRNA |
CTD |
PMID:24793808 |
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
increases secretion increases expression |
EXP |
3-acetyldeoxynivalenol results in increased secretion of CXCL8 protein 3-acetyldeoxynivalenol results in increased expression of CXCL8 mRNA |
CTD |
PMID:23792671 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of DDIT3 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
EIF2A |
eukaryotic translation initiation factor 2A |
increases phosphorylation |
EXP |
3-acetyldeoxynivalenol results in increased phosphorylation of EIF2A protein |
CTD |
PMID:20682335 |
|
NCBI chr 3:150,546,787...150,586,016
Ensembl chr 3:150,546,678...150,586,016
|
|
G |
EIF2AK3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases expression |
ISO |
3-acetyldeoxynivalenol results in increased expression of EIF2AK3 mRNA |
CTD |
PMID:35413383 |
|
NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518
|
|
G |
EIF2S1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of EIF2S1 mRNA 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of EIF2S1 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr14:67,360,328...67,386,516
Ensembl chr14:67,360,328...67,386,516
|
|
G |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
increases expression multiple interactions |
EXP ISO |
3-acetyldeoxynivalenol results in increased expression of ERN1 mRNA 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ERN1 mRNA] |
CTD |
PMID:20682335 PMID:35413383 |
|
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression multiple interactions increases expression |
EXP ISO |
3-acetyldeoxynivalenol results in decreased expression of HSPA5 mRNA 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of HSPA5 mRNA] |
CTD |
PMID:20682335 PMID:35413383 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
IFNB1 |
interferon beta 1 |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of IFNB1 mRNA 3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IFNB1 protein; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IFNB1 protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IFNB1 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
|
|
G |
IFNG |
interferon gamma |
multiple interactions increases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IFNG mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL10 |
interleukin 10 |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of IL10 mRNA 3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL10 protein; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL10 protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL10 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
IL17A |
interleukin 17A |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of IL17A mRNA 3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL17A protein; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL17A protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL17A mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL1A |
interleukin 1 alpha |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of IL1A mRNA 3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL1A protein; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL1A protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL1A mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of IL1B mRNA 3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL1B protein; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL1B protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL1B mRNA] |
CTD |
PMID:24793808 PMID:35413383 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL2 |
interleukin 2 |
affects secretion increases expression |
ISO |
3-acetyldeoxynivalenol affects the secretion of IL2 protein 3-acetyldeoxynivalenol results in increased expression of IL2 mRNA |
CTD |
PMID:8560498 |
|
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL4 |
interleukin 4 |
affects secretion |
ISO |
3-acetyldeoxynivalenol affects the secretion of IL4 protein |
CTD |
PMID:8560498 |
|
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
|
|
G |
IL5 |
interleukin 5 |
affects secretion |
ISO |
3-acetyldeoxynivalenol affects the secretion of IL5 protein |
CTD |
PMID:8560498 |
|
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
|
|
G |
IL6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of IL6 mRNA 3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL6 protein; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of IL6 protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of IL6 mRNA] |
CTD |
PMID:24793808 PMID:35413383 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of MAPK8 mRNA 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of MAPK8 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MPO |
myeloperoxidase |
increases secretion multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased secretion of MPO protein 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased secretion of MPO protein] |
CTD |
PMID:35413383 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
decreases activity |
EXP |
3-acetyldeoxynivalenol results in decreased activity of PPARG protein |
CTD |
PMID:27481073 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
3-acetyldeoxynivalenol results in increased expression of PTGS2 mRNA |
CTD |
PMID:14514436 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
THRB |
thyroid hormone receptor beta |
decreases activity multiple interactions |
EXP |
3-acetyldeoxynivalenol results in decreased activity of THRB protein [15-acetyldeoxynivalenol co-treated with 3-acetyldeoxynivalenol co-treated with deoxynivalenol co-treated with zearalenol co-treated with Zearalenone] results in decreased activity of THRB protein |
CTD |
PMID:27481073 |
|
NCBI chr 3:24,117,153...24,495,708
Ensembl chr 3:24,117,153...24,495,756
|
|
G |
TNF |
tumor necrosis factor |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of TNF mRNA 3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of TNF protein; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of and results in increased secretion of TNF protein]; 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of TNF mRNA] |
CTD |
PMID:24793808 PMID:35413383 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
XBP1 |
X-box binding protein 1 |
increases expression multiple interactions |
ISO |
3-acetyldeoxynivalenol results in increased expression of XBP1 mRNA 4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of XBP1 mRNA] |
CTD |
PMID:35413383 |
|
NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597
|
|